QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||||
☒ | Smaller reporting company | ||||||||||
Emerging growth company |
Page | |||||
June 30, 2022 | December 31, 2021 | ||||||||||
(unaudited) | (restated)(a) | ||||||||||
Assets | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Available-for-sale securities, current | |||||||||||
Accounts receivable, net | |||||||||||
Inventories, net current | |||||||||||
Prepaid expenses and other current assets | |||||||||||
Total current assets | |||||||||||
Available-for-sale securities, non-current | |||||||||||
Internally developed software, net | |||||||||||
Inventories, net non-current | |||||||||||
Property and equipment, net | |||||||||||
Other non-current assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | $ | |||||||||
Accrued expenses | |||||||||||
Deferred revenue, current | |||||||||||
Other current liabilities | |||||||||||
Total current liabilities | |||||||||||
Deferred revenue, non-current | |||||||||||
Warrant liability | |||||||||||
Other non-current liabilities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies (see Note 9) | |||||||||||
Stockholders’ Equity | |||||||||||
Common stock - $ | |||||||||||
Additional paid-in-capital | |||||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Accumulated deficit | ( | ( | |||||||||
Total stockholders’ equity | |||||||||||
Total liabilities and stockholders’ equity | $ | $ |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(restated)(a) | (restated)(a) | |||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||
Hardware | $ | $ | $ | $ | ||||||||||||||||||||||
Software | ||||||||||||||||||||||||||
Installation services | ||||||||||||||||||||||||||
Total revenue | ||||||||||||||||||||||||||
Cost of revenue(b): | ||||||||||||||||||||||||||
Hardware | ||||||||||||||||||||||||||
Software | ||||||||||||||||||||||||||
Installation services | ||||||||||||||||||||||||||
Total cost of revenue | ||||||||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Research and development | ||||||||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||||
Depreciation and amortization | ||||||||||||||||||||||||||
Total operating expenses | ||||||||||||||||||||||||||
Loss from operations | ( | ( | ( | ( | ||||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Change in fair value of derivative liabilities | ( | ( | ||||||||||||||||||||||||
Change in fair value of warrant liability | ( | ( | ||||||||||||||||||||||||
Change in fair value of trading securities | ( | ( | ||||||||||||||||||||||||
Loss on extinguishment of debt | ( | ( | ||||||||||||||||||||||||
Interest expense, net | ( | ( | ( | ( | ||||||||||||||||||||||
Other income (expense), net | ( | ( | ||||||||||||||||||||||||
Total other income (expense), net | ( | ( | ( | |||||||||||||||||||||||
Loss before income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
Provision for income taxes | ||||||||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | ( | ( | ||||||||||||||||||||||||
Foreign currency translation adjustment | ( | ( | ||||||||||||||||||||||||
Comprehensive loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Net loss per common share | ||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Weighted average shares outstanding | ||||||||||||||||||||||||||
Basic and diluted |
Six months ended June 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||
Redeemable Convertible Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
January 1, 2021 (restated) | $ | $ | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||||||||||||||||||
Retroactive application of Exchange Ratio | ( | — | ( | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
January 1, 2021 as adjusted | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Exercises of common stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
March 31, 2021 (restated) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Exercises of common stock options | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Conversion of Convertible Notes | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Conversion of Legacy Latch warrants | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common shares | ( | ( | — | — | |||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net of transaction costs(a) | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
June 30, 2021 (restated) | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||||||
Six months ended June 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Redeemable Convertible Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
January 1, 2022 (restated) | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||
Exercises of common stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon settlement of restricted stock units | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Tax withholdings on settlement of equity awards | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
Transaction costs related to reverse capitalization | — | — | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
March 31, 2022 (restated) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Exercises of common stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon settlement of restricted stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Tax withholdings on settlement of equity awards | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
June 30, 2022 | $ | $ | $ | $ | ( | $ | ( | $ |
Six months ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
(restated)(a) | |||||||||||
Operating activities | |||||||||||
Net loss | $ | ( | $ | ( | |||||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||||
Depreciation and amortization | |||||||||||
Non-cash interest expense | |||||||||||
Change in fair value of derivative liabilities | |||||||||||
Change in fair value of warrant liability | ( | ||||||||||
Change in fair value of trading securities | |||||||||||
Realized gains/losses on available-for-sale securities | |||||||||||
Impairment loss on intangible assets | |||||||||||
Loss on extinguishment of debt | |||||||||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | ( | ||||||||||
Provision for doubtful accounts | |||||||||||
Stock-based compensation | |||||||||||
Changes in assets and liabilities | |||||||||||
Accounts receivable | ( | ( | |||||||||
Inventories, net | ( | ( | |||||||||
Prepaid expenses and other current assets | ( | ||||||||||
Other non-current assets | ( | ( | |||||||||
Accounts payable | |||||||||||
Accrued expenses | |||||||||||
Other current liabilities | ( | ||||||||||
Other non-current liabilities | |||||||||||
Deferred revenue | |||||||||||
Net cash used in operating activities | ( | ( | |||||||||
Investing activities | |||||||||||
Purchase of available-for-sale securities | ( | ||||||||||
Proceeds from maturities and call redemptions | |||||||||||
Purchases of trading securities | ( | ||||||||||
Purchase of property and equipment | ( | ( | |||||||||
Development of internal software | ( | ( | |||||||||
Net cash provided by (used in) investing activities | ( | ||||||||||
Financing activities | |||||||||||
Proceeds from Business Combination and private offering, net of issuance costs | |||||||||||
Repayment of term loan | ( | ||||||||||
Proceeds from issuance of common stock | |||||||||||
Payments for tax withholding on net settlement of equity awards | ( | ||||||||||
Proceeds from revolving credit facility | |||||||||||
Repayment of revolving credit facility | ( | ( | |||||||||
Net cash (used in) provided by financing activities | ( | ||||||||||
Effect of exchange rate on cash | ( | ( | |||||||||
Net change in cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents | |||||||||||
Beginning of period | |||||||||||
End of period | $ | $ | |||||||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||||
Capitalization of stock-based compensation to internally developed software | $ | $ | |||||||||
Accrued issuance costs | $ | $ | |||||||||
Accrued fixed assets | $ | $ | |||||||||
Receivable from option exercises | $ | $ | |||||||||
Private placement warrants received as part of Business Combination | $ | $ | |||||||||
Cash - TSIA trust and cash, net of redemptions | $ | |||||||
Cash - PIPE Investment including cash election funding | ||||||||
Less: transaction costs and advisory fees paid | ( | |||||||
Less: cash election payment, net | ( | |||||||
Less: issuance and other costs paid | ( | |||||||
Net proceeds from Business Combination | ||||||||
Less: Private placement warrants received as part of Business Combination | ( | |||||||
Plus: prepaid expenses received as part of Business Combination | ||||||||
Reverse recapitalization, net of transaction costs | $ |
Three months ended | Three months ended | Six months ended | ||||||||||||||||||
March 31, 2022 | June 30, 2021 | June 30, 2021 | ||||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | ||||||||||||||||||
Adjustments to hardware revenue: | ||||||||||||||||||||
Adjustments to hardware revenue excluding channel partner discounts | $ | $ | ( | $ | ( | |||||||||||||||
Adjustments to hardware revenue - channel partner discounts | ( | ( | ( | |||||||||||||||||
Total | $ | $ | ( | $ | ( |
Adjustments to cost of hardware revenue: | ||||||||||||||||||||
Adjustments to cost of hardware revenue excluding channel partner discounts | $ | $ | ( | $ | ( | |||||||||||||||
Adjustments to cost of hardware revenue - channel partner discounts | ( | ( | ( | |||||||||||||||||
Total | $ | $ | ( | $ | ( |
Three months ended | Three months ended | Six months ended | ||||||||||||||||||
March 31, 2022 | June 30, 2021 | June 30, 2021 | ||||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | ||||||||||||||||||
Access related | $ | ( | $ | ( | $ | ( | ||||||||||||||
Other | ( | ( | ( | |||||||||||||||||
Total | $ | ( | $ | ( | $ | ( |
Latch, Inc. and Subsidiaries | ||||||||||||||||||||||||||
Comparison of previously reported and restated Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||||||||
(unaudited) | ||||||||||||||||||||||||||
Previously Reported | Adjustments | Category Reference(a) | Restated | |||||||||||||||||||||||
Revenue | ||||||||||||||||||||||||||
Hardware | $ | $ | HW | $ | ||||||||||||||||||||||
Software | ( | SW | ||||||||||||||||||||||||
Installation services | ||||||||||||||||||||||||||
Total revenue | ( | |||||||||||||||||||||||||
Cost of revenue(b) | ||||||||||||||||||||||||||
Hardware | HW1, OC1, SBC1 | |||||||||||||||||||||||||
Software | SW2, OC2 | |||||||||||||||||||||||||
Installation services | OC | |||||||||||||||||||||||||
Total cost of revenue | ||||||||||||||||||||||||||
Operating expenses | ||||||||||||||||||||||||||
Research and development | OC3, IDS3, SBC3 | |||||||||||||||||||||||||
Sales and marketing | OC4, SBC4 | |||||||||||||||||||||||||
General and administrative | HW5, SW5, OC5, RC5, SBC5 | |||||||||||||||||||||||||
Depreciation and amortization | ( | RC6, IDS6 | ||||||||||||||||||||||||
Total operating expenses | ||||||||||||||||||||||||||
Loss from operations | ( | ( | ( | |||||||||||||||||||||||
Other income, net | ||||||||||||||||||||||||||
Change in fair value of warrant liability | ||||||||||||||||||||||||||
Change in fair value of trading securities | ||||||||||||||||||||||||||
Interest income (expense), net | ( | SW | ( | |||||||||||||||||||||||
Other expense, net | ( | ( | ||||||||||||||||||||||||
Total other income, net | ||||||||||||||||||||||||||
Loss before income taxes | ( | ( | ( | |||||||||||||||||||||||
Provision for income taxes | ||||||||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | ( | ( | ||||||||||||||||||||||||
Foreign currency translation adjustment | ||||||||||||||||||||||||||
Comprehensive loss | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||
Net loss per common share: | ||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||||||||
Basic and diluted |
Latch, Inc. and Subsidiaries | ||||||||||||||||||||
Comparison of previously reported and restated Condensed Consolidated Statements of Cash Flows | ||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Previously Reported | Adjustments | Restated | ||||||||||||||||||
Operating activities | ||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | ||||||||||||||
Adjustments to reconcile net loss to net cash used by operating activities | ||||||||||||||||||||
Depreciation and amortization | ( | |||||||||||||||||||
Non-cash interest expense | ( | |||||||||||||||||||
Change in fair value of warrant liability | ( | ( | ||||||||||||||||||
Change in fair value of trading securities | ( | ( | ||||||||||||||||||
Impairment loss on internally developed software | ||||||||||||||||||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | ( | ( | ||||||||||||||||||
(Reversal) provision for doubtful accounts | ( | |||||||||||||||||||
Stock-based compensation expense | ||||||||||||||||||||
Changes in assets and liabilities | ||||||||||||||||||||
Accounts receivable | ( | ( | ( | |||||||||||||||||
Inventories, net | ( | ( | ||||||||||||||||||
Prepaid expenses and other current assets | ( | |||||||||||||||||||
Other non-current assets | ( | ( | ||||||||||||||||||
Accounts payable | ( | ( | ( | |||||||||||||||||
Accrued expenses | ||||||||||||||||||||
Other current liabilities | ( | ( | ||||||||||||||||||
Other non-current liabilities | ||||||||||||||||||||
Deferred revenue | ( | |||||||||||||||||||
Net cash (used in) provided by operating activities | ( | ( | ||||||||||||||||||
Investing activities | ||||||||||||||||||||
Purchase of available-for-sale securities | ( | ( | ||||||||||||||||||
Proceeds from maturities of available-for-sale securities | ||||||||||||||||||||
Purchases of trading securities | ( | ( | ||||||||||||||||||
Purchase of property and equipment | ( | ( | ( | |||||||||||||||||
Capitalized internally-developed software | ( | ( | ||||||||||||||||||
Net cash provided by (used in) investing activities | ( | |||||||||||||||||||
Financing activities | ||||||||||||||||||||
Proceeds from issuance of common stock | ( | |||||||||||||||||||
Payments for tax withholding on net settlement of equity awards | ( | ( | ||||||||||||||||||
Proceeds from revolving credit facility | ||||||||||||||||||||
Repayment of revolving credit facility | ( | ( | ||||||||||||||||||
Net cash used in financing activities | ( | ( | ( | |||||||||||||||||
Effect of exchange rates on cash | ( | ( | ||||||||||||||||||
Net change in cash and cash equivalents | ( | ( | ||||||||||||||||||
Cash and cash equivalents | ||||||||||||||||||||
Beginning of year | ||||||||||||||||||||
End of period | $ | $ | $ | |||||||||||||||||
Supplemental disclosure of non-cash investing and financing activities | ||||||||||||||||||||
Capitalization of stock-based compensation to internally-developed software | $ | $ | ( | $ | ||||||||||||||||
Accrued issuance costs | $ | $ | $ | |||||||||||||||||
Accrued fixed assets | $ | $ | ( | $ |
Latch, Inc. and Subsidiaries | ||||||||||||||||||||||||||
Comparison of previously reported and restated Consolidated Balance Sheet | ||||||||||||||||||||||||||
As of December 31, 2021 | ||||||||||||||||||||||||||
Previously Reported | Adjustments | Category Reference(a) | Restated | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Current assets | ||||||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | |||||||||||||||||||||||
Available-for-sale securities, current | ||||||||||||||||||||||||||
Accounts receivable, net | ( | HW1, SW1, RC1 | ||||||||||||||||||||||||
Inventories, net | HW2, OC2 | |||||||||||||||||||||||||
Prepaid expenses and other current assets | HW3, SW3, OC3, RC3 | |||||||||||||||||||||||||
Total current assets | ( | |||||||||||||||||||||||||
Available-for-sale securities, non-current | ||||||||||||||||||||||||||
Property and equipment, net | ||||||||||||||||||||||||||
Internally-developed software, net | ( | IDS | ||||||||||||||||||||||||
Other non-current assets | ( | OC | ||||||||||||||||||||||||
Total assets | $ | $ | ( | $ | ||||||||||||||||||||||
Liabilities and Stockholders’ Equity | ||||||||||||||||||||||||||
Current liabilities | ||||||||||||||||||||||||||
Accounts payable | $ | $ | HW4, OC4 | $ | ||||||||||||||||||||||
Accrued expenses | HW5, OC5 | |||||||||||||||||||||||||
Deferred revenue, current | HW6, SW6 | |||||||||||||||||||||||||
Other current liabilities | OC | |||||||||||||||||||||||||
Total current liabilities | ||||||||||||||||||||||||||
Deferred revenue, non-current | ( | HW7, SW7 | ||||||||||||||||||||||||
Warrant liability | ||||||||||||||||||||||||||
Total liabilities | ||||||||||||||||||||||||||
Commitments and contingencies (see Note 9) | ||||||||||||||||||||||||||
Stockholders’ Equity | ||||||||||||||||||||||||||
Common stock, $ | ( | OC | ||||||||||||||||||||||||
Additional paid-in capital | ( | HW9, SBC9 | ||||||||||||||||||||||||
Accumulated other comprehensive loss | ( | ( | ||||||||||||||||||||||||
Accumulated deficit | ( | ( | ( | |||||||||||||||||||||||
Total stockholders’ equity | ( | |||||||||||||||||||||||||
Total liabilities and stockholders’ equity | $ | $ | ( | $ |
Latch, Inc. and Subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||||
Comparison of previously reported and restated Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||||||||||||||||||||||||||||||||||||||||||||
Three months ended June 30, 2021 | Six months ended June 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
(unaudited) | (unaudited) | |||||||||||||||||||||||||||||||||||||||||||||||||
Previously Reported | Adjustments | Category Reference(a) | Restated | Previously Reported | Adjustments | Category Reference(a) | Restated | |||||||||||||||||||||||||||||||||||||||||||
Revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||
Hardware | $ | $ | ( | HW | $ | $ | $ | ( | HW | $ | ||||||||||||||||||||||||||||||||||||||||
Software | ( | SW | ( | SW | ||||||||||||||||||||||||||||||||||||||||||||||
Installation services | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total revenue | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Cost of revenue(b) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Hardware | ( | HW1, OC1, SBC1 | ( | HW6, OC6, SBC6 | ||||||||||||||||||||||||||||||||||||||||||||||
Software | SW2, OC2 | SW7, OC7 | ||||||||||||||||||||||||||||||||||||||||||||||||
Installation services | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total cost of revenue | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Research and development | OC3, IDS3, SBC3 | OC8, IDS8, SBC8 | ||||||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing | OC4, SBC4 | OC9, SBC9 | ||||||||||||||||||||||||||||||||||||||||||||||||
General and administrative | HW5, SW5, OC5, SBC5 | HW10, SW10, OC10, SBC10 | ||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization | ( | IDS | IDS | |||||||||||||||||||||||||||||||||||||||||||||||
Total operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Loss from operations | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||||||||||||||||||||||||||
Change in fair value of derivative liabilities | ( | ( | ( | OC | ( | |||||||||||||||||||||||||||||||||||||||||||||
Change in fair value of warrant liability | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Interest income (expense), net | ( | SW | ( | ( | SW | ( | ||||||||||||||||||||||||||||||||||||||||||||
Other income, net | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total other income (expense), net | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Loss before income taxes | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Provision for income taxes | OC | OC | ||||||||||||||||||||||||||||||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment | ( | ( |
Comprehensive loss | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
Net loss per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Basic and diluted |
Latch, Inc. and Subsidiaries | ||||||||||||||||||||
Comparison of previously reported and restated Condensed Consolidated Statements of Cash Flows | ||||||||||||||||||||
Six months ended June 30, 2021 | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Previously Reported | Adjustments | Restated | ||||||||||||||||||
Operating activities | ||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | ||||||||||||||
Adjustments to reconcile net loss to net cash used by operating activities | ||||||||||||||||||||
Depreciation and amortization | ||||||||||||||||||||
Non-cash interest expense | ||||||||||||||||||||
Change in fair value of derivative liabilities | ( | |||||||||||||||||||
Change in fair value of warrant liability | ||||||||||||||||||||
Loss on extinguishment of debt | ||||||||||||||||||||
Provision for excess and obsolete inventory | ||||||||||||||||||||
Provision for doubtful accounts | ||||||||||||||||||||
Stock-based compensation expense | ||||||||||||||||||||
Changes in assets and liabilities | ||||||||||||||||||||
Accounts receivable | ( | ( | ||||||||||||||||||
Inventories, net | ( | ( | ( | |||||||||||||||||
Prepaid expenses and other current assets | ( | |||||||||||||||||||
Other non-current assets | ( | ( | ||||||||||||||||||
Accounts payable | ||||||||||||||||||||
Accrued expenses | ( | |||||||||||||||||||
Other current liabilities | ||||||||||||||||||||
Other non-current liabilities | ( | |||||||||||||||||||
Deferred revenue | ||||||||||||||||||||
Net cash used in operating activities | ( | ( | ( | |||||||||||||||||
Investing activities | ||||||||||||||||||||
Purchase of property and equipment | ( | ( | ( | |||||||||||||||||
Capitalized internally-developed software | ( | ( | ||||||||||||||||||
Net cash (used in) provided by investing activities | ( | ( | ||||||||||||||||||
Financing activities | ||||||||||||||||||||
Proceeds from Business Combination and private offering, net of issuance costs | ( | |||||||||||||||||||
Repayment of term loan | ( | ( | ||||||||||||||||||
Proceeds from issuance of common stock | ||||||||||||||||||||
Proceeds from revolving credit facility | ||||||||||||||||||||
Repayment of revolving credit facility | ( | ( | ||||||||||||||||||
Net cash provided by financing activities | ||||||||||||||||||||
Effect of exchange rates on cash | ( | ( | ||||||||||||||||||
Net change in cash and cash equivalents | ||||||||||||||||||||
Cash and cash equivalents | ||||||||||||||||||||
Beginning of year | ||||||||||||||||||||
End of period | $ | $ | $ | |||||||||||||||||
Supplemental disclosure of non-cash investing and financing activities | ||||||||||||||||||||
Capitalization of stock-based compensation to internally-developed software | $ | $ | ( | $ | ||||||||||||||||
Accrued issuance costs | $ | $ | $ | |||||||||||||||||
Accrued fixed assets | $ | $ | ( | $ | ||||||||||||||||
Private placement warrants received as part of Business Combination | $ | $ | $ | |||||||||||||||||
Prepaid expense received as part of Business Combination | $ | $ | $ |
Balance as of January 1, 2022 (restated) | $ | |||||||
Provision for doubtful accounts | ||||||||
Balance as of June 30, 2022 | $ |
Useful life in years | ||||||||
Office furniture | ||||||||
Computers and equipment |
June 30, 2022 | December 31, 2021 | |||||||||||||
Assembled workforce | $ | $ | ||||||||||||
Domain names | ||||||||||||||
Patents | ||||||||||||||
Other intangibles | ||||||||||||||
Intangible assets | ||||||||||||||
Less: accumulated amortization | ( | ( | ||||||||||||
Total intangible assets, net | $ | $ |
Useful life in years | ||||||||
Assembled workforce | ||||||||
Domain names | ||||||||
Patents | ||||||||
Other intangibles |
Balance as of January 1, 2022 (restated) | $ | ||||
Additions to deferred contract costs | |||||
Amortization of deferred contract costs | ( | ||||
Balance as of June 30, 2022 | $ |
June 30, 2022 | December 31, 2021 | ||||||||||
(restated) | |||||||||||
Contract assets (unbilled receivables) | $ | $ | |||||||||
Contract liabilities (deferred revenue) | $ | $ |
As of June 30, 2022 | ||||||||||||||||||||
Amortized Cost | Gross Unrealized Loss | Estimated Fair Value | ||||||||||||||||||
Asset backed securities | $ | $ | ( | $ | ||||||||||||||||
Commercial paper and corporate bonds | ( | |||||||||||||||||||
U.S. government agency debt securities | ( | |||||||||||||||||||
Total available-for-sale securities | $ | $ | ( | $ |
As of December 31, 2021 | ||||||||||||||||||||
Amortized Cost | Gross Unrealized Loss | Estimated Fair Value | ||||||||||||||||||
Asset-backed securities | $ | $ | ( | $ | ||||||||||||||||
Commercial paper and corporate bonds | ( | |||||||||||||||||||
U.S. government agency debt securities | ( | |||||||||||||||||||
Total available-for-sale securities | $ | $ | ( | $ |
As of June 30, 2022 | ||||||||||||||
Amortized Cost | Estimated Fair Value | |||||||||||||
Due in less than one year | $ | $ | ||||||||||||
Due in one to five years | ||||||||||||||
Total investments | $ | $ |
As of June 30, 2022 | |||||||||||||||||||||||
Fair Value Measurements Using | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash | $ | $ | $ | $ | |||||||||||||||||||
Money market funds and other cash equivalents | |||||||||||||||||||||||
Total cash and cash equivalents | |||||||||||||||||||||||
Available-for-sale securities | |||||||||||||||||||||||
Trading securities | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Warrant liability | |||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
As of December 31, 2021 | |||||||||||||||||||||||
Fair Value Measurements Using | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash | $ | $ | $ | $ | |||||||||||||||||||
Money market funds | |||||||||||||||||||||||
Total cash and cash equivalents | |||||||||||||||||||||||
Available-for-sale securities | |||||||||||||||||||||||
Trading securities | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Warrant liability | |||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
Trading Securities | ||||||||
Balance at December 31, 2021 | $ | |||||||
Purchases | ||||||||
Change in fair value(a) | ( | |||||||
Balance at June 30, 2022 | $ |
June 30, 2022 | December 31, 2021 | ||||||||||
(restated) | |||||||||||
Raw materials | $ | $ | |||||||||
Finished goods | |||||||||||
Channel inventory | |||||||||||
Excess and obsolete inventory reserve | ( | ( | |||||||||
Total current inventories, net | |||||||||||
Finished goods - non-current | |||||||||||
Total inventories, net | $ | $ |
June 30, 2022 | December 31, 2021 | ||||||||||
(restated) | |||||||||||
Internally-developed software | $ | $ | |||||||||
Software-in-development | |||||||||||
Less: Accumulated amortization | ( | ( | |||||||||
Total internally-developed software, net | $ | $ |
June 30, 2022 | December 31, 2021 | ||||||||||
(restated) | |||||||||||
Accrued compensation | $ | $ | |||||||||
Accrued warranties | |||||||||||
Accrued purchases | |||||||||||
Accrued non-cancellable purchase commitments | |||||||||||
Accrued operating expense | |||||||||||
Accrued litigation costs | |||||||||||
Accrued restructuring costs | |||||||||||
Other accrued expenses | |||||||||||
Total accrued expenses | $ | $ |
June 30, 2022 | December 31, 2021(1) | |||||||||||||
Stock options issued and outstanding | ||||||||||||||
Restricted stock units issued and outstanding | ||||||||||||||
Public warrants outstanding | ||||||||||||||
Private placement warrants outstanding | ||||||||||||||
2021 Incentive Award Plan available shares | ||||||||||||||
Total |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(restated) | (restated) | |||||||||||||||||||||||||
Net loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Basic weighted-average common shares | ||||||||||||||||||||||||||
Effect of dilutive securities | ||||||||||||||||||||||||||
Diluted weighted-average common shares | ||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | ( | $ | ( | $ | ( | $ | ( |
June 30, 2022 | December 31, 2021 | |||||||||||||
(restated) | ||||||||||||||
Stock options | ||||||||||||||
Restricted stock units(1) | ||||||||||||||
Warrants | ||||||||||||||
Total |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(restated) | (restated) | |||||||||||||||||||||||||
Stock options | $ | $ | $ | $ | ||||||||||||||||||||||
Restricted stock units | ||||||||||||||||||||||||||
Capitalized costs (1) | ( | ( | ( | |||||||||||||||||||||||
Total stock-based compensation expense | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(restated) | (restated) | |||||||||||||||||||||||||
Cost of revenue | $ | $ | $ | $ | ||||||||||||||||||||||
Research and development | ||||||||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||||
Total stock-based compensation expense | $ | $ | $ | $ |
Options Outstanding | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | ||||||||||||||||||||
Balance at December 31, 2021(1) | $ | ||||||||||||||||||||||
Options forfeited | ( | $ | |||||||||||||||||||||
Options expired | ( | $ | |||||||||||||||||||||
Options exercised | ( | $ | |||||||||||||||||||||
Balance at June 30, 2022 | $ | $ | |||||||||||||||||||||
Exercisable at June 30, 2022 | $ | $ |
Number of RSUs | Weighted Average Grant Date Fair Value (per unit) | |||||||||||||
Balance at December 31, 2021 | $ | |||||||||||||
Granted | $ | |||||||||||||
Vested | ( | $ | ||||||||||||
Forfeited | ( | $ | ||||||||||||
Balance at June 30, 2022 | $ |
Number of RSUs | ||||||||
Balance at December 31, 2021 | ||||||||
Granted | ||||||||
Vested | ( | |||||||
Forfeited | ||||||||
Balance at June 30, 2022 |
Share Price Threshold | Percent of Consideration Shares Released | |||||||
$ | ||||||||
$ | ||||||||
$ | ||||||||
$ |
Earned Tranche | Shares Subject to the Performance Option | Share Price Hurdle | ||||||
1 | $ | |||||||
2 | $ | |||||||
3 | $ |
Three months ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | $ Change | % Change(a) | |||||||||||||||||||||||
(restated) | ||||||||||||||||||||||||||
GAAP Measures: | ||||||||||||||||||||||||||
Software revenue | $ | 3,239 | $ | 1,627 | $ | 1,612 | 99 | % | ||||||||||||||||||
Total revenue | $ | 9,830 | $ | 6,745 | $ | 3,085 | 46 | % | ||||||||||||||||||
Net loss | $ | (51,616) | $ | (41,485) | $ | (10,131) | 24 | % | ||||||||||||||||||
Non-GAAP Measure: | ||||||||||||||||||||||||||
Adjusted EBITDA | $ | (35,584) | $ | (18,543) | $ | (17,041) | (92 | %) |
Six months ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | $ Change | % Change(a) | |||||||||||||||||||||||
(restated) | ||||||||||||||||||||||||||
GAAP Measures: | ||||||||||||||||||||||||||
Software revenue | $ | 5,946 | $ | 3,104 | $ | 2,842 | 92 | % | ||||||||||||||||||
Total revenue | $ | 23,386 | $ | 11,719 | $ | 11,667 | 100 | % | ||||||||||||||||||
Net loss | $ | (98,448) | $ | (80,041) | $ | (18,407) | 23 | % | ||||||||||||||||||
Non-GAAP Measure: | ||||||||||||||||||||||||||
Adjusted EBITDA | $ | (75,214) | $ | (33,116) | $ | (42,098) | (127 | %) |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(restated) | (restated) | |||||||||||||||||||||||||
Net loss | $ | (51,616) | $ | (41,485) | $ | (98,448) | $ | (80,041) | ||||||||||||||||||
Depreciation and amortization | 1,381 | 678 | 2,511 | 1,345 | ||||||||||||||||||||||
Interest expense, net(a) | 1,263 | 2,864 | 2,100 | 6,177 | ||||||||||||||||||||||
Provision for income taxes | 17 | 34 | 34 | 34 | ||||||||||||||||||||||
Loss on extinguishment of debt | — | 1,469 | — | 1,469 | ||||||||||||||||||||||
Change in fair value of derivative liabilities | — | 8,991 | — | 12,512 | ||||||||||||||||||||||
Change in fair value of warrant liability | (2,699) | 4,795 | (8,966) | 4,795 | ||||||||||||||||||||||
Change in fair value of trading securities | 2,500 | — | 1,500 | — | ||||||||||||||||||||||
Restructuring costs(b) | 6,226 | — | 6,226 | — | ||||||||||||||||||||||
Transaction-related costs(c) | 156 | 3,543 | 510 | 5,641 | ||||||||||||||||||||||
Non-ordinary course legal fees and settlement reserves(d) | 30 | — | 43 | — | ||||||||||||||||||||||
Stock-based compensation expense(e) | 7,158 | 568 | 19,276 | 14,952 | ||||||||||||||||||||||
Adjusted EBITDA | $ | (35,584) | $ | (18,543) | $ | (75,214) | $ | (33,116) |
Three months ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | |||||||||||||||||||||||
(in thousands, except share and per share data) | (restated)(a) | |||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||
Hardware | $ | 4,710 | $ | 4,948 | $ | (238) | (4.8 | %) | ||||||||||||||||||
Software | 3,239 | 1,627 | 1,612 | 99.1 | % | |||||||||||||||||||||
Installation services | 1,881 | 170 | 1,711 | 1006.5 | % | |||||||||||||||||||||
Total revenue | 9,830 | 6,745 | 3,085 | 45.7 | % | |||||||||||||||||||||
Cost of revenue(b): | ||||||||||||||||||||||||||
Hardware | 11,003 | 6,001 | 5,002 | 83.4 | % | |||||||||||||||||||||
Software | 334 | 174 | 160 | 92.0 | % | |||||||||||||||||||||
Installation services | 1,743 | 502 | 1,241 | 247.2 | % | |||||||||||||||||||||
Total cost of revenue | 13,080 | 6,677 | 6,403 | 95.9 | % | |||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Research and development | 16,710 | 7,063 | 9,647 | 136.6 | % | |||||||||||||||||||||
Sales and marketing | 16,824 | 5,097 | 11,727 | 230.1 | % | |||||||||||||||||||||
General and administrative | 12,341 | 10,585 | 1,756 | 16.6 | % | |||||||||||||||||||||
Depreciation and amortization | 1,381 | 678 | 703 | 103.7 | % | |||||||||||||||||||||
Total operating expenses | 47,256 | 23,423 | 23,833 | 101.8 | % | |||||||||||||||||||||
Loss from operations | (50,506) | (23,355) | (27,151) | 116.3 | % | |||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Change in fair value of derivative liabilities | — | (8,991) | 8,991 | (100.0 | %) | |||||||||||||||||||||
Change in fair value of warrant liability | 2,699 | (4,795) | 7,494 | 156.3 | % | |||||||||||||||||||||
Change in fair value of trading securities | (2,500) | — | (2,500) | N.M. | ||||||||||||||||||||||
Loss on extinguishment of debt | — | (1,469) | 1,469 | N.M. | ||||||||||||||||||||||
Interest expense, net | (1,263) | (2,864) | 1,601 | (55.9 | %) | |||||||||||||||||||||
Other income (expense), net | (29) | 23 | (52) | N.M. | ||||||||||||||||||||||
Total other income (expense), net | (1,093) | (18,096) | 17,003 | (94.0 | %) | |||||||||||||||||||||
Loss before income taxes | (51,599) | (41,451) | (10,148) | (24.5 | %) | |||||||||||||||||||||
Provision for income taxes | 17 | 34 | (17) | (50.0 | %) | |||||||||||||||||||||
Net loss | $ | (51,616) | $ | (41,485) | $ | (10,131) | 24.4 | % | ||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | (281) | — | (281) | N.M. | ||||||||||||||||||||||
Foreign currency translation adjustment | (1) | 2 | (3) | (150.0 | %) | |||||||||||||||||||||
Comprehensive loss | $ | (51,898) | $ | (41,483) | $ | (10,415) | 25.1 | % | ||||||||||||||||||
Net loss per common share | ||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | (0.36) | $ | (0.81) | $ | 0.45 | (55.6 | %) | ||||||||||||||||||
Weighted average shares outstanding | ||||||||||||||||||||||||||
Basic and diluted | 143,253,837 | 51,256,111 |
Six months ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | |||||||||||||||||||||||
(in thousands, except share and per share data) | (restated)(a) | |||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||
Hardware | $ | 13,998 | $ | 8,445 | $ | 5,553 | 65.8 | % | ||||||||||||||||||
Software | 5,946 | 3,104 | 2,842 | 91.6 | % | |||||||||||||||||||||
Installation services | 3,442 | 170 | 3,272 | 1924.7 | % | |||||||||||||||||||||
Total revenue | 23,386 | 11,719 | 11,667 | 99.6 | % | |||||||||||||||||||||
Cost of revenue(b): | ||||||||||||||||||||||||||
Hardware | 22,852 | 10,825 | 12,027 | 111.1 | % | |||||||||||||||||||||
Software | 661 | 308 | 353 | 114.6 | % | |||||||||||||||||||||
Installation services | 3,511 | 502 | 3,009 | 599.4 | % | |||||||||||||||||||||
Total cost of revenue | 27,024 | 11,635 | 15,389 | 132.3 | % | |||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Research and development | 35,532 | 16,905 | 18,627 | 110.2 | % | |||||||||||||||||||||
Sales and marketing | 34,247 | 8,872 | 25,375 | 286.0 | % | |||||||||||||||||||||
General and administrative | 27,821 | 28,100 | (279) | (1.0) | % | |||||||||||||||||||||
Depreciation and amortization | 2,511 | 1,345 | 1,166 | 86.7 | % | |||||||||||||||||||||
Total operating expenses | 100,111 | 55,222 | 44,889 | 81.3 | % | |||||||||||||||||||||
Loss from operations | (103,749) | (55,138) | (48,611) | 88.2 | % | |||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Change in fair value of derivative liabilities | — | (12,512) | 12,512 | (100.0) | % | |||||||||||||||||||||
Change in fair value of warrant liability | 8,966 | (4,795) | 13,761 | 287.0 | % | |||||||||||||||||||||
Change in fair value of trading securities | (1,500) | — | (1,500) | N.M. | ||||||||||||||||||||||
Loss on extinguishment of debt | — | (1,469) | 1,469 | (100.0) | % | |||||||||||||||||||||
Interest expense, net | (2,100) | (6,177) | 4,077 | (66.0) | % | |||||||||||||||||||||
Other income (expense), net | (31) | 84 | (115) | (136.9) | % | |||||||||||||||||||||
Total other income (expense), net | 5,335 | (24,869) | 30,204 | (121.5) | % | |||||||||||||||||||||
Loss before income taxes | (98,414) | (80,007) | (18,407) | 23.0 | % | |||||||||||||||||||||
Provision for income taxes | 34 | 34 | — | — | % | |||||||||||||||||||||
Net loss | $ | (98,448) | $ | (80,041) | $ | (18,407) | 23.0 | % | ||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | (1,899) | — | (1,899) | N.M. | ||||||||||||||||||||||
Foreign currency translation adjustment | 1 | (5) | 6 | 120.0 | % | |||||||||||||||||||||
Comprehensive loss | $ | (100,346) | $ | (80,046) | $ | (20,300) | 25.4 | % | ||||||||||||||||||
Net loss per common share | ||||||||||||||||||||||||||
Basic and diluted net loss per common share | $ | (0.69) | $ | (2.59) | $ | 1.90 | (73.4) | % | ||||||||||||||||||
Weighted average shares outstanding | ||||||||||||||||||||||||||
Basic and diluted | 142,615,560 | 30,960,173 |
Six months ended June 30, | ||||||||||||||
2022 | 2021 | |||||||||||||
(restated) | ||||||||||||||
Net cash used in operating activities | $ | (83,464) | $ | (33,187) | ||||||||||
Net cash provided by (used in) investing activities | 44,883 | (4,040) | ||||||||||||
Net cash (used in) provided by financing activities | (5,596) | 448,702 | ||||||||||||
Effect of exchange rates on cash | (7) | (5) | ||||||||||||
Net change in cash and cash equivalents | $ | (44,184) | $ | 411,470 |
Incorporated by Reference | ||||||||||||||||||||||||||
Exhibit | Exhibit Description | Form | Exhibit | Filing Date | ||||||||||||||||||||||
2.1* | S-4/A | 2.1 | 5/12/2021 | |||||||||||||||||||||||
2.2 | 8-K | 2.1 | 5/16/2023 | |||||||||||||||||||||||
2.3 | ||||||||||||||||||||||||||
2.4* | 8-K | 2.1 | 6/24/2024 | |||||||||||||||||||||||
3.1 | 8-K | 3.1 | 6/10/2021 | |||||||||||||||||||||||
3.2 | 8-K | 3.2 | 6/10/2021 | |||||||||||||||||||||||
4.1 | 8-K | 4.1 | 5/16/2023 | |||||||||||||||||||||||
4.2 | 8-K | 4.1 | 4/15/2024 | |||||||||||||||||||||||
31.1 | ||||||||||||||||||||||||||
31.2 | ||||||||||||||||||||||||||
32.1 | ||||||||||||||||||||||||||
32.2 | ||||||||||||||||||||||||||
101 | The following financial information from Latch, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline XBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets - Unaudited, (ii) the Condensed Consolidated Statements of Operations and Comprehensive Loss - Unaudited, (iii) the Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - Unaudited, (iv) the Condensed Consolidated Statements of Cash Flows - Unaudited and (v) the Notes to Condensed Consolidated Financial Statements - Unaudited (submitted electronically herewith). | |||||||||||||||||||||||||
104 | Cover Page Interactive Data File, formatted in Inline XBRL (included as Exhibit 101). |
LATCH, INC. | |||||
By: | /s/ Jason Keyes | ||||
Jason Keyes | |||||
Interim Chief Executive Officer | |||||
December 19, 2024 | |||||
By: | /s/ Marc Landy | ||||
Marc Landy | |||||
Interim Chief Financial Officer | |||||
December 19, 2024 |
LATCH, INC. | ||||||||
By: | /s/ Priyen Patel | |||||||
Name: Priyen Patel | ||||||||
Title: General Counsel and Secretary | ||||||||
LS KEY MERGER SUB 1, INC. | ||||||||
By: | /s/ Priyen Patel | |||||||
Name: Priyen Patel | ||||||||
Title: Secretary | ||||||||
LS KEY MERGER SUB 2, LLC | ||||||||
By: | /s/ Priyen Patel | |||||||
Name: Priyen Patel | ||||||||
Title: Secretary | ||||||||
HONEST DAY’S WORK, INC. | ||||||||
By: | /s/ James Siminoff | |||||||
Name: James Siminoff | ||||||||
Title: Chief Executive Officer |
Date: December 19, 2024 | LATCH, INC. | ||||
/s/ Jason Keyes | |||||
Jason Keyes Interim Chief Executive Officer (Principal Executive Officer) |
Date: December 19, 2024 | LATCH, INC. | ||||
/s/ Marc Landy | |||||
Marc Landy Interim Chief Financial Officer (Principal Financial Officer) |
Date: December 19, 2024 | LATCH, INC. | ||||
/s/ Jason Keyes | |||||
Jason Keyes Interim Chief Executive Officer (Principal Executive Officer) |
Date: December 19, 2024 | LATCH, INC. | ||||
/s/ Marc Landy | |||||
Marc Landy Interim Chief Financial Officer (Principal Financial Officer) |
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 04, 2021 |
||||
---|---|---|---|---|---|---|---|
Statement of Financial Position [Abstract] | |||||||
Common stock, par value (in dollars per share) | $ 0.0001 | [1] | $ 0.0001 | [1] | $ 0.0001 | ||
Common stock, authorized (in shares) | 1,000,000,000 | [1] | 1,000,000,000 | [1] | 1,000,000,000.0 | ||
Common stock, outstanding (in shares) | 144,086,282 | [1] | 141,585,530 | [1] | 140,500,000 | ||
Common stock, issued (in shares) | 144,086,282 | [1] | 141,585,530 | [1] | 140,500,000 | ||
Shares subject to vesting restrictions (in shares) | 738,000 | 738,000 | 738,000 | ||||
|
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
[1] | Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
[1] | |||||||||
Revenue: | ||||||||||||||||
Total revenue | $ 9,830 | $ 13,556 | $ 6,745 | $ 23,386 | $ 11,719 | |||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 13,080 | [2] | 13,944 | 6,677 | [2] | 27,024 | [2] | 11,635 | [2] | |||||||
Operating expenses: | ||||||||||||||||
Research and development | 16,710 | 18,822 | 7,063 | 35,532 | 16,905 | |||||||||||
Sales and marketing | 16,824 | 17,423 | 5,097 | 34,247 | 8,872 | |||||||||||
General and administrative | 12,341 | 15,480 | 10,585 | 27,821 | 28,100 | |||||||||||
Depreciation and amortization | 1,381 | 1,130 | 678 | 2,511 | 1,345 | [3] | ||||||||||
Total operating expenses | 47,256 | 52,855 | 23,423 | 100,111 | 55,222 | |||||||||||
Loss from operations | (50,506) | (53,243) | (23,355) | (103,749) | (55,138) | |||||||||||
Other income (expense), net | ||||||||||||||||
Change in fair value of derivative liabilities | 0 | (8,991) | 0 | (12,512) | [3] | |||||||||||
Change in fair value of warrant liability | 2,699 | 6,267 | (4,795) | 8,966 | (4,795) | [3] | ||||||||||
Change in fair value of trading securities | (2,500) | 1,000 | 0 | (1,500) | 0 | [3] | ||||||||||
Loss on extinguishment of debt | 0 | (1,469) | 0 | (1,469) | [3] | |||||||||||
Interest expense, net | (1,263) | (837) | (2,864) | (2,100) | (6,177) | |||||||||||
Other income (expense), net | (29) | (2) | 23 | (31) | 84 | |||||||||||
Total other income (expense), net | (1,093) | 6,428 | (18,096) | 5,335 | (24,869) | |||||||||||
Loss before income taxes | (51,599) | (46,815) | (41,451) | (98,414) | (80,007) | |||||||||||
Provision for income taxes | 17 | 17 | 34 | 34 | 34 | |||||||||||
Net loss | (51,616) | (46,832) | (41,485) | $ (38,556) | (98,448) | (80,041) | [3] | |||||||||
Other comprehensive loss | ||||||||||||||||
Unrealized loss on available-for-sale securities | (281) | (1,618) | 0 | (1,899) | 0 | |||||||||||
Foreign currency translation adjustment | (1) | 2 | 2 | $ (7) | 1 | (5) | ||||||||||
Comprehensive loss | $ (51,898) | $ (48,448) | $ (41,483) | $ (100,346) | $ (80,046) | |||||||||||
Net loss per common share | ||||||||||||||||
Basic net loss per common share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | $ (0.69) | $ (2.59) | |||||||||||
Diluted net loss per common share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | $ (0.69) | $ (2.59) | |||||||||||
Weighted average shares outstanding | ||||||||||||||||
Basic weighted average shares outstanding (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | 142,615,560 | 30,960,173 | |||||||||||
Diluted weighted average shares outstanding (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | 142,615,560 | 30,960,173 | |||||||||||
Hardware | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | $ 4,710 | $ 9,288 | $ 4,948 | $ 13,998 | $ 8,445 | |||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 11,003 | [2] | 11,849 | 6,001 | [2] | 22,852 | [2] | 10,825 | [2] | |||||||
Software | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 3,239 | 2,707 | 1,627 | 5,946 | 3,104 | |||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 334 | [2] | 327 | 174 | [2] | 661 | [2] | 308 | [2] | |||||||
Installation services | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 1,881 | 1,561 | 170 | 3,442 | 170 | |||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | $ 1,743 | [2] | $ 1,768 | $ 502 | [2] | $ 3,511 | [2] | $ 502 | [2] | |||||||
|
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Previously Reported |
Revision of Prior Period, Adjustment |
Common Stock |
Common Stock
Previously Reported
|
Common Stock
Revision of Prior Period, Adjustment
|
Additional Paid-In Capital |
Additional Paid-In Capital
Previously Reported
|
Accumulated Other Comprehensive Income (Loss) |
Accumulated Other Comprehensive Income (Loss)
Previously Reported
|
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
Accumulated Deficit
Previously Reported
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Temporary equity, beginning balance (in shares) at Dec. 31, 2020 | 63,756,000 | 71,069,000 | (7,313,000) | ||||||||||||||||||||||
Temporary equity, beginning balance at Dec. 31, 2020 | $ 160,605 | $ 160,605 | |||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Mar. 31, 2021 | 63,756,000 | ||||||||||||||||||||||||
Temporary equity, ending balance at Mar. 31, 2021 | $ 160,605 | ||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2020 | 8,169,000 | 9,106,000 | (937,000) | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | (155,930) | $ (155,930) | $ 0 | $ 0 | $ 8,127 | $ 8,127 | $ 9 | $ 9 | $ (164,066) | $ (164,066) | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Exercises of common stock options (in shares) | 5,428,000 | ||||||||||||||||||||||||
Exercises of common stock options | 2,816 | 2,816 | |||||||||||||||||||||||
Stock-based compensation | 14,451 | 14,451 | |||||||||||||||||||||||
Foreign currency translation adjustment | (7) | (7) | |||||||||||||||||||||||
Net loss | (38,556) | (38,556) | |||||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2021 | 13,597,000 | ||||||||||||||||||||||||
Ending balance at Mar. 31, 2021 | $ (177,226) | $ 0 | 25,394 | 2 | (202,622) | ||||||||||||||||||||
Temporary equity, beginning balance (in shares) at Dec. 31, 2020 | 63,756,000 | 71,069,000 | (7,313,000) | ||||||||||||||||||||||
Temporary equity, beginning balance at Dec. 31, 2020 | $ 160,605 | $ 160,605 | |||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Jun. 30, 2021 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Jun. 30, 2021 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2020 | 8,169,000 | 9,106,000 | (937,000) | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | (155,930) | (155,930) | $ 0 | $ 0 | 8,127 | 8,127 | 9 | 9 | (164,066) | (164,066) | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Foreign currency translation adjustment | (5) | [1] | (5) | $ 0 | |||||||||||||||||||||
Unrealized loss on available-for-sale securities | [1] | 0 | |||||||||||||||||||||||
Net loss | (80,041) | [1],[2] | $ (78,172) | $ (1,869) | |||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2021 | 140,522,000 | ||||||||||||||||||||||||
Ending balance at Jun. 30, 2021 | $ 448,768 | $ 15 | 692,856 | 4 | (244,107) | ||||||||||||||||||||
Temporary equity, beginning balance (in shares) at Dec. 31, 2020 | 63,756,000 | 71,069,000 | (7,313,000) | ||||||||||||||||||||||
Temporary equity, beginning balance at Dec. 31, 2020 | $ 160,605 | $ 160,605 | |||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Dec. 31, 2021 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2020 | 8,169,000 | 9,106,000 | (937,000) | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | $ (155,930) | (155,930) | $ 0 | $ 0 | 8,127 | $ 8,127 | 9 | $ 9 | (164,066) | $ (164,066) | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2016-13 [Member] | ||||||||||||||||||||||||
Ending balance (in shares) at Dec. 31, 2021 | 141,585,530 | [3] | 141,586,000 | ||||||||||||||||||||||
Ending balance at Dec. 31, 2021 | $ 373,992 | [4] | $ (38) | 377,556 | $ (3,564) | $ 15 | 705,865 | (676) | (331,212) | $ (38) | |||||||||||||||
Temporary equity, beginning balance (in shares) at Mar. 31, 2021 | 63,756,000 | ||||||||||||||||||||||||
Temporary equity, beginning balance at Mar. 31, 2021 | $ 160,605 | ||||||||||||||||||||||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common shares (in shares) | (63,756,000) | ||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common shares | $ (160,605) | ||||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Jun. 30, 2021 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Jun. 30, 2021 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2021 | 13,597,000 | ||||||||||||||||||||||||
Beginning balance at Mar. 31, 2021 | (177,226) | $ 0 | 25,394 | 2 | (202,622) | ||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Exercises of common stock options | 34 | 34 | |||||||||||||||||||||||
Conversion of Convertible Notes (in shares) | 6,925,000 | ||||||||||||||||||||||||
Conversion of Convertible Notes | 69,252 | 69,252 | |||||||||||||||||||||||
Conversion of warrants (in shares) | 233,000 | ||||||||||||||||||||||||
Conversion of warrants | 2,143 | 2,143 | |||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common shares (in shares) | 63,756,000 | ||||||||||||||||||||||||
Conversion of redeemable convertible preferred stock to common shares | 160,605 | $ 1 | 160,604 | ||||||||||||||||||||||
Reverse recapitalization, net of transaction costs (in shares) | [5] | 56,011,000 | |||||||||||||||||||||||
Reverse recapitalization, net of transaction costs | [5] | 434,891 | $ 14 | 434,877 | |||||||||||||||||||||
Stock-based compensation | 552 | 552 | |||||||||||||||||||||||
Foreign currency translation adjustment | 2 | [1] | 2 | 0 | 2 | ||||||||||||||||||||
Unrealized loss on available-for-sale securities | [1] | 0 | |||||||||||||||||||||||
Net loss | (41,485) | [1] | (40,071) | (1,414) | (41,485) | ||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2021 | 140,522,000 | ||||||||||||||||||||||||
Ending balance at Jun. 30, 2021 | $ 448,768 | $ 15 | 692,856 | 4 | (244,107) | ||||||||||||||||||||
Temporary equity, beginning balance (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||||||||||||
Temporary equity, beginning balance at Dec. 31, 2021 | $ 0 | ||||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Mar. 31, 2022 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Mar. 31, 2022 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 141,585,530 | [3] | 141,586,000 | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2021 | $ 373,992 | [4] | (38) | 377,556 | (3,564) | $ 15 | 705,865 | (676) | (331,212) | (38) | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Exercises of common stock options (in shares) | 365,000 | ||||||||||||||||||||||||
Exercises of common stock options | 177 | 177 | |||||||||||||||||||||||
Issuance of common stock upon settlement of restricted stock units (in shares) | 490,000 | ||||||||||||||||||||||||
Tax withholdings on settlement of equity awards (in shares) | (202,000) | ||||||||||||||||||||||||
Tax withholdings on settlement of equity awards | (1,292) | (1,292) | |||||||||||||||||||||||
Transaction costs related to reverse capitalization | (25) | (25) | |||||||||||||||||||||||
Stock-based compensation | 13,075 | 13,075 | |||||||||||||||||||||||
Foreign currency translation adjustment | 2 | 2 | 0 | 2 | |||||||||||||||||||||
Unrealized loss on available-for-sale securities | (1,618) | (1,618) | 0 | (1,618) | |||||||||||||||||||||
Net loss | (46,832) | (44,231) | (2,601) | (46,832) | |||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2022 | 142,239,000 | ||||||||||||||||||||||||
Ending balance at Mar. 31, 2022 | $ 337,441 | $ 15 | 717,800 | (2,292) | (378,082) | ||||||||||||||||||||
Temporary equity, beginning balance (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||||||||||||
Temporary equity, beginning balance at Dec. 31, 2021 | $ 0 | ||||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Jun. 30, 2022 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Jun. 30, 2022 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 141,585,530 | [3] | 141,586,000 | ||||||||||||||||||||||
Beginning balance at Dec. 31, 2021 | $ 373,992 | [4] | $ (38) | $ 377,556 | $ (3,564) | $ 15 | 705,865 | (676) | (331,212) | $ (38) | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Exercises of common stock options (in shares) | 1,001,889 | ||||||||||||||||||||||||
Foreign currency translation adjustment | $ 1 | ||||||||||||||||||||||||
Unrealized loss on available-for-sale securities | (1,899) | ||||||||||||||||||||||||
Net loss | $ (98,448) | ||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | 144,086,282 | [3] | 144,087,000 | ||||||||||||||||||||||
Ending balance at Jun. 30, 2022 | $ 292,029 | $ 16 | 724,285 | (2,574) | (429,698) | ||||||||||||||||||||
Temporary equity, beginning balance (in shares) at Mar. 31, 2022 | 0 | ||||||||||||||||||||||||
Temporary equity, beginning balance at Mar. 31, 2022 | $ 0 | ||||||||||||||||||||||||
Temporary equity, ending balance (in shares) at Jun. 30, 2022 | 0 | ||||||||||||||||||||||||
Temporary equity, ending balance at Jun. 30, 2022 | $ 0 | ||||||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2022 | 142,239,000 | ||||||||||||||||||||||||
Beginning balance at Mar. 31, 2022 | 337,441 | $ 15 | 717,800 | (2,292) | (378,082) | ||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||
Exercises of common stock options (in shares) | 637,000 | ||||||||||||||||||||||||
Exercises of common stock options | 528 | 528 | |||||||||||||||||||||||
Issuance of common stock upon settlement of restricted stock units (in shares) | 1,833,000 | ||||||||||||||||||||||||
Issuance of common stock upon settlement of restricted stock units | 1 | $ 1 | |||||||||||||||||||||||
Tax withholdings on settlement of equity awards (in shares) | (622,000) | ||||||||||||||||||||||||
Tax withholdings on settlement of equity awards | (1,883) | (1,883) | |||||||||||||||||||||||
Stock-based compensation | 7,840 | 7,840 | |||||||||||||||||||||||
Foreign currency translation adjustment | (1) | (1) | |||||||||||||||||||||||
Unrealized loss on available-for-sale securities | (281) | (281) | |||||||||||||||||||||||
Net loss | $ (51,616) | (51,616) | |||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | 144,086,282 | [3] | 144,087,000 | ||||||||||||||||||||||
Ending balance at Jun. 30, 2022 | $ 292,029 | $ 16 | $ 724,285 | $ (2,574) | $ (429,698) | ||||||||||||||||||||
|
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - shares |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 04, 2021 |
---|---|---|---|
Statement of Stockholders' Equity [Abstract] | |||
Shares subject to vesting restrictions (in shares) | 738,000 | 738,000 | 738,000 |
Condensed Consolidated Statement of Cash Flows (unaudited) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Jun. 30, 2022
USD ($)
|
Jun. 30, 2021
USD ($)
|
[1] | |||||
Operating activities | |||||||||
Net loss | $ (51,616) | $ (46,832) | $ (98,448) | $ (80,041) | [2] | ||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||
Depreciation and amortization | 1,381 | 1,130 | 2,511 | 1,345 | [2] | ||||
Non-cash interest expense | 952 | 1,622 | 3,490 | ||||||
Change in fair value of derivative liabilities | 0 | 0 | 12,512 | [2] | |||||
Change in fair value of warrant liability | (2,699) | (6,267) | (8,966) | 4,795 | [2] | ||||
Change in fair value of trading securities | 2,500 | (1,000) | 1,500 | 0 | [2] | ||||
Realized gains/losses on available-for-sale securities | 8 | 0 | |||||||
Impairment loss on intangible assets | 307 | 428 | 0 | ||||||
Loss on extinguishment of debt | 0 | 0 | 1,469 | [2] | |||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | (110) | (50) | 53 | ||||||
Provision for doubtful accounts | 428 | 795 | 397 | ||||||
Stock-based compensation | 12,118 | 19,276 | 14,952 | ||||||
Changes in assets and liabilities | |||||||||
Accounts receivable | (4,256) | (1,496) | (3,388) | ||||||
Inventories, net | (5,460) | (13,992) | (1,489) | ||||||
Prepaid expenses and other current assets | 707 | (3,231) | 731 | ||||||
Other non-current assets | (681) | (833) | (86) | ||||||
Accounts payable | (626) | 1,580 | 406 | ||||||
Accrued expenses | 1,263 | 5,465 | 3,867 | ||||||
Other current liabilities | (330) | (28) | 299 | ||||||
Other non-current liabilities | 178 | 141 | 1,157 | ||||||
Deferred revenue | 4,780 | 10,254 | 6,344 | ||||||
Net cash used in operating activities | (43,699) | (83,464) | (33,187) | ||||||
Investing activities | |||||||||
Purchase of available-for-sale securities | (24,367) | (44,487) | 0 | ||||||
Proceeds from maturities and call redemptions | 55,800 | 39,587 | 95,399 | 0 | |||||
Purchases of trading securities | (250) | (250) | 0 | ||||||
Purchase of property and equipment | (1,219) | (1,956) | (624) | ||||||
Development of internal software | (1,688) | (3,823) | (3,416) | ||||||
Net cash provided by (used in) investing activities | 12,063 | 44,883 | (4,040) | ||||||
Financing activities | |||||||||
Proceeds from Business Combination and private offering, net of issuance costs | 0 | 449,967 | |||||||
Repayment of term loan | 0 | (5,000) | |||||||
Proceeds from issuance of common stock | 178 | 707 | 2,933 | ||||||
Payments for tax withholding on net settlement of equity awards | (1,293) | (3,176) | 0 | ||||||
Proceeds from revolving credit facility | 1,345 | 1,345 | 855 | ||||||
Repayment of revolving credit facility | (2,409) | (4,472) | (53) | ||||||
Net cash (used in) provided by financing activities | (2,179) | (5,596) | 448,702 | ||||||
Effect of exchange rate on cash | (8) | (7) | (5) | ||||||
Net change in cash and cash equivalents | (33,823) | (44,184) | 411,470 | ||||||
Beginning of period | 90,959 | 124,782 | 124,782 | 60,529 | |||||
End of period | 80,598 | 90,959 | 80,598 | 471,999 | |||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||
Capitalization of stock-based compensation to internally developed software | 682 | 957 | 1,639 | 51 | |||||
Accrued issuance costs | $ 0 | 25 | 0 | 1,715 | |||||
Accrued fixed assets | $ 0 | 0 | 93 | ||||||
Receivable from option exercises | 0 | 13,872 | |||||||
Private placement warrants received as part of Business Combination | $ 0 | $ 510 | |||||||
|
DESCRIPTION OF BUSINESS |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DESCRIPTION OF BUSINESS | DESCRIPTION OF BUSINESS Latch, Inc. (referred to herein, collectively with its subsidiaries, as “Latch” or the “Company”) is a technology company primarily serving the multifamily rental home market segment of the smart building industry deploying hardware and software technology to digitize otherwise manual processes, including building and unit access and in-unit device control. On June 4, 2021 (the “Closing Date”), the Company consummated the previously announced merger pursuant to that certain Agreement and Plan of Merger, dated as of January 24, 2021 (the “Merger Agreement”), by and among the Company (formerly known as TS Innovation Acquisitions Corp. (“TSIA”)), Latch Systems, Inc. (formerly known as Latch, Inc. (“Legacy Latch”)) and Lionet Merger Sub Inc., a wholly-owned subsidiary of TSIA (“Merger Sub”), pursuant to which Merger Sub merged with and into Legacy Latch, with Legacy Latch becoming a wholly-owned subsidiary of the Company (the “Business Combination” and, collectively with the other transactions described in the Merger Agreement, the “Transactions”). In connection with the consummation of the Transactions (the “Closing”), the Company changed its name from TS Innovation Acquisitions Corp. to Latch, Inc. The “Post-Combination Company” following the Business Combination is Latch, Inc. In May 2019, the Company incorporated Latch Taiwan, Inc., a wholly-owned subsidiary, in the state of Delaware. In October 2020, the Company incorporated Latch Insurance Solutions, LLC, a wholly-owned subsidiary, in the state of Delaware. In September 2021, the Company incorporated Latch Systems Ltd, a wholly-owned subsidiary, in England and Wales. The Company’s revenues are derived primarily from operations in North America. In May 2023, in connection with the HDW Acquisition (as defined and further described below), the Company formed two subsidiaries, one of which was the surviving entity of the HDW Acquisition and was renamed Honest Day’s Work, LLC. In June 2024, in connection with the HelloTech Merger (as defined and further described below), the Company formed a subsidiary into which HelloTech, Inc. merged as the surviving entity of the HelloTech Merger. Effective November 1, 2023, the Company relocated its headquarters to St. Louis (Olivette), Missouri. From 2020 through 2023, the Company operated offices in Denver, Colorado, New York, New York, Los Angeles, California and Taipei, Taiwan. Business Combination On January 24, 2021, TSIA entered into the Merger Agreement with Merger Sub and Legacy Latch. Legacy Latch’s board of directors unanimously approved Legacy Latch’s entry into the Merger Agreement. On June 3, 2021, TSIA held a special meeting of its stockholders (the “Special Meeting”), at which the TSIA stockholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Merger Agreement and (b) approving the other Transactions contemplated by the Merger Agreement. Upon the Closing the following occurred: •The mandatory conversion feature upon a business combination was triggered for the convertible notes issued by Legacy Latch between August 11, 2020 and October 23, 2020 with a maturity date of April 23, 2022 for an aggregate principal amount of $50.0 million (the “Convertible Notes”), causing a conversion of the $50.0 million outstanding principal amount of the Convertible Notes and any unpaid accrued interest into equity securities at a specified price. The noteholders received approximately 6.9 million shares of common stock in the Post-Combination Company. The embedded derivative related to the Convertible Notes was extinguished as part of the Closing. •The 71.1 million outstanding shares of redeemable convertible preferred stock were exchanged for 63.8 million shares of common stock in the Post-Combination Company. •Legacy Latch repaid in full the outstanding principal and accrued interest on the term loan in the total amount of $5.0 million. The embedded derivative in the warrants issued in connection with the term loan was extinguished as part of the Closing. •Holders of 5,916 shares of TSIA’s Class A common stock sold in its initial public offering (the “Initial Shares”) properly exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from TSIA’s initial public offering (the “TSIA IPO”), calculated as of two business days prior to the consummation of the Business Combination, which was approximately $10.00 per share, or approximately $0.06 million in the aggregate. •The shares of TSIA Class B common stock held by TS Innovation Acquisitions Sponsor, L.L.C. (“Sponsor”) automatically converted to 7.4 million shares of common stock in the Post-Combination Company. Of the 7.4 million shares of common stock held by the Sponsor, 738,000 are subject to vesting under certain conditions (the “Sponsor Earnout Shares”), including that the volume-weighted average price (“VWAP”) of the Post-Combination Company equals or exceeds $14.00 for any 20 trading days within a 30 trading day period on or prior to the five year anniversary of the Closing. •Pursuant to subscription agreements entered into in connection with the Merger Agreement, certain investors agreed to subscribe for an aggregate of approximately 19.3 million newly-issued shares of common stock at a purchase price of $10.00 per share for an aggregate purchase price of approximately $192.6 million (the “PIPE Investment”). The PIPE Investment included approximately 0.3 million newly issued shares of common stock at a purchase price of $10.00 per share for an aggregate purchase price of $2.6 million of cash election funding. See Note 13. Stock-Based Compensation. At the Closing, the Company consummated the PIPE Investment. •After giving effect to the Transactions, the redemption of Initial Shares as described above and the consummation of the PIPE Investment, there were approximately 140.5 million shares of common stock issued and outstanding (excluding the Sponsor Earnout Shares). As noted above, an aggregate of $0.06 million was paid from TSIA’s trust account to holders that properly exercised their right to have Initial Shares redeemed, and the remaining balance immediately prior to the Closing of approximately $300.0 million remained in the trust account. The remaining amount in the trust account was used to fund the Business Combination. Latch received approximately $450.0 million in cash proceeds, net of fees and expenses funded in connection with the Closing of the Business Combination, which included approximately $192.6 million from the PIPE Investment mentioned above. The following table reconciles the elements of the Business Combination to the Consolidated Statement of Cash Flows and the Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholders’ Equity for the year ended December 31, 2021.
As a result of the Business Combination, each share of Legacy Latch redeemable convertible preferred stock and common stock was converted into the right to receive approximately 0.8971 shares of the common stock of the Post-Combination Company (the “Exchange Ratio”). Based on the following factors, the Company determined under the Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) 805, Business Combinations, that the Business Combination was a reverse recapitalization. •Legacy Latch stockholders owned approximately 60.0% of the shares in the Post-Combination Company and thus had sufficient voting rights to exert influence over the Post-Combination Company. •Legacy Latch appointed a majority of the Post-Combination Company’s board of directors and maintained a majority of the composition of management at the time of the transaction. •Legacy Latch was the larger entity based on historical revenues and business operations and comprised the ongoing operations of the Post-Combination Company. •The Post-Combination Company assumed the name “Latch, Inc.” The accounting for the transaction was similar to that resulting from a reverse acquisition, except that goodwill or other intangibles were not recognized, and the transaction was followed by a recapitalization. In accordance with guidance applicable to these circumstances, the equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, par value $0.0001 per share, issued to Legacy Latch’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Latch redeemable convertible preferred stock and Legacy Latch common stock prior to the Business Combination have been retroactively recast as shares reflecting the Exchange Ratio of 0.8971 established in the Business Combination. Post-Combination Company common stock and warrants commenced trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “LTCH” and “LTCHW,” respectively, on June 7, 2021. Since the August 10, 2023 suspension of trading in the Company’s common stock and warrants on Nasdaq and subsequent delisting, the Company’s securities have been traded on OTC Markets Group Inc.’s Expert Market.
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION | RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION During the quarter ended June 30, 2022, the audit committee (the “Audit Committee”) of the Company’s board of directors (the “Board”) commenced an investigation (the “Investigation”) of certain of the Company’s key performance indicators and revenue recognition practices, including the accounting treatment, financial reporting and internal controls related thereto. The Audit Committee determined that the Company’s consolidated financial statements for the years ended December 31, 2021, 2020 and 2019 included in the Annual Report on Form 10-K for the year ended December 31, 2021, as well as the condensed consolidated financial statements for the first quarter of 2022 included in the Quarterly Report on Form 10-Q for the three months ended March 31, 2022, should no longer be relied upon as a result of material errors and possible irregularities relating to, among other things, the manner in which the Company recognized revenue associated with the sale of hardware devices, primarily through third-party channel partners. Following the Investigation, the Company completed a comprehensive review of its previously issued financial statements (the “Financial Statement Review”). As a result, the Company is restating certain financial data. Errors Identified Through the Investigation and the Financial Statement Review, the Company identified errors in various categories, including: 1.Revenue recognition - Hardware In connection with the Investigation and the Financial Statement Review, the Company determined that its historical revenue was misstated, primarily as a result of the following: (a) a failure of certain sales personnel in certain cases to disclose relevant terms they had negotiated and a failure to identify, consider or properly account for such terms; (b) a failure to consider fully the impact of certain terms of sales agreements in determining the revenue to be recognized and (c) a failure to adequately assess collectability. As a result of the foregoing, in certain circumstances, the Company originally had recognized revenues before there was evidence that a contract existed and control had passed to the customer. Additionally, the Company determined that there was not sufficient evidence to recognize amounts of gross revenue that were subject to certain discounts provided to channel partners. Accordingly, certain previously reported revenue related to such channel partner discounts and an offsetting and equal cost of revenue needed to be reversed. In transactions in which discounts originally had been allocated between hardware and software revenues, deferred software was also adjusted. In addition, there were adjustments related to the returns reserve. Restated hardware revenues are recorded in the amount of consideration the Company received or expected to receive when it had evidence that a contract existed and control had passed to the customer. The impact of the foregoing on hardware revenue and cost of hardware revenue on the previously reported Condensed Consolidated Statements of Operations and Comprehensive Loss is as follows (in thousands):
In addition to the impact of these adjustments on hardware revenue and cost of hardware revenue on the previously reported Consolidated Statements of Operations and Comprehensive Loss, additional accounts impacted by the Financial Statement Review include: •General and administrative; •Accounts receivable, net; •Inventories, net; •Accrued expenses; •Deferred revenue, current; •Deferred revenue, non-current; •Other current liabilities; •Prepaid expenses and other current assets; and •Retained earnings. 2.Revenue recognition - Software Revenue related to software as a service (“SaaS”) is generally recognized ratably over the subscription period beginning when or as control of the promised services is transferred to the customer. In connection with the Financial Statement Review, the Company determined: •In certain cases, access to software was not transferred to the customers upon execution of the software contract, which is when the revenue had been recognized. For such contracts, software revenue has been restated to reflect the date on which Latch provided access to the customer. In the tables below, the related adjustments are described as “access related.” •Certain software licensing contracts did not meet revenue recognition criteria primarily due to collectability not being reasonably assured. As a result, certain balance sheet accounts, including accounts receivable and deferred revenue, have been restated to correct the amounts associated with such transactions. For certain software license renewals, revenue was recorded in a lump sum instead of over the subscription period. Revenues were restated to record the revenue over the subscription period. The impacts of these adjustments on software revenue are reflected in the tables below as “other.” The adjustments associated with these corrections primarily impact software revenue on the previously reported Condensed Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):
In addition to the impact of these adjustments on software revenue on the previously reported Consolidated Statements of Operations and Comprehensive Loss, additional accounts impacted by the Financial Statement Review include: •General and administrative; •Other income / (expense); •Accounts receivable, net; •Prepaid expenses and other current assets; •Deferred revenue, current; •Deferred revenue, non-current; and •Retained earnings. 3.Internally-developed software The Company capitalizes certain development costs incurred in connection with its internally-developed software (including specific software upgrades and enhancements when it is probable the expenditures will result in additional features and functionality). These capitalized costs are primarily related to software that is hosted by the Company and the firmware in the Company’s devices. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization of costs ceases upon completion of all substantial testing, at which time amortization of the capitalized software begins. In connection with the Financial Statement Review, the Company determined that, due to flawed operating procedures, the Company did not (i) begin to amortize certain amounts that had been recorded as software-in-development during 2020, 2021 and 2022 when the asset was ready for its intended use or (ii) expense certain amounts when the Company determined that the planned feature was discontinued. The adjustments associated with this correction had a net impact that increased the loss before income taxes by $0.4 million, $0.1 million and $0.3 million for the three months ended March 31, 2022, the three months ended June 30, 2021 and the six months ended June 30, 2021, respectively. The restated amounts presented in the tables below reflect corrections of internally-developed software, amortization expense and accumulated amortization. The adjustments associated with these corrections impact the following accounts on the previously reported Condensed Consolidated Financial Statements: •Research and development; •Depreciation and amortization; and •Internally-developed software, net. 4.Stock-based compensation The Company accounts for stock-based compensation expense ratably over the service period. Historically, the Company accelerated a portion of the restricted stock units’ (“RSUs”) fair value at grant date instead of recognizing that amount ratably over the award’s requisite service period. The adjustments associated with this correction, along with other stock-based compensation expense corrections, had a net impact that increased the loss before income taxes by $0.3 million, $0.1 million and $0.03 million for the three months ended March 31, 2022, the three months ended June 30, 2021 and the six months ended June 30, 2021, respectively. The restated amounts presented in the tables below reflect stock-based compensation expense recognized ratably over the service period beginning at the grant date. 5.Other corrections In connection with the Financial Statement Review, the Company determined that certain historical amounts did not meet the recognition criteria due to errors in amounts and/or the timing of recognition on the financial statements. The adjustments associated with these corrections had a net impact that increased the loss before income taxes by $0.4 million, $0.4 million and $0.4 million for the three months ended March 31, 2022, the three months ended June 30, 2021 and the six months ended June 30, 2021, respectively. The restated amounts presented in the tables below reflect amounts in the periods they were incurred. The tables below present the impact of the Restatement adjustments on previously reported financial statements. Restatement adjustments are reflected as follows: •Related to hardware revenue recognition are labeled “HW” •Related to software revenue recognition are labeled “SW” •Related to internally-developed software and software-in-development are labeled “IDS” •Related to stock-based compensation are labeled “SBC” •Related to other corrections are labeled “OC” In those cases where an account has been adjusted due to more than one category, a footnote reference detailing the components has been added. Certain amounts reported previously have been reclassified and are labeled “RC”.
(a)Category references are described above under “—Errors Identified.” Where adjustments relate to multiple categories, the adjustment amounts of each category are noted below and sum to the total adjustment reflected in the table above: HW1 $909; OC1 $(56); SBC1 $4; SW2 $8; OC2 $(4); OC3 $42; IDS3 $445; SBC3 $78; OC4 $(94); SBC4 $221; HW5 $295; SW5 $183; OC5 $482; RC5 $307; SBC5 $35; RC6 $(306); IDS6 $(70) (b)Exclusive of depreciation and amortization shown in operating expenses below.
HW1 $(11,846); SW1 $(1,275); RC1 $(633); HW2 $11,949; OC2 $(489); HW3 $24; SW3 $55; OC3 $387; RC3 $633; HW4 $181; OC4 $107; HW5 $218; OC5 $(93); HW6 $467; SW6 $776; HW7 $1; SW7 $(982); HW8 $10; SBC8 $(858) (b) Shares issued and outstanding as of December 31, 2021 exclude 738,000 shares subject to vesting requirements. See Note 1. Description of Business.
(a)Category references are described above under “—Errors Identified.” Where adjustments relate to multiple categories, the adjustment amounts of each category are noted below and sum to the total adjustment reflected in the table above: HW1 $(1,650); OC1 $81; SBC1 $3; SW2 $2; OC2 $(1); OC3 $(67); IDS3 $114; SBC3 $27; OC4 $33; SBC4 $9; HW5 $149; SW5 $100; OC5 $289; SBC5 $54; HW6 $(2,953); OC6 $180; SBC6 $3; SW7 $2; OC7 $(1); OC8 $(8); IDS8 $248; SBC8 $61; OC9 $57; SBC9 $10; HW10 $143; SW10 $96; OC10 $214; SBC10 $(42) (b)Exclusive of depreciation and amortization shown in operating expenses below.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The condensed consolidated financial statements and related notes of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial reporting and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC for interim financial reporting. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s financial position, results of operations and cash flows have been included and are of a normal and recurring nature. The operating results presented for interim periods are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. These financial statements should be read in conjunction with the Company’s consolidated financial statements and the notes thereto, which are included in the Company’s 2022 Annual Report filed concurrently herewith. Principles of Consolidation The condensed consolidated financial statements include the accounts of Latch, Inc. and its wholly-owned subsidiaries as of June 30, 2022, Latch Systems, Inc., Latch Taiwan, Inc., Latch Insurance Solutions, LLC and Latch Systems Ltd. All intercompany transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications would not have a material effect on the reported financial results. Use of Estimates The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expense during the reporting period. Estimates are used when accounting for revenue recognition, allowance for doubtful accounts, allowance for hardware returns, estimates of excess and obsolete inventory, stock-based compensation, warrants, impairment of fixed assets, investment in trading securities and capitalized internally-developed software. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; actual results could differ from those estimates. The Company’s significant accounting policies for its Condensed Consolidated Financial Statements as of June 30, 2022 are summarized below. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash and cash equivalents. Cash and cash equivalents are recorded at cost, which approximates fair value. As of June 30, 2022 and December 31, 2021, cash consisted primarily of funds held in the Company’s checking accounts, money market funds and commercial paper. The Company considers these money market funds and commercial paper to be Level 1 financial instruments. The Company’s cash balances exceed the limits that are federally insured. To date, the Company has not recognized any losses caused by uninsured balances. Marketable Securities The Company classifies its fixed income marketable securities as available-for-sale based on its intentions with regard to these instruments. Accordingly, marketable securities are reported at fair value, with all unrealized holding gains and losses reflected in stockholders’ equity. If it is determined that an investment has an other-than-temporary decline in fair value, the Company recognizes the investment loss in other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. The Company periodically evaluates its investments to determine if impairment charges are required. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at net realizable value, net of allowance for doubtful accounts and reserve for returns (see “Revenue Recognition” below for further information). The Company adopted Accounting Standards Update (“ASU”) 2016-13 effective January 1, 2022. Following the adoption, the Company recognizes an accounts receivable allowance based on estimates of expected credit losses. The Company estimates the total expected credit loss over the lifetime of the receivables using historical loss data and by applying a loss-rate method using relevant available information from internal and external sources, including historical write-off activity, current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for changes in economic conditions. When certain amounts are deemed uncollectible, those balances are reserved in full. The allowance for doubtful accounts is measured on a pooled basis when similar risk characteristics exist. When assessing whether to measure certain financial assets on a pooled basis, the Company considers various risk characteristics, including the financial asset type, size and historical or expected credit loss pattern. These risk characteristics are relevant to accounts receivable and contract assets. The Company has considered customer identity, customer type and product lines and determined that further segmentation of the accounts receivable and contract assets would not yield a materially different credit loss allowance. The Company only segments its receivables based on the age of the outstanding balance. Restated hardware revenues are recorded in the amount of the consideration the Company received or expected to receive when the Company had evidence that a contract existed and control had passed to the customer. See Note 2. Restatement of Prior Period Financial Statements and Information. As of June 30, 2022 and December 31, 2021, the allowance for doubtful accounts contains an estimate of credit losses for outstanding invoices related to (1) hardware accounts receivable when revenue was recognized for consideration received from the related software contract and (2) invoices related to software accounts receivable. The Company generally does not require any security or collateral to support its receivables. The following table represents a roll-forward of the Company’s allowance for doubtful accounts:
Inventories, Net Inventories consist of finished goods and component parts. Finished goods are manufactured by the Company or purchased from contract manufacturers and component suppliers. Inventories are stated at the lower of cost or net realizable value with cost being determined using the average cost method. The Company periodically assesses the valuation of inventory and writes down the value for estimated excess and obsolete inventory based upon estimates of future demand and market conditions, when necessary. As of June 30, 2022, net inventories in excess of one year of historical sales are classified as other non-current assets on the Consolidated Balance Sheets. Hardware shipped to channel partners is considered channel inventory until there is evidence a contract exists and control has passed to the customer. Channel inventory is included within inventory, net on the Consolidated Balance Sheets. Channel inventory is stated at the lower of cost or net realizable value with cost being determined using the average cost method. Property and Equipment, Net Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets as follows:
The Company capitalizes the cost of pre-production tooling that it owns. Pre-production tooling that the Company will not own or that will not be used in producing products under long-term supply arrangements, including the related engineering costs, is expensed as incurred. Software Development Costs The Company capitalizes certain development costs incurred in connection with its internally-developed software (including specific software upgrades and enhancements when it is probable the expenditures will result in additional features and functionality). These capitalized costs are primarily related to software that is hosted by the Company and the firmware in the Company’s devices. Costs incurred in the preliminary stages of development are expensed as incurred. Once a project has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the application is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific software upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. Internally-developed software is amortized on a straight-line basis over its estimated useful life, generally to five years. Intangible Assets Intangible assets are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. Effective October 2021, the Company entered into an asset purchase agreement. The Company evaluated the acquisition under ASC 805, Business Combinations. The acquisition included the purchase of an assembled workforce to support certain of the Company’s business development efforts. The Company determined that there were no substantive assets outside of the assembled workforce, which was performing services for the Company prior to the acquisition. The Company determined that the acquisition did not qualify as a business. Therefore, the Company accounted for the $0.7 million acquisition of the assembled workforce as an asset acquisition, which is included in intangible assets as of December 31, 2021. Intangible assets consisted of the following, which are included within other non-current assets on the Consolidated Balance Sheets.
Total amortization expense related to intangible assets was $0.1 million and $0.2 million for the three and six months ended June 30, 2022, respectively, and zero for both of the three and six months ended June 30, 2021. Total intangible impairment expense was zero for the three and six months ended June 30, 2022 and the three and six months ended June 30, 2021. The estimated useful life of intangible assets is as follows:
Leases On January 1, 2022, the Company adopted ASU 2016-02, Leases (Topic 842) (“ASC 842”) using a modified retrospective approach, recording a cumulative-effect adjustment to retained earnings. The Company elected to adopt the practical expedients that permit it to combine lease and non-lease components for all lease contracts and also elected not to recognize right-of-use (“ROU”) assets and lease liabilities for leases with terms of 12 months or less. The Company determines if an arrangement contains a lease at the inception of the arrangement. As part of the lease determination process, the Company assesses several factors, including, but not limited to, whether there is a right to control and direct the use of the asset and whether the other party has a substantive substitution right. As the Company’s leases generally do not have identical or nearly identical contract provisions, the Company accounts for each of its leases at the contract level. The Company has made the policy election to not separate lease and non-lease components for any of its leases within its existing classes of assets. The Company will evaluate this election for any new leases involving a new underlying class of asset. The Company has also made the policy election to not recognize a lease liability or an ROU asset for any leases with a term of 12 months or less. These lease payments are recognized on a straight-line basis over the lease term. The Company has evaluated lease renewal options on a contract-by-contract basis to determine whether specific circumstances would result in the conclusion that any options are reasonably certain to be exercised. Generally, the Company does not enter into lease arrangements where the option to renew or terminate a lease is controlled by the lessor. The Company cannot readily determine the interest rate implicit in leases where it is the lessee. As such, it uses its IBR to measure lease liabilities. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of comparable value to the ROU asset in a similar economic environment. IBR therefore reflects what the Company “would have to pay,” which requires estimation when no observable rates are available or where the applicable rates need to be adjusted to reflect the terms and conditions of the lease. The Company estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates. The Company’s leases are generally not sensitive to changes in IBR due to their relatively short terms. ROU assets represent the right to use an underlying asset for the term of the lease, and lease liabilities represent the obligation to make lease payments throughout the term of the lease. ROU assets and lease liabilities are recognized as of the commencement date of the lease based on the present value of contractual lease payments due over the term of the lease. The Company uses an incremental borrowing rate to determine the present value of the lease payments, as the leases do not state the rate implicit in the lease. ROU assets resulting from operating leases are recorded within other non-current assets, and lease liabilities from operating leases are recorded within current liabilities and non-current liabilities, on the Condensed Consolidated Balance Sheets. The Company did not have any finance leases or subleases as of June 30, 2022 and December 31, 2021. Rent expense is allocated among cost of revenue, research and development, sales and marketing, and general and administrative, based on headcount and the use of the underlying leased property. Equity Issuance Costs Costs incurred in connection with the issuance of the Company’s series preferred stock have been recorded as a direct reduction against redeemable convertible preferred stock within the Consolidated Balance Sheets. Additionally, certain transaction costs incurred in connection with the Merger Agreement that are direct and incremental to the Business Combination (see Note 1. Description of Business) have been recorded as a component of additional paid-in capital within the Consolidated Balance Sheets. Revenue Recognition In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i) identify contracts with customers; (ii) identify performance obligations; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations; and (v) recognize revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer and is the unit of account in ASC 606 and its related amendments (collectively known as ASC 606, Revenue from Contracts with Customers). Revenues are recognized when control of the promised goods or services are transferred to a customer in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company currently generates its revenues from three primary sources: (1) sales of hardware devices, (2) licenses of software products and (3) installation services related to the hardware devices. Performance Obligations The Company enters into contracts that contain multiple distinct performance obligations: hardware, software and installation services. The hardware performance obligation includes the delivery of hardware, the software performance obligation allows the customer access to the software during the contracted-use term when the promised service is transferred to the customer and the installation services obligation includes the delivery of activation and installation of the hardware. The Company has determined that the hardware, software and installation services are individual distinct performance obligations because they can be and generally are sold by the Company on a standalone basis, and because other vendors sell similar technologies and services on a standalone basis. For each performance obligation identified, the Company estimates the standalone selling price, which represents the price at which the Company would sell the good or service separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price, taking into account available information such as market conditions, historical pricing data and internal pricing guidelines related to the performance obligations. The Company then allocates the transaction price among those obligations based on the estimation of standalone selling price. For software revenue, the Company estimates the transaction price, including variable consideration, at the commencement of the contract and recognizes revenue over the contract term. Hardware The Company generates hardware revenue primarily from the sale of its portfolio of devices. The Company sells hardware to customers, which include real estate developers, builders, building owners and property managers, directly or through its channel partners, who act as intermediaries, installers or wholesalers. The Company recognizes hardware revenue when there is evidence a contract exists and control has been transferred to the customer. The Company provides warranties that its hardware will be substantially free from defects in materials and workmanship for a period of or two years for electronic components depending on the hardware product, and five years for mechanical components. The Company determines in its sole discretion whether to replace, repair or refund warrantable devices. The Company determined these warranties are not separate performance obligations as they cannot be purchased separately and do not provide a service in addition to an assurance the hardware will function as expected. The Company records a reserve as a component of cost of hardware revenue based on historical costs of replacement units for returns of defective products. For the three and six months ended June 30, 2022, the reserve recorded for hardware warranties was approximately 2% and 2%, respectively, of cost of hardware revenue. For the three and six months ended June 30, 2021, the reserve recorded for hardware warranties was approximately 2% and 2%, respectively, of cost of hardware revenue. The Company also provides certain customers a right of return for non-defective product, which is treated as a reduction of hardware revenue based on the Company’s expectations and historical experience. For the three and six months ended June 30, 2022, the allowance for returns reduced revenue by zero and $0.4 million, respectively. For the three and six months ended June 30, 2021, the allowance for returns reduced revenue by $0.4 million and $0.2 million, respectively. Software The Company generates software revenue primarily through the license of its SaaS cloud-based platform to customers on a subscription-based arrangement. Subscription fees vary depending on the features selected by customers as well as the term. SaaS arrangements generally have term lengths of , , or ten years and include a fixed fee generally paid in advance, annually or monthly. When significant discounts were provided to customers on the longer-term software contracts paid in advance, the Company has determined that there is a significant financing component related to the time value of money and therefore has recorded the interest expense in interest expense, net on the Consolidated Statements of Operations and Comprehensive Loss. The interest expense related to the significant financing component is recorded using the effective interest method, which has higher interest expense at inception and declines over time to match the underlying economics of the transaction. The amount of interest expense related to this component was $1.4 million and $2.4 million for the three and six months ended June 30, 2022, respectively, and $0.7 million and $1.3 million for the three and six months ended June 30, 2021, respectively. The SaaS licenses provided by the Company are considered stand-ready performance obligations where customers benefit from the services evenly throughout the service period. Revenue generally is recognized ratably over the subscription period beginning when or as control of the promised services is transferred to the customer. Installation Services The Company generates revenues by facilitating hardware installation and activation services. These revenues are recognized over time on a percentage of completion basis. The Company recognized installation services revenue of $1.9 million and $3.4 million for the three and six months ended June 30, 2022, respectively, and $0.2 million for both the three and six months ended June 30, 2021. Deferred Contract Costs The Company capitalizes commission expenses paid that are incremental to obtaining customer software contracts. Costs related to the initial signing of software contracts are amortized over the average customer life, which has been estimated to be ten years. The Company determined the period of benefit by taking into consideration the length of terms in its customer contracts, including renewals and extensions. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current and are included in prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets; the remaining portion is recorded as deferred contract costs, non-current and is included in other non-current assets on the Condensed Consolidated Balance Sheets. Amortization expense is included in sales and marketing expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss. The following table represents a roll-forward of the Company’s deferred contract costs:
Contract Assets and Contract Liabilities
The Company enters into contracts with its customers, which may give rise to contract assets (unbilled receivables) and contract liabilities (deferred revenue) due to revenue recognition differing from the timing of billing to customers. The Company recognizes unbilled receivables when the performance obligation precedes the invoice date. The Company reports unbilled receivables within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company records contract liabilities as deferred revenue when the Company bills customers in advance of the performance obligations being satisfied, which is generally the case for the Company’s software contracts. The Company recognized $5.2 million of prior year deferred software revenue during the six months ended June 30, 2022 and $4.5 million during the year ended December 31, 2021. As of June 30, 2022, total deferred revenue was $40.7 million. The current amount, which is expected to be recognized over the next 12 months, of $9.9 million is comprised of $14.6 million, which will be recognized as revenue, and $4.6 million, which will be recognized as interest expense related to the significant financing component. The non-current amount of $30.8 million is comprised of $41.7 million, which will be recognized as revenue, and $10.9 million, which will be recognized as interest expense related to the significant financing component. Increase in deferred revenue for the three and six months ended June 30, 2022 primarily resulted from growth of contracts with new and existing customers. Cost of Revenue Cost of hardware revenue consists primarily of product costs, including manufacturing costs, duties and other applicable importation costs, shipping and handling costs, packaging, warranty costs, assembly costs and warehousing costs, as well as other non-inventoriable costs including personnel-related expenses associated with supply chain logistics. Costs of hardware revenue also include charges related to lower of cost or market adjustments and reserves for excess inventory and non-cancellable purchase commitments. Cost of software revenue consists primarily of outsourced hosting costs and personnel-related expenses associated with monitoring and managing outsourced hosting service providers. Cost of installation services revenue consists primarily of third-party installation labor costs, parts and materials and personnel-related expenses associated with deployment of hardware. Cost of revenue excludes depreciation and amortization shown in operating expenses. Research and Development Research and development (“R&D”) expense consists primarily of personnel and related expenses for employees working on product design and engineering teams, including salaries, bonuses, benefits, payroll taxes, travel and stock-based compensation. Also included are non-personnel costs such as amounts paid to third-party contract manufacturers for tooling, engineering and prototype costs of hardware products, fees paid to third-party consultants, R&D supplies, rent and restructuring costs. R&D costs that do not meet the criteria for capitalization are expensed as incurred. Sales and Marketing Sales and marketing expense consists primarily of personnel and related expenses for employees working on sales, customer success, deployment and marketing teams, including salaries, bonuses, benefits, payroll taxes, travel, commissions and stock-based compensation. Also included are non-personnel costs such as marketing activities (trade shows and events, conferences and advertising), professional fees, rent, restructuring costs and customer support. Advertising expense was $1.2 million and $2.1 million for the three and six months ended June 30, 2022, respectively, and $0.2 million and $0.3 million for the three and six months ended June 30, 2021, respectively. General and Administrative General and administrative expense consists primarily of personnel and related expenses for executive, legal, human resources, finance and IT functions, including salaries, bonuses, benefits, payroll taxes, travel and stock-based compensation. Additional expenses included in this category are non-personnel costs such as legal fees, rent, professional fees, audit fees, investigation and restatement costs, restructuring costs, bad debt expense and insurance costs. Depreciation and Amortization Depreciation and amortization expense consists primarily of depreciation expense related to investments in property and equipment, internally-developed software and intangible assets. Impairment of Long-Lived Assets The Company assesses long-lived assets for impairment in accordance with the provisions of ASC 350, Goodwill and Other, and ASC 360, Property, Plant and Equipment. Long-lived assets, such as property and equipment and internally-developed software costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposition of the asset. The amount of impairment loss, if any, is measured as the difference between the carrying value of the asset and its estimated fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the three and six months ended June 30, 2022, the Company recorded $0.1 million and $0.4 million of impairment of internally-developed software costs. The Company did not record any impairment charges for the three and six months ended June 30, 2021. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2022 and December 31, 2021, the Company recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in estimate occurs. Stock-Based Compensation The Company measures and records the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. The Company recognizes stock-based compensation expense over the requisite service period of the individual grant, generally equal to the vesting period, and uses the straight-line method. The fair value of RSUs is determined using the closing trading price on the grant date. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option-pricing model to determine the fair value of stock options. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions to determine the fair value of stock options, including the option’s expected term and the price volatility of the underlying stock. The Company calculates the fair value of options granted by using the Black-Scholes option-pricing model with the following assumptions: •Expected Volatility—The Company estimates volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the option’s expected term. •Expected Term—The expected term of the Company’s options represents the period that the stock-based awards are expected to be outstanding. The Company has elected to use the midpoint between the stock option’s vesting term and contractual expiration period to compute the expected term, as the Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. •Risk-Free Interest Rate—The risk-free interest rate is based on the implied yield currently available on U.S. Treasury zero-coupon issues with a term that is equal to the option’s expected term at the grant date. •Dividend Yield—The Company has not declared or paid dividends to date and does not anticipate declaring dividends. As such, the dividend yield has been estimated to be zero. Cash Settled RSUs The Company grants cash settled RSUs that are classified as liability awards as defined in ASC 718, Compensation - Stock Compensation. Cash settlement is required (no election for share settlement) and the cash settlement is not contingent on the occurrence of an event. These awards are recorded as a share-based liability, and fair value is remeasured quarterly. Each vested award is released for cash equal to the trading value of the Company’s common stock. Fair Value Measurement Fair value accounting is applied for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis (at least annually). Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820, Fair Value Measurements, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The levels of the fair value hierarchy are as follows: •Level 1—Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. •Level 2—Inputs are observable, either directly or indirectly, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. •Level 3—Inputs are generally unobservable and typically reflect management’s best estimate of assumptions that market participants would use in pricing the asset or liability. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. Convertible Notes and Derivatives The Company accounts for convertible notes, net using an amortized cost model pursuant to ASC 835, Interest. Convertible notes are classified as liabilities measured at amortized cost, net of debt discounts from debt issuance costs, lender fees and the initial fair value of bifurcated derivatives, which reduce the initial carrying amount of the notes. The carrying value is accreted to the stated principal amount at contractual maturity using the effective-interest method with a corresponding charge to interest expense pursuant to ASC 835. Debt discounts are presented on the balance sheet as a direct deduction from the carrying amount of the related debt. The Company accounts for its derivatives in accordance with ASC 815-10, Derivatives and Hedging, or ASC 815-15, Embedded Derivatives, depending on the nature of the derivative instrument. ASC 815 requires each contract that is not a derivative in its entirety to be assessed to determine whether it contains embedded derivatives that are required to be bifurcated and accounted for as a derivative financial instrument. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if (i) the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings, (ii) the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and (iii) a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Embedded derivatives are measured at fair value and re-measured at each subsequent reporting period and recorded within convertible notes, net on the consolidated balance sheets and changes in fair value recorded in other income (expense), net within the statements of operations and comprehensive loss. Earnings per Share The calculation of earnings per share is based on the weighted average number of shares of common stock or common stock equivalents outstanding during the applicable period. The dilutive effect of common stock equivalents is excluded from basic earnings per share and is included in the calculation of diluted earnings per share. Potentially dilutive securities include convertible preferred stock, common stock options, common stock warrants and RSUs. The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method determines net loss per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company’s redeemable convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in the Company’s losses. For periods in which the Company reports net losses, diluted net loss per share is the same as basic net loss per share because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. Diluted shares outstanding are calculated using the treasury stock method or the two-class method, depending on which method is more dilutive for a given period. Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized and the amount of benefits that would be recorded in common shares when the award becomes deductible for tax purposes are assumed to be used to repurchase shares, based on the average share price for the fiscal period. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade accounts receivable. The Company primarily invests its excess cash in low-risk, highly liquid money market funds with major financial institutions as well as marketable securities (see Note 4. Investments). Significant customers are those that represent more than 10% of the Company’s total revenue or gross accounts receivable balance at each balance sheet date. As of June 30, 2022, the Company had one customer that accounted for $3.0 million, or 19%, of gross accounts receivable. As of December 31, 2021, the Company had one customer that accounted for $2.7 million, or 19%, of gross accounts receivable. For the three and six months ended June 30, 2022, the Company had one customer that accounted for $2.2 million and $6.6 million, or 22% and 28%, of total revenue, respectively. For the three months ended June 30, 2021, the Company had two customers that accounted for $2.4 million, or 35%, of total revenue. For the six months ended June 30, 2021, the Company had one customer that accounted for $1.9 million, or 16%, of total revenue. Segment Information As of June 30, 2022, the Company had one operating and reportable segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker. Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (the “FASB”) issued ASC 842, which requires lessees to recognize most leases on the balance sheet as a right of use asset and related lease liability. On January 1, 2022, the Company adopted ASC 842 using a modified retrospective approach, recording a cumulative-effect adjustment to retained earnings. The Company elected to adopt the practical expedients that permit it to combine lease and non-lease components for all lease contracts and also elected not to recognize ROU assets and lease liabilities for leases with terms of 12 months or less. Upon adoption, the Company recognized (i) $0.4 million of operating lease ROU assets recorded in other non-current assets on the Condensed Consolidated Balance Sheets and (ii) operating lease liabilities of $0.2 million recorded in other current liabilities and $0.2 million recorded in other non-current liabilities on the Condensed Consolidated Balance Sheets. The adoption of ASC 842 did not materially impact the condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of equity and condensed consolidated statements of cash flows. In June 2016, the FASB issued ASU 2016-13, which, together with subsequent amendments, amends the requirement on the measurement and recognition of expected credit losses for financial assets held. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with early adoption permitted. The Company determined that available-for-sale securities, accounts receivable and contract assets are the applicable financial assets that are subject to this ASU and adopted the guidance on January 1, 2022. The Company modified the impairment model related to the available-for-sale securities from the “other-than-temporary” impairment model to the “current expected credit losses” model and determined that an allowance for credit loss is not needed as of January 1, 2022 based on various factors, including the length of time and extent to which fair value has been lower than the cost basis, the financial condition and near-term prospects of the issuer and forecasted economic data. The Company adopted the new guidance on a modified retrospective basis through a cumulative-effect adjustment to the accumulated deficit on January 1, 2022. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740. The update also simplifies GAAP for other areas of ASC 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update was effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. The Company adopted this standard effective January 1, 2021. The Company has completed its assessment of this ASU and determined that it does not have a material impact on the Company’s consolidated financial statements.
|
INVESTMENTS |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVESTMENTS | INVESTMENTS Available-for-Sale Securities (Marketable Securities) The Company’s investments in marketable securities are classified and accounted for as available-for-sale and consist of high quality asset-backed securities, commercial paper, corporate bonds and U.S. government agency debt securities. The Company’s marketable securities with remaining effective maturities of 12 months or less from the balance sheet date are classified as current; otherwise, they are classified as non-current on the Consolidated Balance Sheets. Unrealized gains and losses on marketable securities classified as available-for-sale are recognized in other comprehensive income (loss). The Company’s marketable securities by security type are summarized as follows:
As of June 30, 2022 and December 31, 2021, the Company recorded $2.6 million and $0.7 million, respectively, of gross unrealized losses in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets, primarily due to a decrease in the fair value of the corporate bonds. Contractual maturities of the Company’s available-for-sale and trading securities are summarized as follows:
The Company regularly reviews its investment portfolio to identify and evaluate investments that have indications of possible impairment. Investments that are impaired are those that are considered to have losses that are other-than-temporary. Factors considered in determining whether a loss is temporary include: •the length of time and extent to which fair value has been lower than the cost basis; •the financial condition, credit quality and near-term prospects of the investee; and •whether it is more likely than not that the Company will be required to sell the security prior to recovery. As of June 30, 2022, the Company had not identified any impairment indicators in its investments. During the three and six months ended June 30, 2022, the Company received $55.8 million and $95.4 million, respectively, of proceeds from maturities and call redemptions. The Company received $20.6 million and $28.7 million of proceeds from sales of money market funds, which are classified as cash and cash equivalents, for the three and six months ended June 30, 2022, respectively. The Company recorded minimal realized losses from the sale of available-for-sale securities. Gains and losses are determined using the first-in first-out method. The Company did not sell or redeem marketable securities during the three and six months ended June 30, 2021. Trading Securities (Convertible Promissory Note) In July 2021, the Company purchased a convertible promissory note (the “Note”) from a counterparty for $4.0 million. In November 2021 and March 2022, the Company executed additional convertible promissory notes in the amounts of $0.3 million and $0.3 million, respectively, under the same terms as the initial Note (collectively referred to as the “Notes”). The outstanding principal of the Notes, together with unpaid and accrued interest, was originally due and payable on September 30, 2022. The maturity date was extended to November 15, 2022. The Notes contained certain embedded features, including: acceleration in the event of default; automatic conversion into the equity of the counterparty upon a subsequent equity financing by the counterparty; optional conversion into equity upon the sale of preferred stock by the counterparty; and optional acceleration or conversion into equity upon certain corporate transactions by the counterparty. Interest accrued at 6% per annum. The Notes met the definition of a debt security under the provisions of ASC 320, Investments - Debt Securities. During the three and six months ended June 30, 2022, the Company recorded a loss on the Notes of $2.5 million and $1.5 million, respectively. The Company did not have Level 3 investments during the three and six months ended June 30, 2021. The change in fair value of the Notes is recorded on the Condensed Consolidated Statements of Operations and Comprehensive Loss. As of June 30, 2022, the fair value of the Notes was $3.1 million and classified as trading securities and presented in prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets.
|
FAIR VALUE MEASUREMENTS |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS The Company’s financial assets and liabilities that are measured at fair value on a recurring basis are summarized as follows:
The Company’s investments in money market funds backed by U.S. government securities have been classified as Level 1 as they are valued utilizing quoted prices (unadjusted) in active markets for identical assets. Investments in asset-backed securities, commercial paper, corporate bonds and U.S. government agency debt securities have been classified as Level 2 as they are valued using quoted prices in less active markets or other directly or indirectly observable inputs. Fair values of corporate bonds and U.S. government agency debt securities were derived from a consensus or weighted-average price based on input of market prices from multiple sources for the reporting period. With regard to commercial paper, all of the securities had high credit ratings and one year or less to maturity; therefore, fair value was derived from accretion of purchase price to face value over the term of maturity or quoted market prices for similar instruments if available. The Company’s investments in the Notes were classified as Level 3 in the fair value hierarchy because they relied significantly on inputs that are unobservable in the market. The conversion price was dependent on varying events and equity value and therefore has been estimated using a Monte Carlo model to simulate the various future events. Significant assumptions included: (i) the timing and amount of a subsequent equity financing, if any; (ii) the equity value of the counterparty as of June 30, 2022; (iii) once converted into equity, the timing of any liquidity event; (iv) the counterparty undergoing a dissolution if the new equity financing did not occur before the maturity of the Notes; and (v) an assumed recovery rate in a dissolution event. The Notes were measured at fair value using a Monte Carlo simulation model at each measurement date. The Company elected to apply the fair value option and account for the hybrid instrument containing the Notes and the embedded derivatives at fair value as a single instrument, with any subsequent changes in fair value being reported in earnings. As of June 30, 2022, Level 3 fair value measurement inputs were (i) volatility, 80%; (ii) risk free rate, U.S. Constant Maturity Treasury Yields, and (iii) term, 0.24 years. During the three and six months ended June 30, 2022, there were no transfers of financial assets between Level 1 and Level 2. The Company’s warrant liability includes private placement warrants that were originally issued in connection with the TSIA IPO that Legacy Latch assumed as part of the Closing of the Business Combination (the “Private Placement Warrants”). The Private Placement Warrants are recorded on the Condensed Consolidated Balance Sheets at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the valuation will be adjusted to fair value, with the change in fair value recognized in the consolidated statements of operations and comprehensive loss. The Private Placement Warrants are held by a single holder. ASC 820, Fair Value Measurements, indicates that the fair value should be determined “from the perspective of a market participant that holds the identical item” and “use the quoted price in an active market held by another party, if that price is available.” As the only market for the transfer of the Private Placement Warrants is the public market, the Company has determined that the fair value of the Private Placement Warrants at a specific date is determined by the closing price of the Company’s public warrants, traded under the symbol “LTCHW,” and within Level 2 of the fair value hierarchy. The closing price of the public warrants was $0.15 and $1.84 as of June 30, 2022 and December 31, 2021, respectively. The fair value of the Private Placement Warrants was $0.8 million and $9.8 million as of June 30, 2022 and December 31, 2021, respectively. The following table represents the activity of the Level 3 instruments:
(a)Recorded in other income (expense) within the Condensed Consolidated Statements of Operations and Comprehensive Loss. The Company purchased trading securities during the six months ended June 30, 2022, which are categorized as Level 3 in the fair value hierarchy. Except as discussed in Note 4. Investments in relation to the conversion of the Notes and as shown in the table above, there were no sales of Level 3 instruments during the three and six months ended June 30, 2022. There were no transfers of instruments into or out of Level 3 during the three and six months ended June 30, 2022.
|
INVENTORIES, NET |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVENTORIES, NET | INVENTORIES, NET Inventories, net consisted of the following:
Hardware shipped to channel partners is considered channel inventory until there is evidence a contract exists and control has passed to the customer. Inventories, net are stated at the lower of cost or net realizable value at their cost being determined using the average cost method. Inventories, net are written down to their net realizable value if they have a cost basis in excess of expected net realizable value. The Company did not write down channel inventory for the three and six months ended June 30, 2022 and did not experience any significant inventory write-downs for the three and six months ended June 30, 2021. There was no charge on channel partner inventory to the lower of cost or net realizable value for the three and six months ended June 30, 2022. As of June 30, 2022, net inventories in excess of one year of historical sales are classified as other non-current assets on the Condensed Consolidated Balance Sheets.
|
INTERNALLY DEVELOPED SOFTWARE, NET |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research and Development [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INTERNALLY DEVELOPED SOFTWARE, NET | INTERNALLY-DEVELOPED SOFTWARE, NET Internally-developed software, net consisted of the following:
During the three and six months ended June 30, 2022, the Company capitalized $2.7 million and $5.1 million, respectively, in internally-developed software. During the three and six months ended June 30, 2021, the Company capitalized $2.1 million and $3.5 million, respectively, in internally-developed software. Capitalized costs associated with software-in-development are not amortized into amortization expense until the related assets are put into service. Total amortization expense related to internally-developed software for the three and six months ended June 30, 2022 was $0.9 million and $1.7 million, respectively. Total amortization expense related to internally-developed software for the three and six months ended June 30, 2021 was $0.5 million and $1.0 million, respectively. Impairment expense was $0.1 million and $0.4 million for the three and six months ended June 30, 2022, which is included in general and administrative expense on the Condensed Consolidated Statement of Operations and Comprehensive Loss. Impairment expense was zero and zero for the three and six months ended June 30, 2021, which is included in amortization expense on the Condensed Consolidated Statement of Operations and Comprehensive Loss.
|
ACCRUED EXPENSES |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCRUED EXPENSES | ACCRUED EXPENSES Accrued expenses consisted of the following:
|
COMMITMENTS AND CONTINGENCIES |
6 Months Ended |
---|---|
Jun. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Purchase Commitments The Company subcontracts with third-party contract manufacturers to build most Latch hardware products. During the normal course of business and consistent with industry practice, contract manufacturers procure components and build finished goods based upon a forecasted demand plan provided by the Company. Although the Company is allowed to cancel or reschedule orders, there are situations when orders cannot be cancelled, such as when a demand plan change occurs after a contract manufacturer has purchased the components or built the finished goods based on a previous demand plan. The Company materially reduced its demand plan in the second quarter of 2022 and started engaging in discussions with its contract manufacturers regarding the Company’s obligation to purchase inventory based on the original demand plan. As of June 30, 2022, the Company had unfunded non-cancellable purchase commitments of approximately $26.3 million. The Company records a liability for non-cancellable orders to the extent it does not expect to be able to use the inventory related to such orders. As of June 30, 2022 and the year ended December 31, 2021, the Company accrued $4.0 million and $0.5 million, respectively, for non-cancellable inventory purchase commitments. See Note 8. Accrued Expenses. Registration Rights Agreement In connection with the execution of the Merger Agreement, the Company and certain stockholders of Legacy Latch and TSIA entered into an amended and restated registration rights agreement (the “2021 Registration Rights Agreement”). Pursuant to the 2021 Registration Rights Agreement, in June 2021, the Company filed a registration statement on Form S-1 with respect to the registrable securities under the 2021 Registration Rights Agreement. Certain Legacy Latch stockholders and TSIA stockholders may each request to sell all or any portion of their registrable securities in an underwritten offering up to two times in any 12-month period, so long as the total offering price is reasonably expected to exceed $75.0 million. The Company also agreed to provide certain demand and “piggyback” registration rights. The 2021 Registration Rights Agreement also provides that the Company pays certain expenses relating to such registrations and indemnifies the stockholders against certain liabilities. The Company bears the expenses incurred in connection with the filing of any such registration statements. The 2021 Registration Rights Agreement does not provide for any penalties connected with delays in registering the Company’s common stock. Legal Contingencies Securities Litigation On August 31, 2022, an alleged stockholder of Latch stock filed a purported securities class action complaint in the United States District Court for the Southern District of New York (Brennan v. Latch, Inc., et al., Case No. 1:22-cv-07473, the “Brennan Action”). The complaint alleges that the Company and certain of its former officers violated Section 10(b) of the Exchange Act, Rule 10b-5 promulgated thereunder and Section 20(a) of the Exchange Act by making false or misleading statements regarding the Company’s business, operations and prospects. The complaint includes claims for damages, including interest, and an award of reasonable costs and attorneys’ fees and expert fees to the putative class. On January 17, 2023, the court appointed VB PTC Establishment as Trustee of Gersec Trust as lead plaintiff. On November 12, 2024, the Company and lead plaintiff filed with the court a settlement agreement pursuant to which the Company agreed to pay the settlement class in the amount of $1.95 million in exchange for the dismissal of all claims against the defendants (including the Company). The settlement remains subject to approval by the court, and a preliminary hearing has been set for January 16, 2025. Under the terms of the proposed settlement, the defendants (including the Company) continue to deny any liability or wrongdoing. Latch does not expect insurers to contribute to the settlement amount. Because the complaint was filed in the quarter ended September 30, 2022, the amount of the proposed settlement is not reflected in the accompanying condensed consolidated financial statements. On January 11, 2023, an alleged stockholder of Latch stock filed a purported securities class action complaint in the United States District Court for the District of Delaware (Schwartz v. Latch, Inc., et al., Case No. 1:23-cv-00027, the “Schwartz Action”). The complaint alleges that the Company and certain of its current and former directors violated Sections 11 and 15 of the Securities Act by making false or misleading statements regarding the Company’s business, operations and prospects. The complaint includes claims for damages, including interest, and an award of reasonable costs and attorneys’ fees and expert fees to the putative class. At this time, the Company is unable to estimate potential losses, if any, related to this action. The Company does not believe the allegations are meritorious and intends to vigorously defend against them. On April 24, 2023, the court appointed Scott Schwartz as lead plaintiff. In May 2023, the parties agreed to stay the action pending completion of the Restatement, and to allow the lead plaintiff a period of 21 days following completion of the Restatement in which to file an amended complaint. On September 27, 2024, the Company filed a motion to transfer the complaint to the United States District Court for the Southern District of New York. The motion was denied on November 13, 2024. In December 2024, the parties agreed in principle to a settlement and entered into a binding memorandum of understanding pursuant to which the Company agreed to pay the settlement class in the amount of $1.95 million in exchange for the dismissal of all claims against the defendants (including the Company). The settlement remains subject to a final stipulation of settlement and approval by the court. On May 9, 10, and 19, 2023, three alleged stockholders of Latch stock filed purported class action complaints in the Court of Chancery of the State of Delaware: Kilari v. TS Innovation Acquisitions Sponsor, LLC, et al., C.A. No. 2023-0509; Subramanian v. TS Innovation Acquisitions Sponsor, LLC, et al., C.A. No. 2023-0514; and Garfield v. Speyer, et al., C.A. No. 2023-0504 (together, the “Fiduciary Lawsuits”). On July 6, 2023, the court consolidated the Fiduciary Lawsuits under the caption In re TS Innovation Acquisitions Sponsor, LLC Stockholder Litigation, No. 2023-0509-LWW (Del. Ch.) and appointed Phanindra Kilari, Subash Subramanian and Robert Garfield as co-lead plaintiffs. The Fiduciary Lawsuits allege that TSIA and certain of its former members and directors breached their fiduciary duties by making false or misleading statements in connection with the merger between Latch and TSIA. The Fiduciary Lawsuits include claims for unjust enrichment, damages, and an award of costs and attorneys’ fees to the putative class. Pursuant to the January 24, 2021 Merger Agreement between the Sponsor and Legacy Latch, Latch has agreed to indemnify and hold harmless, to the fullest extent permitted by law, TSIA and each of its directors and officers (present and former) named as defendants in the Fiduciary Lawsuits against any costs or expenses, reasonable attorneys’ fees, losses, damages, or liabilities incurred in connection with these actions. On December 2, 2024, the defendants and lead plaintiffs filed with the court a settlement pursuant to which the defendants agreed to pay the settlement class in the amount of $29.75 million in exchange for the dismissal of all claims against the defendants and the Company. The settlement remains subject to approval by the court. Latch and TS Innovation Acquisitions Sponsor, LLC agreed to share the costs of the settlement amount equally. Latch expects insurers to pay $10.0 million of Latch’s $14.875 million share of the settlement amount. Because the complaints were filed in 2023, neither the amount of the proposed settlement nor any expected insurance contributions are reflected in the accompanying condensed consolidated financial statements. Derivative Litigation On February 15 and July 13, 2023, two alleged stockholders of Latch stock filed derivative actions purportedly on behalf of Latch in the United States District Court for the Southern District of New York: Manley v. Latch, Inc., et al., Case No. 1:23-cv-01273 (the “Manley Action”) and Gottlieb v. Latch, Inc., et al., Case No. 1:23-cv-07473 (the “Gottlieb Action”). The complaints generally allege that that certain directors and former officers of the Company breached their fiduciary duties and violated Section 14(a) of the Exchange Act by making false or misleading statements regarding the Company’s business, operations and prospects. Both complaints seek orders permitting plaintiffs to maintain each action derivatively on behalf of the Company, awarding unspecified damages allegedly sustained by the Company, awarding restitution from the individual defendants, requiring the Company to make certain reforms to its corporate governance and controls and awarding costs and attorneys’ fees. The Gottlieb Action includes additional claims for unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets and contribution against certain individual defendants named in the Brennan Action and Schwartz Action. At this time, the Company is unable to estimate potential losses, if any, related to these actions. The Company does not believe the allegations are meritorious and intends to vigorously defend against them. On August 1, 2023, the court consolidated the Manley Action and Gottlieb Action under the caption In re Latch Inc. Derivative Litigation, Case No. 1:23-cv-01273. The parties agreed to stay the action until 21 days following the resolution of any and all motions to dismiss both the Brennan Action and the Schwartz Action. Service Provider Demand The Company is in discussions with a service provider related to a demand for payment under a prior agreement. The Company does not believe that the service provider is entitled to any fees under the prior agreement. However, the Company believes it is probable that an agreement with the service provider will be reached and that the amount the Company will pay the service provider in connection with the dispute and the resolution thereof can be reasonably estimated. As of June 30, 2022 and December 31, 2021, the Company had accrued approximately $6.8 million in connection with the dispute. The Company believes it is reasonably possible that this potential exposure may change based on the resolution of the ongoing discussions. No legal proceedings have been initiated with respect to this demand for payment or the prior agreement with the service provider. SEC Investigation In March 2023, the staff of the SEC (the “SEC Staff”) requested a meeting with the Company’s outside counsel to discuss the findings of the Investigation and related matters (the “SEC Investigation”). The SEC Staff also asked that the Company voluntarily provide certain documents in advance of the meeting, which the Company did. In April 2023, outside counsel and advisors conducted an initial meeting with the SEC Staff to discuss the findings of the Investigation. In August 2023, the SEC Staff requested the Company voluntarily provide additional documents and information relating to the Investigation and related matters. The Company has continued to communicate with the SEC Staff, and the Company has continued to voluntarily produce documents and information. The Company may receive additional requests for documents and information from the SEC Staff. The Company has cooperated fully with the SEC Investigation and will continue to do so. Other The Company is and may become, from time to time, involved in other legal actions in the ordinary course of business, including governmental and administrative investigations, inquiries and proceedings concerning employment, labor, environmental and other claims. Although management is unable to predict with certainty the eventual outcome of any legal action, management believes the ultimate liability arising from such actions, individually and in the aggregate, which existed at June 30, 2022 (other than detailed above), will not materially affect the Company’s consolidated results of operations, financial position or cash flows. Given the inherent unpredictability of these types of proceedings, however, it is possible that future adverse outcomes could have a material effect on the Company’s financial results.
|
EQUITY |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EQUITY | EQUITY The Company’s second amended and restated certificate of incorporation designates and authorizes the Company to issue 1.1 billion shares, consisting of (i) 1.0 billion shares of common stock, par value $0.0001 per share; and (ii) 100.0 million shares of preferred stock, par value $0.0001 per share. Common Stock Reserved for Future Issuance As of June 30, 2022 and December 31, 2021, the Company’s reserved shares for future issuance included the following:
(1) As adjusted for the Exchange Ratio. Warrants As part of the Closing of the Business Combination, 10.0 million public warrants sold during the TSIA IPO converted into 10.0 million public warrants to purchase up to 10.0 million shares of common stock of the Post-Combination Company, which are exercisable at $11.50 per share. The Company accounts for warrants as required under ASC 815 and has concluded that equity classification would be met for the public warrants as the Company has a single class of equity, and thus all holders vote 100% on all matters submitted to the Company’s stockholders and receive the same form of consideration in the event of a change of control (thus qualifying for the exception to the net cash settlement model), and the other conditions of equity classification would be met. Fair Valuation Methodology - Private Placement Warrants The Private Placement Warrants, which Legacy Latch assumed as part of the Closing of the Business Combination, are recorded as warrant liabilities. See Note 5. Fair Value Measurements.
|
EARNINGS PER SHARE |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EARNINGS PER SHARE | EARNINGS PER SHARE The following table sets forth the computation of basic and diluted net loss per share for common stock:
The table below sets forth the number of potential common shares underlying outstanding common stock options, RSUs and common stock warrants that were excluded from diluted net loss per share as the Company had net losses for the six months ended June 30, 2022 and twelve months ended December 31, 2021, and their inclusion would be anti-dilutive:
(1) Amount includes 17,373 and 21,356 liability-based RSUs as of June 30, 2022 and December 31, 2021, respectively, that the Company settled in cash. As a result, the shares of common stock underlying the liability-based RSUs upon vesting were not issued and were returned to the 2021 Incentive Award Plan as available shares.
|
INCOME TAXES |
6 Months Ended |
---|---|
Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES The income tax provision for the three and six months ended June 30, 2022 was $0.02 million and $0.03 million, respectively. The income tax provision for both the three and six months ended June 30, 2021 was $0.03 million. For the three and six months ended June 30, 2022 and 2021, the Company’s effective tax rate was different from the U.S. federal statutory rate. This difference is primarily attributable to the effect of state and local income taxes and permanent differences between expenses deductible for financial reporting purposes offset by the valuation allowances placed on the Company’s deferred tax assets. As of June 30, 2022, no liability for unrecognized tax benefits was required to be recorded by the Company. Management does not expect any significant changes in its unrecognized tax benefits in the next 12 months. To date, the Company has incurred cumulative net losses and maintains a full valuation allowance on its net deferred tax assets as the Company has determined that it is more than likely than not that these assets will not be fully realized.
|
STOCK-BASED COMPENSATION |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION For the years ended June 30, 2022 and 2021, the components of stock-based compensation expense were as follows:
Stock-based compensation expense is included in cost of revenue, research and development, sales and marketing and general and administrative on the Consolidated Statements of Operations and Comprehensive Loss as follows:
Stock Incentive Plans In January 2016, Legacy Latch adopted the Latch, Inc. 2016 Stock Plan (the “2016 Plan” and, together with the Latchable, Inc. 2014 Stock Incentive Plan, the “Prior Plans”). Under the 2016 Plan, Legacy Latch’s board of directors was authorized (i) to grant either incentive stock options (“ISOs”) or non-qualified stock options (“NSOs”) to purchase shares of the Company’s common stock to its employees and (ii) to grant NSOs to purchase shares of the Company’s common stock to outside directors and consultants. When the 2021 Plan (defined below) became effective, 22,797,955 shares (adjusted for the Exchange Ratio) had been authorized for issuance under the 2016 Plan. Stock options under the 2016 Plan were granted with an exercise price equal to the stock’s fair market value at the grant date. Stock options outstanding under the 2016 Plan generally have ten-year terms and vest over a four-year period starting from the date specified in each award agreement. Since the effectiveness of the 2021 Plan, no additional awards have been or will be granted under the 2016 Plan. Upon the effectiveness of the Business Combination, all outstanding stock options under the Prior Plans, whether vested or unvested, converted into options to purchase a number of shares of common stock of the Post-Combination Company based on the Exchange Ratio. Awards previously granted under a Prior Plan remain subject to the provisions of such Prior Plan. The Latch, Inc. 2021 Incentive Award Plan (the “2021 Plan”) was approved by the TSIA stockholders at the Special Meeting on June 3, 2021 and became effective upon the Closing. The 2021 Plan provides for the grant of stock options, including ISOs and NSOs, stock appreciation rights, restricted stock, RSUs and other stock-based and cash-based awards. The 2021 Plan has a term of ten years. The aggregate number of shares of the Company’s common stock available for issuance under the 2021 Plan is equal to (i) 22,500,611 shares plus (ii) an annual increase for ten years on the first day of each calendar year beginning on January 1, 2022, equal to the lesser of (A) 5% of the aggregate number of shares of the Company’s common stock outstanding on the last day of the immediately preceding calendar year and (B) such smaller amount of shares as determined by the Board. Effective January 1, 2022, the number of shares reserved for future issuance under the 2021 Plan increased by 7,116,177 shares. As of June 30, 2022, 24,359,792 shares had been granted under the 2021 Plan. Effective January 1, 2023 and January 1, 2024, the number of shares reserved for future issuance under the 2021 Plan increased by 7,267,376 shares and 8,810,007 shares, respectively. Stock Options A summary of the status of employee and non-employee stock options as of June 30, 2022, and changes during 2022, is presented below:
The weighted average grant date fair value of options granted during the year ended December 31, 2021 was $1.60. No stock options were granted during the quarter ended June 30, 2022. The Company records stock-based compensation expense on a straight-line basis over the vesting period. As of June 30, 2022, total compensation expense not yet recognized related to unvested stock options was $1.0 million, which was expected to be recognized over a weighted-average period of 1.5 years. Additionally, the Company records forfeitures as they occur. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which affect the fair value of each stock option. Restricted Stock Units During 2022 and 2021, the Company granted RSUs to employees, independent directors and consultants under the 2021 Plan. The equity-based RSUs are settled in shares of common stock upon vesting and the liability-based RSUs are settled in cash upon vesting. The RSUs vest over a period of to four years. The Company has the option, but not the obligation, to treat a participant’s failure to provide timely payment of any withholding tax arising in connection with RSUs as such participant’s election to satisfy all or any portion of the withholding tax by requesting the Company retain shares otherwise issuable pursuant to the RSU. As noted above, in connection with the Restatement, the Company suspended use of its registration statement on Form S-8 under the Securities Act on August 10, 2022. Since such date, the Company has not granted any RSUs. Equity-based A summary of equity-based RSU activity for the six months ended June 30, 2022 is presented below.
Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the RSUs. The unrecognized stock-based compensation expense related to the unvested RSUs was $66.8 million as of June 30, 2022 and will be expensed over a weighted-average period of 2.2 years. In addition, approximately 0.1 million and 0.2 million RSUs vested during the three and six months ended June 30, 2022, respectively, but were not released at the time of vesting due to the suspension of the S-8 Registration Statement. Liability-based A summary of liability-based RSU activity for the six months ended June 30, 2022 is presented below.
Liability-based RSU expense is recognized on a straight-line basis through the vesting date of the RSUs. For the quarter ended June 30, 2022, the Company recognized $0.003 million of bonus expense within cost of hardware revenue in the Consolidated Statements of Operations and Comprehensive Loss. The unrecognized expense related to the unvested liability-based RSUs was $0.02 million as of June 30, 2022 and will be expensed over a weighted-average period of 2.0 years. The Company settled 1,992 liability-based RSUs for $0.01 million in cash for the three months ended June 30, 2022. Modification of Stock Options and RSUs In the six months ended June 30, 2022, the Company completed a reduction in force (the “May 2022 RIF”). In connection with the May 2022 RIF, the Company modified the option and RSU awards of approximately 70 employees to accelerate the vesting of 505,451 unvested RSUs that were improbable of vesting as of the modification date. The modification was treated as a Type III modification in accordance with ASC 718, which is accounted for as the cancellation of the original award and the issuance of a new award under the modified terms. This led to the reversal of previously recognized share-based compensation expense amounting to $4.0 million, offset by the fair value of the new award of $0.7 million as of the modification date, resulting in a net reversal of $3.3 million to the share-based compensation expense. Secondary Purchase On January 19, 2021, one of Legacy Latch’s existing equity holders acquired an additional 2.8 million shares (as adjusted based on the Exchange Ratio) of Legacy Latch’s common stock from certain employees and non-employee service providers at a price per share of $9.92 (as adjusted based on the Exchange Ratio). This price was determined based on the pre-money equity valuation ascribed to the Post-Combination Company by TSIA and the estimated conversion ratio at the time of the sales. The foregoing sales were consummated directly among the equity holders to satisfy the acquiring equity holder’s demand for additional shares of Legacy Latch’s common stock without increasing the size of the PIPE Investment and causing incremental dilution to investors in the Post-Combination Company. Legacy Latch determined that the price per share paid by the equity holder was in excess of fair value. The Company recorded $13.8 million during the year ended December 31, 2021 in stock-based compensation expense related to the transaction, which was allocated to research and development, sales and marketing, and general and administrative in the Consolidated Statements of Operations and Comprehensive Loss. Cash Election Prior to the Business Combination, Legacy Latch’s holders of vested stock options were given an election to cancel up to 25% of the vested stock options in exchange for $10.00 per share less the exercise price applicable to each share. An aggregate amount of approximately 0.3 million options were cancelled (adjusted for the Exchange Ratio). Payment for the cash election in the amount of $2.6 million was funded as part of the PIPE Investment and 0.3 million newly issued shares of common stock were granted (see Note 1. Description of Business).
|
RELATED-PARTY TRANSACTIONS |
6 Months Ended |
---|---|
Jun. 30, 2022 | |
Related Party Transactions [Abstract] | |
RELATED-PARTY TRANSACTIONS | RELATED-PARTY TRANSACTIONS Throughout the Company’s history, the Company has obtained equity funding from strategic partners with whom the Company transacts through the ordinary course of business. As such, the Company has customers who are also stockholders and directors, or affiliates thereof, in the Company. The Company charges market rates for products and services that are offered to these customers. As of June 30, 2022 and December 31, 2021, the Company had $0.2 million and $0.4 million, respectively, of receivables due from these customers, which are included within accounts receivable on the Condensed Consolidated Balance Sheets. For the three and six months ended June 30, 2022, the Company had $0.01 million and $0.01 million, respectively, of hardware revenue from these customers, and $0.04 million and $0.1 million, respectively, of software revenue from these customers, which was included within the Condensed Consolidated Statements of Operations and Comprehensive Loss. For the three and six months ended June 30, 2021, the Company had $0.2 million and $0.3 million, respectively, of hardware revenue from these customers, and $0.1 million and $0.3 million, respectively, of software revenue from these customers, which was included within the Condensed Consolidated Statements of Operations and Comprehensive Loss. In January 2021, one of the Company’s existing equity holders acquired shares of Legacy Latch’s common stock from certain employees and non-employee service providers. See Note 13. Stock-Based Compensation.
|
SUBSEQUENT EVENTS |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date of these financial statements and determined that there have been no events that have occurred that would require adjustments to its disclosures in the consolidated financial statements, except for the following: HDW Acquisition On May 15, 2023, the Company, LS Key Merger Sub 1, Inc., a wholly-owned subsidiary of the Company (“Merger Sub I”), and LS Key Merger Sub 2, LLC, a wholly-owned subsidiary of the Company (“Merger Sub II”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Honest Day’s Work, Inc. (“HDW”). On July 3, 2023 (the “Closing Date”), (i) Merger Sub I merged with and into HDW, with HDW continuing as the surviving corporation (the “First Merger”), and subsequently, (ii) HDW merged with and into Merger Sub II, with Merger Sub II continuing as the surviving entity and a wholly-owned subsidiary of the Company (together with the First Merger, the “Mergers”) (the “HDW Acquisition”). On the Closing Date, the Company issued to HDW’s stockholders as merger consideration (i) $22.0 million aggregate principal amount of unsecured promissory notes (the “Promissory Notes”) and (ii) approximately 29.0 million shares of the Company’s common stock (the “Consideration Shares”). Certain of HDW’s stockholders (the “Ineligible Holders”) that were not eligible to receive unregistered shares of the Company’s common stock received $0.76 in lieu of each Consideration Share such stockholder would otherwise have received as merger consideration, with the total cash consideration paid to all Ineligible Holders equaling approximately $0.02 million. Upon the Closing Date, Latch indirectly acquired all of HDW’s assets, including its intellectual property and $8.0 million in cash. Additionally, approximately 35 HDW team members joined Latch. The Consideration Shares were originally non-transferable until July 3, 2028 (the “Restricted Period”), subject to certain accelerated releases. As a result of the Company’s delisting from Nasdaq, the Restricted Period now terminates on April 15, 2027. In the event the Company’s 60 trading day VWAP exceeds the price thresholds set forth in the table below (the “Share Price Thresholds”), the applicable portion of the Consideration Shares set forth below will be released from transfer restrictions:
In addition, there may be accelerated releases of the Consideration Shares in connection with a change of control of the Company. In connection with the Mergers, the Company and Jamie Siminoff entered into a stock restriction agreement, dated May 15, 2023 (the “Original Siminoff Stock Restriction Agreement”). Pursuant to the Original Siminoff Stock Restriction Agreement, in the event Mr. Siminoff ceased to be an employee of the Company prior to July 3, 2028, the Company had the right to repurchase all of Mr. Siminoff’s Consideration Shares that had not already been released from transfer restriction, subject to certain exceptions. In the event Mr. Siminoff was terminated without Cause or resigned for Good Reason (each as defined in the Siminoff Employment Agreement (as defined below)), or upon his death or disability (each, an “Exit”), his Consideration Shares would accelerate in an amount equal to the greater of (i) the number of Consideration Shares to which he was entitled pursuant to the Share Price Thresholds (with linear interpolation of Consideration Shares based on the 60 trading day VWAP as of the date of Exit) and (ii) the number of Consideration Shares equal to the product of (a) his total Consideration Shares multiplied by (b) the quotient of (x) the number of calendar days between July 3, 2023 and his Exit divided by (y) 1,825; provided, however, that in no event would the number of Mr. Siminoff’s Consideration Shares that accelerate in connection with an Exit be less than 40% of the total number of his Consideration Shares. The Promissory Notes accrued paid-in-kind interest at a rate of 10% per annum and were scheduled to mature on July 3, 2025, unless earlier accelerated in connection with an event of default (including certain events of delisting from Nasdaq) or change of control of the Company. On April 26, 2024, the Company repaid the Promissory Notes in full without penalty. The Company paid an aggregate of $23.9 million in principal and accrued interest to the holders of the Promissory Notes. On the Closing Date, in connection with the consummation of the Mergers and as contemplated by the Merger Agreement, the Company and certain of HDW’s stockholders (the “Holders”) entered into that certain Registration Rights Agreement (the “2023 Registration Rights Agreement”), pursuant to which the Company agreed to file a shelf registration statement registering the resale of the Registrable Securities (as defined in the 2023 Registration Rights Agreement) as promptly as reasonably practicable after the date on which the Company files its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (and no later than the 20th business day following the filing date of such Quarterly Report). Up to twice in any 12-month period, the Holders may request to sell all or any portion of their Registrable Securities in an underwritten offering so long as the total offering price is reasonably expected to exceed $25 million. The Company also agreed to provide customary “piggyback” registration rights to certain Holders designated as “Major Equityholders,” subject to certain requirements and customary conditions. The 2023 Registration Rights Agreement also provides that the Company will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities. In connection with the Mergers, the Company and Mr. Siminoff entered into an employment agreement, dated May 15, 2023 (the “Siminoff Employment Agreement”). Pursuant to the Siminoff Employment Agreement, on the Closing Date, Mr. Siminoff was appointed as the Company’s Chief Strategy Officer. At the time, Mr. Siminoff was expected to be appointed as Chief Executive Officer of the Company following the completion of the Restatement. As described below under “— November 2024 Executive Transition,” Mr. Siminoff will no longer be appointed as the Company’s Chief Executive Officer upon completion of the Restatement. 2023 RIFs and Severance Payments In July 2023, the Company commenced a reduction in force (the “July 2023 RIF”) in order to streamline its business operations, reduce costs and complexities in the business and create further operating efficiencies. The July 2023 RIF, substantially completed in the fourth quarter of 2023, impacted approximately 95 employees, or approximately 70% of the Company’s full-time employees at the time. In connection with the January 2023 resignation of Luke Schoenfelder, Chief Executive Officer, and Barry Schaeffer, Interim Chief Financial Officer, (i) Mr. Schoenfelder was entitled to receive severance compensation of $708,000 and the extension of the post-termination exercise window applicable to Mr. Schoenfelder’s stock options granted on May 11, 2016 and (ii) Mr. Schaeffer was entitled to receive severance compensation of $403,200. In connection with the July 2023 Transition and Separation Agreement entered into between Brian Jones, Chief Technology Officer, and the Company, Mr. Jones was entitled to receive severance compensation of $406,250, the acceleration of the vesting of 50,000 of his outstanding RSUs and the extension of his post-termination exercise window for certain of his outstanding stock options. Delisting On August 8, 2023, the Company received a notice from Nasdaq stating that it had determined to suspend trading of the Company’s securities on August 10, 2023 and commence delisting procedures because of the Company’s failure to regain compliance with its periodic filing obligations by the August 4, 2023 deadline previously set by Nasdaq. On March 21, 2024, Nasdaq filed a Form 25 with the SEC notifying the SEC of Nasdaq’s determination to remove the Company’s securities from listing on Nasdaq. The delisting was effective April 1, 2024. Headquarters Effective November 1, 2023, the Company relocated its headquarters to Olivette, Missouri occupying approximately 49,000 square feet of leased warehouse and office space. In January 2024, the Company entered into an amendment to the lease agreement, expanding the premises by approximately 13,000 square feet. The term of the lease agreement commenced March 1, 2024 and continues through June 1, 2029. The total commitment of approximately $2.1 million and is payable monthly with escalating rental payments over the approximate five year lease term. HelloTech Merger and Loan Agreement On June 21, 2024, the Company and LS HT Merger Sub, Inc., a wholly-owned subsidiary of the Company (“HT Merger Sub”), entered into an Agreement and Plan of Merger (the “HelloTech Merger Agreement”) with HelloTech, Inc. (“HelloTech”). On July 1, 2024, HT Merger Sub merged with and into HelloTech, with HelloTech continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “HelloTech Merger”). As consideration for the HelloTech Merger, the Company (i) as further specified below, assumed HelloTech’s outstanding borrowings under its existing term loan, which had outstanding borrowings of approximately $6.9 million as of July 1, 2024 (the “Prior Loan”) with Customers Bank and (ii) paid $250,000 of HelloTech’s merger-related expenses. HelloTech’s stockholders or other equity holders (including option holders, warrant holders or holders of simple agreements for future equity) did not receive any consideration in connection with the HelloTech Merger. On July 15, 2024, the Company, Latch Systems, Inc., a wholly-owned subsidiary of the Company (“Latch Systems”), and HelloTech (collectively with the Company and Latch Systems, the “Borrowers”) entered into an Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with Customers Bank. Pursuant to the Loan Agreement, Customers Bank issued the Borrowers a term loan in the principal amount of $6.0 million (the “New Loan”). The Loan Agreement, which amended and restated the terms of the Prior Loan, did not result in the Borrowers receiving any additional loan proceeds. Interest is payable on the New Loan at a rate equal to the greater of (a) the prime rate published in The Wall Street Journal or (b) 6.0%. The New Loan matures on July 15, 2029 (the “Maturity Date”). The Borrowers are required to pay interest on the New Loan monthly until January 15, 2025. Thereafter, the Borrowers are required to pay equal monthly installments of principal plus accrued interest until the Maturity Date. There is no penalty for prepayment of the New Loan. Pursuant to the Loan Agreement, the Borrowers have granted Customers Bank security interests in substantially all of the Borrowers’ assets, other than intellectual property. HelloTech is required to maintain an operating account with Customers Bank with a sufficient balance to support monthly payments. Additionally, the Borrowers are collectively required to maintain a liquidity ratio of at least 4.00, tested monthly, which is calculated as the quotient of unrestricted cash and cash equivalents of the Company and its subsidiaries (subject to certain limitations with respect to cash of foreign subsidiaries), divided by all outstanding indebtedness owed to Customers Bank. Compensation Program and Executive Officer Appointment On August 11, 2024 (the “Program Effective Date”), the Board approved an extension of its temporary cash-based leadership compensation program that was established in 2023 to provide certain cash compensation to the Company’s officers and key employees during the course of the Restatement. The leadership compensation program is described in more detail below. In addition, on the Program Effective Date, the Board approved a performance-based equity incentive program (the “Performance Equity Program”) pursuant to which awards of performance-vesting stock options (“Performance Options”) and performance-vesting restricted stock units (“PSUs”) will be granted to Company officers and service providers, and the Company granted Performance Options to certain officers and key service providers. The Performance Equity Program is described in more detail below. On the Program Effective Date, the Board also appointed Jason Mitura as the Company’s Chief Product Officer beginning August 16, 2024. On August 12, 2024, the Company entered into an employment agreement with Mr. Mitura in connection with his appointment. Under the Company’s cash-based leadership compensation program, Company officers and other participants receive an additional amount of cash compensation, payable in semi-monthly installments alongside their regular base salary, and are not eligible for any other cash incentive compensation or annual bonuses while the leadership compensation program is in place. On the Program Effective Date, the Board extended this program, originally scheduled to expire on July 31, 2024, until the earlier of (i) the listing of the Company on a national securities exchange or (ii) the date the Board determines in its discretion to terminate it. The annualized amounts payable under the program to Mr. Siminoff, David Lillis, Senior Vice President of Finance, and Mr. Mitura are $1,550,000, $475,000 and $650,000, respectively. The Performance Equity Program provides for the Company to grant awards under the 2021 Plan that will become eligible to vest based on the Company’s common stock reaching specified market trading prices (based on a trailing 60-day daily volume weighted average trading price) within seven years after the Program Effective Date. The Company expects that substantially all of its eligible employees will participate in the Performance Equity Program. Awards under the Performance Equity Program will generally be granted 50% in the form of PSUs that will become eligible to vest, or “earned,” in equally-sized tranches upon attaining a $1, $2 and $3 stock price hurdle, and 50% in the form of Performance Options that will become earned in equally-sized tranches upon attaining a $4, $5 and $6 stock price hurdle. Upon attainment of a stock price hurdle, 25% of the earned tranche of PSUs and Performance Options will vest, with the remaining 75% of such earned tranche vesting in equal annual installments over the next three years, subject to the applicable participant’s continued service through the vesting date. On the Program Effective Date, the Board granted Performance Options under the Performance Equity Program and the 2021 Plan to certain officers and key service providers, including to Messrs. Siminoff, Mitura and Lillis covering the following numbers of shares: Mr. Siminoff: 8,000,000 shares; Mr. Mitura: 7,500,000 shares; and Mr. Lillis: 3,000,000 shares (the “Initial Option Grant”). The Performance Options granted to Messrs. Siminoff and Mitura will be, or were, forfeited on the executives’ respective separation dates. As described above, the Performance Options are eligible to be earned in three tranches based on the Company’s common stock reaching market trading prices (based on a trailing 60-day daily volume weighted average trading price) before the seventh anniversary of the Program Effective Date, as set forth in the following table:
Upon attainment of a stock price hurdle, 25% of each earned tranche of Performance Options will vest, with the remaining 75% of such earned tranche vesting in equal annual installments over the next three years, subject to the applicable participant’s continued service through the vesting date. The Performance Options have an exercise price of $0.41 and a ten year term; however, any portion of the Performance Option corresponding to a tranche that has not become earned based on the achievement of a share price hurdle within seven years after the Program Effective Date will be cancelled and forfeited. In addition to the performance-based and service-based vesting requirements described above, (i) the first tranche of the Performance Option will, to the extent vested, only become exercisable in equal installments on the second, third, fourth and fifth anniversaries of the Program Effective Date, (ii) the second tranche of the Performance Option will, to the extent vested, only become exercisable in equal installments on the third, fourth, fifth and sixth anniversaries of the Program Effective Date, and (iii) the third tranche of the Performance Option will, to the extent vested, only become exercisable in equal installments on the fourth, fifth, sixth and seventh anniversaries of the Program Effective Date. On September 13, 2024, the Company granted approximately 8.6 million Performance Options under the Performance Equity Program to service providers, none of whom participated in the Initial Option Grant. Such Performance Options have an exercise price of $0.48 and are otherwise substantially identical to those granted in the Initial Option Grant. November 2024 Executive Transitions On November 18, 2024 (the “Siminoff Agreement Date”), the Company and Mr. Siminoff mutually agreed that Mr. Siminoff would step down as the Company’s Chief Strategy Officer on December 31, 2024 (the “Siminoff Separation Date”). Mr. Siminoff will remain in his current role through the Siminoff Separation Date, after which he will serve in an advisory role through December 31, 2026 (such advisory services, the “Advisory Services,” and such date, the “Advisory End Date”). Mr. Siminoff will cease to serve as an “executive officer” of the Company under Rule 3b-7 of the Exchange Act on the Siminoff Separation Date. Upon the Company’s request, in performing the Advisory Services, Mr. Siminoff is expected to, among other services, (i) meet with customers and stakeholders, (ii) assist or advise on product development, (iii) assist or advise on corporate development or strategic transactions and (iv) provide transition services. In addition, Mr. Siminoff will no longer be appointed as the Company’s Chief Executive Officer upon completion of the Restatement. In connection with Mr. Siminoff’s transition to the advisory role described above, on the Siminoff Agreement Date, Mr. Siminoff and the Company entered into a Separation and Advisory Agreement and Release (the “Siminoff Transition Agreement”). Pursuant to the Siminoff Transition Agreement, the Company and Mr. Siminoff agreed to amend and restate the Original Siminoff Stock Restriction Agreement. In addition, under the Siminoff Transition Agreement, the Company agreed to reimburse Mr. Siminoff for certain legal expenses. Pursuant to an amended and restated common stock restriction agreement, which was entered into between Mr. Siminoff and the Company on the Siminoff Agreement Date (the “Restated Restriction Agreement”), and in accordance with the terms of the Original Siminoff Stock Restriction Agreement, the Company exercised its repurchase option with respect to 15,260,540 shares of the Consideration Shares held by Mr. Siminoff (the “Repurchased Shares”) for $0.00005080 per share (the “Repurchase Price”), or a total payment of $775.24. The Repurchased Shares represent 80% of the 19,075,675 shares of the Consideration Shares received by Mr. Siminoff in connection with the HDW Acquisition. Pursuant to the Restated Restriction Agreement, the 3,815,135 Consideration Shares that were not repurchased by the Company (the “Remaining Shares”) are subject to transfer restrictions and an amended repurchase option (the “Amended Repurchase Option”) pursuant to which the Company has a right to repurchase the Remaining Shares at the Repurchase Price to the extent not released from the transfer restrictions and the Amended Repurchase Option by the fifth anniversary of the effective date of the Restated Restriction Agreement (the “Repurchase Trigger Date”). The Remaining Shares are split into two tranches with different provisions governing their release from the transfer restrictions and the Amended Repurchase Option: the Separation Shares and the Advisory Shares (each as hereafter defined). The “Separation Shares” consist of 2,861,351 shares (representing 75% of the Remaining Shares) and will be released from the transfer restrictions and the Amended Repurchase Option in equal tranches (each, a “Release Tranche”) as follows: i.20% of the Separation Shares will be released when the average final trading price of the Company’s common stock for any 60-trading day period prior to the Repurchase Trigger Date (the “Threshold Price”) is equal to or exceeds $1.00 (the “First Tier”); ii.20% of the Separation Shares will be released when the Threshold Price is equal to or exceeds $2.00 (the “Second Tier”); iii.20% of the Separation Shares will be released when the Threshold Price is equal to or exceeds $3.00 (the “Third Tier”); iv.20% of the Separation Shares will be released when the Threshold Price is equal to or exceeds $4.00 (the “Fourth Tier”); and v.20% of the Separation Shares will be released when the Threshold Price is equal to or exceeds $5.00 (the “Fifth Tier” and, collectively with the other respectively named tiers, the “Price Tiers”). The Restated Restriction Agreement also includes provisions governing the impact of a change in control on the release of certain Separation Shares. The “Advisory Shares” consist of 953,784 shares (representing 25% of the Remaining Shares) and will be released from the transfer restrictions and the Amended Repurchase Option as follows: i.All of the Advisory Shares will be released on the Advisory End Date, provided that a termination of the Advisory Services has not occurred prior to such date. ii.In the event of a termination of the Advisory Services by Mr. Siminoff prior to the Advisory End Date other than due to the Company’s breach of its ongoing contractual obligations to Mr. Siminoff, subject to notice requirements, the Amended Repurchase Option will immediately apply to all of the Advisory Shares as of the date of such termination (the “Advisory Termination Date”), and the Company will be deemed to have automatically exercised such Amended Repurchase Option with respect thereto. iii.In the event of a termination of the Advisory Services by the Company as a result of Mr. Siminoff’s willful failure or refusal to perform the Advisory Services in good faith in accordance with the terms of the Siminoff Transition Agreement (a “Termination for Cause”), subject to notice requirements, the Amended Repurchase Option will immediately apply to all of the Advisory Shares as of the Advisory Termination Date, and the Company will be deemed to have automatically exercised such Amended Repurchase Option with respect thereto. iv.In the event of a termination of the Advisory Services by the Company other than a Termination for Cause or a change in control prior to the Advisory End Date, or in the event Mr. Siminoff terminates the Advisory Services as a result of the Company’s breach of its ongoing contractual obligations to Mr. Siminoff, the Amended Repurchase Option will immediately apply to the portion of the Advisory Shares represented by the solution to the following equation: (1 – X/730) * 953,784, with “X” equaling the number of days elapsed between the Siminoff Separation Date and the Advisory Termination Date, and the Company will be deemed to have automatically exercised such Amended Repurchase Option with respect thereto. With respect to the Advisory Shares to which the Amended Repurchase Option does not apply, such Advisory Shares will be released from the Amended Repurchase Option and the Transfer Restrictions on the Advisory Termination Date. On November 26, 2024, the Company and Mr. Mitura mutually agreed that Mr. Mitura would step down as the Company’s Chief Product Officer effective as of such date, at which time Mr. Mitura ceased to serve as an “executive officer” of the Company under Rule 3b-7 of the Exchange Act. Also on November 26, 2024, the Company and Mr. Mitura entered into a Separation and Transition Agreement and Release (the “Mitura Separation Agreement”). The Mitura Separation Agreement provides that the Company and Mr. Mitura will enter into a consulting agreement pursuant to which Mr. Mitura will continue to assist the Company in product development. In addition, under the Mitura Separation Agreement, the Company agreed to reimburse Mr. Mitura for certain legal expenses.
|
Pay vs Performance Disclosure - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||||||
Pay vs Performance Disclosure | ||||||||||||
Net loss | $ (51,616) | $ (46,832) | $ (41,485) | [1] | $ (38,556) | $ (98,448) | $ (80,041) | [1],[2] | ||||
|
Insider Trading Arrangements |
3 Months Ended |
---|---|
Jun. 30, 2022 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
6 Months Ended |
---|---|
Jun. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | The condensed consolidated financial statements and related notes of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial reporting and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC for interim financial reporting. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s financial position, results of operations and cash flows have been included and are of a normal and recurring nature. The operating results presented for interim periods are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. These financial statements should be read in conjunction with the Company’s consolidated financial statements and the notes thereto, which are included in the Company’s 2022 Annual Report filed concurrently herewith.
|
Principles of Consolidation | The condensed consolidated financial statements include the accounts of Latch, Inc. and its wholly-owned subsidiaries as of June 30, 2022, Latch Systems, Inc., Latch Taiwan, Inc., Latch Insurance Solutions, LLC and Latch Systems Ltd. All intercompany transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications would not have a material effect on the reported financial results.
|
Use of Estimates | The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expense during the reporting period. Estimates are used when accounting for revenue recognition, allowance for doubtful accounts, allowance for hardware returns, estimates of excess and obsolete inventory, stock-based compensation, warrants, impairment of fixed assets, investment in trading securities and capitalized internally-developed software. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; actual results could differ from those estimates.
|
Cash and Cash Equivalents | The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash and cash equivalents. Cash and cash equivalents are recorded at cost, which approximates fair value. As of June 30, 2022 and December 31, 2021, cash consisted primarily of funds held in the Company’s checking accounts, money market funds and commercial paper. The Company considers these money market funds and commercial paper to be Level 1 financial instruments. The Company’s cash balances exceed the limits that are federally insured. To date, the Company has not recognized any losses caused by uninsured balances.
|
Marketable Securities | The Company classifies its fixed income marketable securities as available-for-sale based on its intentions with regard to these instruments. Accordingly, marketable securities are reported at fair value, with all unrealized holding gains and losses reflected in stockholders’ equity. If it is determined that an investment has an other-than-temporary decline in fair value, the Company recognizes the investment loss in other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. The Company periodically evaluates its investments to determine if impairment charges are required.
|
Accounts Receivable and Allowance for Doubtful Accounts | Accounts receivable are stated at net realizable value, net of allowance for doubtful accounts and reserve for returns (see “Revenue Recognition” below for further information). The Company adopted Accounting Standards Update (“ASU”) 2016-13 effective January 1, 2022. Following the adoption, the Company recognizes an accounts receivable allowance based on estimates of expected credit losses. The Company estimates the total expected credit loss over the lifetime of the receivables using historical loss data and by applying a loss-rate method using relevant available information from internal and external sources, including historical write-off activity, current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for changes in economic conditions. When certain amounts are deemed uncollectible, those balances are reserved in full. The allowance for doubtful accounts is measured on a pooled basis when similar risk characteristics exist. When assessing whether to measure certain financial assets on a pooled basis, the Company considers various risk characteristics, including the financial asset type, size and historical or expected credit loss pattern. These risk characteristics are relevant to accounts receivable and contract assets. The Company has considered customer identity, customer type and product lines and determined that further segmentation of the accounts receivable and contract assets would not yield a materially different credit loss allowance. The Company only segments its receivables based on the age of the outstanding balance. Restated hardware revenues are recorded in the amount of the consideration the Company received or expected to receive when the Company had evidence that a contract existed and control had passed to the customer. See Note 2. Restatement of Prior Period Financial Statements and Information. As of June 30, 2022 and December 31, 2021, the allowance for doubtful accounts contains an estimate of credit losses for outstanding invoices related to (1) hardware accounts receivable when revenue was recognized for consideration received from the related software contract and (2) invoices related to software accounts receivable. The Company generally does not require any security or collateral to support its receivables.
|
Inventories, Net | Inventories consist of finished goods and component parts. Finished goods are manufactured by the Company or purchased from contract manufacturers and component suppliers. Inventories are stated at the lower of cost or net realizable value with cost being determined using the average cost method. The Company periodically assesses the valuation of inventory and writes down the value for estimated excess and obsolete inventory based upon estimates of future demand and market conditions, when necessary. As of June 30, 2022, net inventories in excess of one year of historical sales are classified as other non-current assets on the Consolidated Balance Sheets. Hardware shipped to channel partners is considered channel inventory until there is evidence a contract exists and control has passed to the customer. Channel inventory is included within inventory, net on the Consolidated Balance Sheets. Channel inventory is stated at the lower of cost or net realizable value with cost being determined using the average cost method.
|
Property and Equipment, Net | Property and equipment are stated at cost less accumulated depreciation. |
Software Development Costs | The Company capitalizes certain development costs incurred in connection with its internally-developed software (including specific software upgrades and enhancements when it is probable the expenditures will result in additional features and functionality). These capitalized costs are primarily related to software that is hosted by the Company and the firmware in the Company’s devices. Costs incurred in the preliminary stages of development are expensed as incurred. Once a project has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the application is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific software upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. Internally-developed software is amortized on a straight-line basis over its estimated useful life, generally | to five years.
Intangible Assets | Intangible assets are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. Effective October 2021, the Company entered into an asset purchase agreement. The Company evaluated the acquisition under ASC 805, Business Combinations. The acquisition included the purchase of an assembled workforce to support certain of the Company’s business development efforts. The Company determined that there were no substantive assets outside of the assembled workforce, which was performing services for the Company prior to the acquisition. The Company determined that the acquisition did not qualify as a business. Therefore, the Company accounted for the $0.7 million acquisition of the assembled workforce as an asset acquisition, which is included in intangible assets as of December 31, 2021.
|
Leases | The Company determines if an arrangement contains a lease at the inception of the arrangement. As part of the lease determination process, the Company assesses several factors, including, but not limited to, whether there is a right to control and direct the use of the asset and whether the other party has a substantive substitution right. As the Company’s leases generally do not have identical or nearly identical contract provisions, the Company accounts for each of its leases at the contract level. The Company has made the policy election to not separate lease and non-lease components for any of its leases within its existing classes of assets. The Company will evaluate this election for any new leases involving a new underlying class of asset. The Company has also made the policy election to not recognize a lease liability or an ROU asset for any leases with a term of 12 months or less. These lease payments are recognized on a straight-line basis over the lease term. The Company has evaluated lease renewal options on a contract-by-contract basis to determine whether specific circumstances would result in the conclusion that any options are reasonably certain to be exercised. Generally, the Company does not enter into lease arrangements where the option to renew or terminate a lease is controlled by the lessor. The Company cannot readily determine the interest rate implicit in leases where it is the lessee. As such, it uses its IBR to measure lease liabilities. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of comparable value to the ROU asset in a similar economic environment. IBR therefore reflects what the Company “would have to pay,” which requires estimation when no observable rates are available or where the applicable rates need to be adjusted to reflect the terms and conditions of the lease. The Company estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates. The Company’s leases are generally not sensitive to changes in IBR due to their relatively short terms. ROU assets represent the right to use an underlying asset for the term of the lease, and lease liabilities represent the obligation to make lease payments throughout the term of the lease. ROU assets and lease liabilities are recognized as of the commencement date of the lease based on the present value of contractual lease payments due over the term of the lease. The Company uses an incremental borrowing rate to determine the present value of the lease payments, as the leases do not state the rate implicit in the lease. ROU assets resulting from operating leases are recorded within other non-current assets, and lease liabilities from operating leases are recorded within current liabilities and non-current liabilities, on the Condensed Consolidated Balance Sheets. The Company did not have any finance leases or subleases as of June 30, 2022 and December 31, 2021. Rent expense is allocated among cost of revenue, research and development, sales and marketing, and general and administrative, based on headcount and the use of the underlying leased property.
|
Equity Issuance Costs | Costs incurred in connection with the issuance of the Company’s series preferred stock have been recorded as a direct reduction against redeemable convertible preferred stock within the Consolidated Balance Sheets. Additionally, certain transaction costs incurred in connection with the Merger Agreement that are direct and incremental to the Business Combination (see Note 1. Description of Business) have been recorded as a component of additional paid-in capital within the Consolidated Balance Sheets.
|
Revenue Recognition | In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i) identify contracts with customers; (ii) identify performance obligations; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations; and (v) recognize revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer and is the unit of account in ASC 606 and its related amendments (collectively known as ASC 606, Revenue from Contracts with Customers). Revenues are recognized when control of the promised goods or services are transferred to a customer in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company currently generates its revenues from three primary sources: (1) sales of hardware devices, (2) licenses of software products and (3) installation services related to the hardware devices. Performance Obligations The Company enters into contracts that contain multiple distinct performance obligations: hardware, software and installation services. The hardware performance obligation includes the delivery of hardware, the software performance obligation allows the customer access to the software during the contracted-use term when the promised service is transferred to the customer and the installation services obligation includes the delivery of activation and installation of the hardware. The Company has determined that the hardware, software and installation services are individual distinct performance obligations because they can be and generally are sold by the Company on a standalone basis, and because other vendors sell similar technologies and services on a standalone basis. For each performance obligation identified, the Company estimates the standalone selling price, which represents the price at which the Company would sell the good or service separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price, taking into account available information such as market conditions, historical pricing data and internal pricing guidelines related to the performance obligations. The Company then allocates the transaction price among those obligations based on the estimation of standalone selling price. For software revenue, the Company estimates the transaction price, including variable consideration, at the commencement of the contract and recognizes revenue over the contract term. Hardware The Company generates hardware revenue primarily from the sale of its portfolio of devices. The Company sells hardware to customers, which include real estate developers, builders, building owners and property managers, directly or through its channel partners, who act as intermediaries, installers or wholesalers. The Company recognizes hardware revenue when there is evidence a contract exists and control has been transferred to the customer. The Company provides warranties that its hardware will be substantially free from defects in materials and workmanship for a period of or two years for electronic components depending on the hardware product, and five years for mechanical components. The Company determines in its sole discretion whether to replace, repair or refund warrantable devices. The Company determined these warranties are not separate performance obligations as they cannot be purchased separately and do not provide a service in addition to an assurance the hardware will function as expected. The Company records a reserve as a component of cost of hardware revenue based on historical costs of replacement units for returns of defective products. For the three and six months ended June 30, 2022, the reserve recorded for hardware warranties was approximately 2% and 2%, respectively, of cost of hardware revenue. For the three and six months ended June 30, 2021, the reserve recorded for hardware warranties was approximately 2% and 2%, respectively, of cost of hardware revenue. The Company also provides certain customers a right of return for non-defective product, which is treated as a reduction of hardware revenue based on the Company’s expectations and historical experience. For the three and six months ended June 30, 2022, the allowance for returns reduced revenue by zero and $0.4 million, respectively. For the three and six months ended June 30, 2021, the allowance for returns reduced revenue by $0.4 million and $0.2 million, respectively. Software The Company generates software revenue primarily through the license of its SaaS cloud-based platform to customers on a subscription-based arrangement. Subscription fees vary depending on the features selected by customers as well as the term. SaaS arrangements generally have term lengths of , , or ten years and include a fixed fee generally paid in advance, annually or monthly. When significant discounts were provided to customers on the longer-term software contracts paid in advance, the Company has determined that there is a significant financing component related to the time value of money and therefore has recorded the interest expense in interest expense, net on the Consolidated Statements of Operations and Comprehensive Loss. The interest expense related to the significant financing component is recorded using the effective interest method, which has higher interest expense at inception and declines over time to match the underlying economics of the transaction. The amount of interest expense related to this component was $1.4 million and $2.4 million for the three and six months ended June 30, 2022, respectively, and $0.7 million and $1.3 million for the three and six months ended June 30, 2021, respectively. The SaaS licenses provided by the Company are considered stand-ready performance obligations where customers benefit from the services evenly throughout the service period. Revenue generally is recognized ratably over the subscription period beginning when or as control of the promised services is transferred to the customer. Installation Services The Company generates revenues by facilitating hardware installation and activation services. These revenues are recognized over time on a percentage of completion basis. The Company recognized installation services revenue of $1.9 million and $3.4 million for the three and six months ended June 30, 2022, respectively, and $0.2 million for both the three and six months ended June 30, 2021. Deferred Contract Costs The Company capitalizes commission expenses paid that are incremental to obtaining customer software contracts. Costs related to the initial signing of software contracts are amortized over the average customer life, which has been estimated to be ten years. The Company determined the period of benefit by taking into consideration the length of terms in its customer contracts, including renewals and extensions. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current and are included in prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets; the remaining portion is recorded as deferred contract costs, non-current and is included in other non-current assets on the Condensed Consolidated Balance Sheets. Amortization expense is included in sales and marketing expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss. The Company enters into contracts with its customers, which may give rise to contract assets (unbilled receivables) and contract liabilities (deferred revenue) due to revenue recognition differing from the timing of billing to customers. The Company recognizes unbilled receivables when the performance obligation precedes the invoice date. The Company reports unbilled receivables within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company records contract liabilities as deferred revenue when the Company bills customers in advance of the performance obligations being satisfied, which is generally the case for the Company’s software contracts. The Company recognized $5.2 million of prior year deferred software revenue during the six months ended June 30, 2022 and $4.5 million during the year ended December 31, 2021. As of June 30, 2022, total deferred revenue was $40.7 million. The current amount, which is expected to be recognized over the next 12 months, of $9.9 million is comprised of $14.6 million, which will be recognized as revenue, and $4.6 million, which will be recognized as interest expense related to the significant financing component. The non-current amount of $30.8 million is comprised of $41.7 million, which will be recognized as revenue, and $10.9 million, which will be recognized as interest expense related to the significant financing component. Increase in deferred revenue for the three and six months ended June 30, 2022 primarily resulted from growth of contracts with new and existing customers. Cost of Revenue Cost of hardware revenue consists primarily of product costs, including manufacturing costs, duties and other applicable importation costs, shipping and handling costs, packaging, warranty costs, assembly costs and warehousing costs, as well as other non-inventoriable costs including personnel-related expenses associated with supply chain logistics. Costs of hardware revenue also include charges related to lower of cost or market adjustments and reserves for excess inventory and non-cancellable purchase commitments. Cost of software revenue consists primarily of outsourced hosting costs and personnel-related expenses associated with monitoring and managing outsourced hosting service providers. Cost of installation services revenue consists primarily of third-party installation labor costs, parts and materials and personnel-related expenses associated with deployment of hardware. Cost of revenue excludes depreciation and amortization shown in operating expenses.
|
Research and Development | Research and development (“R&D”) expense consists primarily of personnel and related expenses for employees working on product design and engineering teams, including salaries, bonuses, benefits, payroll taxes, travel and stock-based compensation. Also included are non-personnel costs such as amounts paid to third-party contract manufacturers for tooling, engineering and prototype costs of hardware products, fees paid to third-party consultants, R&D supplies, rent and restructuring costs. R&D costs that do not meet the criteria for capitalization are expensed as incurred.
|
Sales and Marketing | Sales and marketing expense consists primarily of personnel and related expenses for employees working on sales, customer success, deployment and marketing teams, including salaries, bonuses, benefits, payroll taxes, travel, commissions and stock-based compensation. Also included are non-personnel costs such as marketing activities (trade shows and events, conferences and advertising), professional fees, rent, restructuring costs and customer support. |
Depreciation and Amortization | Depreciation and amortization expense consists primarily of depreciation expense related to investments in property and equipment, internally-developed software and intangible assets.
|
Impairment of Long-Lived Assets | The Company assesses long-lived assets for impairment in accordance with the provisions of ASC 350, Goodwill and Other, and ASC 360, Property, Plant and Equipment. Long-lived assets, such as property and equipment and internally-developed software costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposition of the asset. The amount of impairment loss, if any, is measured as the difference between the carrying value of the asset and its estimated fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the three and six months ended June 30, 2022, the Company recorded $0.1 million and $0.4 million of impairment of internally-developed software costs. The Company did not record any impairment charges for the three and six months ended June 30, 2021.
|
Income Taxes | Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2022 and December 31, 2021, the Company recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in estimate occurs.
|
Stock-Based Compensation | The Company measures and records the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. The Company recognizes stock-based compensation expense over the requisite service period of the individual grant, generally equal to the vesting period, and uses the straight-line method. The fair value of RSUs is determined using the closing trading price on the grant date. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option-pricing model to determine the fair value of stock options. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions to determine the fair value of stock options, including the option’s expected term and the price volatility of the underlying stock. The Company calculates the fair value of options granted by using the Black-Scholes option-pricing model with the following assumptions: •Expected Volatility—The Company estimates volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the option’s expected term. •Expected Term—The expected term of the Company’s options represents the period that the stock-based awards are expected to be outstanding. The Company has elected to use the midpoint between the stock option’s vesting term and contractual expiration period to compute the expected term, as the Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. •Risk-Free Interest Rate—The risk-free interest rate is based on the implied yield currently available on U.S. Treasury zero-coupon issues with a term that is equal to the option’s expected term at the grant date. •Dividend Yield—The Company has not declared or paid dividends to date and does not anticipate declaring dividends. As such, the dividend yield has been estimated to be zero. Cash Settled RSUs The Company grants cash settled RSUs that are classified as liability awards as defined in ASC 718, Compensation - Stock Compensation. Cash settlement is required (no election for share settlement) and the cash settlement is not contingent on the occurrence of an event. These awards are recorded as a share-based liability, and fair value is remeasured quarterly. Each vested award is released for cash equal to the trading value of the Company’s common stock.
|
Fair Value Measurements | Fair value accounting is applied for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis (at least annually). Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820, Fair Value Measurements, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The levels of the fair value hierarchy are as follows: •Level 1—Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. •Level 2—Inputs are observable, either directly or indirectly, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. •Level 3—Inputs are generally unobservable and typically reflect management’s best estimate of assumptions that market participants would use in pricing the asset or liability. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety.
|
Convertible Notes and Derivatives | The Company accounts for convertible notes, net using an amortized cost model pursuant to ASC 835, Interest. Convertible notes are classified as liabilities measured at amortized cost, net of debt discounts from debt issuance costs, lender fees and the initial fair value of bifurcated derivatives, which reduce the initial carrying amount of the notes. The carrying value is accreted to the stated principal amount at contractual maturity using the effective-interest method with a corresponding charge to interest expense pursuant to ASC 835. Debt discounts are presented on the balance sheet as a direct deduction from the carrying amount of the related debt. The Company accounts for its derivatives in accordance with ASC 815-10, Derivatives and Hedging, or ASC 815-15, Embedded Derivatives, depending on the nature of the derivative instrument. ASC 815 requires each contract that is not a derivative in its entirety to be assessed to determine whether it contains embedded derivatives that are required to be bifurcated and accounted for as a derivative financial instrument. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if (i) the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings, (ii) the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and (iii) a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Embedded derivatives are measured at fair value and re-measured at each subsequent reporting period and recorded within convertible notes, net on the consolidated balance sheets and changes in fair value recorded in other income (expense), net within the statements of operations and comprehensive loss.
|
Earnings per Share | The calculation of earnings per share is based on the weighted average number of shares of common stock or common stock equivalents outstanding during the applicable period. The dilutive effect of common stock equivalents is excluded from basic earnings per share and is included in the calculation of diluted earnings per share. Potentially dilutive securities include convertible preferred stock, common stock options, common stock warrants and RSUs. The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method determines net loss per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company’s redeemable convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in the Company’s losses. For periods in which the Company reports net losses, diluted net loss per share is the same as basic net loss per share because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. Diluted shares outstanding are calculated using the treasury stock method or the two-class method, depending on which method is more dilutive for a given period. Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized and the amount of benefits that would be recorded in common shares when the award becomes deductible for tax purposes are assumed to be used to repurchase shares, based on the average share price for the fiscal period.
|
Concentrations of Credit Risk | Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade accounts receivable. The Company primarily invests its excess cash in low-risk, highly liquid money market funds with major financial institutions as well as marketable securities (see Note 4. Investments). Significant customers are those that represent more than 10% of the Company’s total revenue or gross accounts receivable balance at each balance sheet date. As of June 30, 2022, the Company had one customer that accounted for $3.0 million, or 19%, of gross accounts receivable. As of December 31, 2021, the Company had one customer that accounted for $2.7 million, or 19%, of gross accounts receivable. For the three and six months ended June 30, 2022, the Company had one customer that accounted for $2.2 million and $6.6 million, or 22% and 28%, of total revenue, respectively. For the three months ended June 30, 2021, the Company had two customers that accounted for $2.4 million, or 35%, of total revenue. For the six months ended June 30, 2021, the Company had one customer that accounted for $1.9 million, or 16%, of total revenue.
|
Segment Information | As of June 30, 2022, the Company had one operating and reportable segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker.
|
Recent Accounting Pronouncements | In February 2016, the Financial Accounting Standards Board (the “FASB”) issued ASC 842, which requires lessees to recognize most leases on the balance sheet as a right of use asset and related lease liability. On January 1, 2022, the Company adopted ASC 842 using a modified retrospective approach, recording a cumulative-effect adjustment to retained earnings. The Company elected to adopt the practical expedients that permit it to combine lease and non-lease components for all lease contracts and also elected not to recognize ROU assets and lease liabilities for leases with terms of 12 months or less. Upon adoption, the Company recognized (i) $0.4 million of operating lease ROU assets recorded in other non-current assets on the Condensed Consolidated Balance Sheets and (ii) operating lease liabilities of $0.2 million recorded in other current liabilities and $0.2 million recorded in other non-current liabilities on the Condensed Consolidated Balance Sheets. The adoption of ASC 842 did not materially impact the condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of equity and condensed consolidated statements of cash flows. In June 2016, the FASB issued ASU 2016-13, which, together with subsequent amendments, amends the requirement on the measurement and recognition of expected credit losses for financial assets held. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with early adoption permitted. The Company determined that available-for-sale securities, accounts receivable and contract assets are the applicable financial assets that are subject to this ASU and adopted the guidance on January 1, 2022. The Company modified the impairment model related to the available-for-sale securities from the “other-than-temporary” impairment model to the “current expected credit losses” model and determined that an allowance for credit loss is not needed as of January 1, 2022 based on various factors, including the length of time and extent to which fair value has been lower than the cost basis, the financial condition and near-term prospects of the issuer and forecasted economic data. The Company adopted the new guidance on a modified retrospective basis through a cumulative-effect adjustment to the accumulated deficit on January 1, 2022. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740. The update also simplifies GAAP for other areas of ASC 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update was effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. The Company adopted this standard effective January 1, 2021. The Company has completed its assessment of this ASU and determined that it does not have a material impact on the Company’s consolidated financial statements.
|
DESCRIPTION OF BUSINESS (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Reverse Recapitalization | The following table reconciles the elements of the Business Combination to the Consolidated Statement of Cash Flows and the Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholders’ Equity for the year ended December 31, 2021.
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Error Corrections and Prior Period Adjustments |
The adjustments associated with these corrections primarily impact software revenue on the previously reported Condensed Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):
(a)Category references are described above under “—Errors Identified.” Where adjustments relate to multiple categories, the adjustment amounts of each category are noted below and sum to the total adjustment reflected in the table above: HW1 $909; OC1 $(56); SBC1 $4; SW2 $8; OC2 $(4); OC3 $42; IDS3 $445; SBC3 $78; OC4 $(94); SBC4 $221; HW5 $295; SW5 $183; OC5 $482; RC5 $307; SBC5 $35; RC6 $(306); IDS6 $(70) (b)Exclusive of depreciation and amortization shown in operating expenses below.
HW1 $(11,846); SW1 $(1,275); RC1 $(633); HW2 $11,949; OC2 $(489); HW3 $24; SW3 $55; OC3 $387; RC3 $633; HW4 $181; OC4 $107; HW5 $218; OC5 $(93); HW6 $467; SW6 $776; HW7 $1; SW7 $(982); HW8 $10; SBC8 $(858) (b) Shares issued and outstanding as of December 31, 2021 exclude 738,000 shares subject to vesting requirements. See Note 1. Description of Business.
(a)Category references are described above under “—Errors Identified.” Where adjustments relate to multiple categories, the adjustment amounts of each category are noted below and sum to the total adjustment reflected in the table above: HW1 $(1,650); OC1 $81; SBC1 $3; SW2 $2; OC2 $(1); OC3 $(67); IDS3 $114; SBC3 $27; OC4 $33; SBC4 $9; HW5 $149; SW5 $100; OC5 $289; SBC5 $54; HW6 $(2,953); OC6 $180; SBC6 $3; SW7 $2; OC7 $(1); OC8 $(8); IDS8 $248; SBC8 $61; OC9 $57; SBC9 $10; HW10 $143; SW10 $96; OC10 $214; SBC10 $(42) (b)Exclusive of depreciation and amortization shown in operating expenses below.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable, Allowance for Credit Loss | The following table represents a roll-forward of the Company’s allowance for doubtful accounts:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property and Equipment | Depreciation is calculated using the straight-line method over the estimated useful lives of the assets as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets | Intangible assets consisted of the following, which are included within other non-current assets on the Consolidated Balance Sheets.
The estimated useful life of intangible assets is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Deferred Contract Cost | The following table represents a roll-forward of the Company’s deferred contract costs:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Contract Assets and Contract Liabilities | Contract Assets and Contract Liabilities
|
INVESTMENTS (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Available-for-sale | The Company’s marketable securities by security type are summarized as follows:
Contractual maturities of the Company’s available-for-sale and trading securities are summarized as follows:
|
FAIR VALUE MEASUREMENTS (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The Company’s financial assets and liabilities that are measured at fair value on a recurring basis are summarized as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following table represents the activity of the Level 3 instruments:
(a)Recorded in other income (expense) within the Condensed Consolidated Statements of Operations and Comprehensive Loss.
|
INVENTORIES, NET (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories, Net | Inventories, net consisted of the following:
|
INTERNALLY DEVELOPED SOFTWARE, NET (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research and Development [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Internally Developed Software, Net | Internally-developed software, net consisted of the following:
|
ACCRUED EXPENSES (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accrued Expenses | Accrued expenses consisted of the following:
|
EQUITY (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stock by Class |
(1) As adjusted for the Exchange Ratio.
|
EARNINGS PER SHARE (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted net loss per share for common stock:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The table below sets forth the number of potential common shares underlying outstanding common stock options, RSUs and common stock warrants that were excluded from diluted net loss per share as the Company had net losses for the six months ended June 30, 2022 and twelve months ended December 31, 2021, and their inclusion would be anti-dilutive:
(1) Amount includes 17,373 and 21,356 liability-based RSUs as of June 30, 2022 and December 31, 2021, respectively, that the Company settled in cash. As a result, the shares of common stock underlying the liability-based RSUs upon vesting were not issued and were returned to the 2021 Incentive Award Plan as available shares.
|
STOCK-BASED COMPENSATION (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of stock-based compensation expense | For the years ended June 30, 2022 and 2021, the components of stock-based compensation expense were as follows:
Stock-based compensation expense is included in cost of revenue, research and development, sales and marketing and general and administrative on the Consolidated Statements of Operations and Comprehensive Loss as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of the Employee and Nonemployee Stock Options | A summary of the status of employee and non-employee stock options as of June 30, 2022, and changes during 2022, is presented below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Stock Unit, Activity | A summary of equity-based RSU activity for the six months ended June 30, 2022 is presented below.
Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the RSUs. The unrecognized stock-based compensation expense related to the unvested RSUs was $66.8 million as of June 30, 2022 and will be expensed over a weighted-average period of 2.2 years. In addition, approximately 0.1 million and 0.2 million RSUs vested during the three and six months ended June 30, 2022, respectively, but were not released at the time of vesting due to the suspension of the S-8 Registration Statement. Liability-based A summary of liability-based RSU activity for the six months ended June 30, 2022 is presented below.
|
SUBSEQUENT EVENTS (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Business Combination Consideration Shares Threshold | In the event the Company’s 60 trading day VWAP exceeds the price thresholds set forth in the table below (the “Share Price Thresholds”), the applicable portion of the Consideration Shares set forth below will be released from transfer restrictions:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award | As described above, the Performance Options are eligible to be earned in three tranches based on the Company’s common stock reaching market trading prices (based on a trailing 60-day daily volume weighted average trading price) before the seventh anniversary of the Program Effective Date, as set forth in the following table:
|
DESCRIPTION OF BUSINESS - Narrative (Details) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Jun. 04, 2021
USD ($)
day
$ / shares
Rate
shares
|
Jun. 30, 2021
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Jun. 30, 2022
$ / shares
shares
|
|||||
Business Acquisition [Line Items] | ||||||||
Stock issued during period, conversion of convertible securities (in shares) | 6,900,000 | |||||||
Temporary equity, shares, conversion of convertible securities (in shares) | 71,100,000 | 63,756,000 | ||||||
Sale of stock, number of shares issued in transaction (in shares) | 19,300,000 | |||||||
Shares subject to vesting restrictions (in shares) | 738,000 | 738,000 | 738,000 | |||||
Number of shares issued in transaction, used to fund cash election (in shares) | 300,000 | |||||||
Sale of stock, price per share. used to fund cash election (in dollars per share) | $ / shares | $ 10.00 | |||||||
Consideration received on transaction, used to fund cash election | $ | $ 2,600 | |||||||
Common stock, issued (in shares) | 140,500,000 | 141,585,530 | [1] | 144,086,282 | [1] | |||
Common stock, outstanding (in shares) | 140,500,000 | 141,585,530 | [1] | 144,086,282 | [1] | |||
Net proceeds from business combination | $ | $ 450,000 | $ 447,955 | ||||||
Proceeds from issuance of private placement | $ | $ 192,600 | $ 192,550 | ||||||
Recapitalization exchange ratio | 0.8971 | |||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | [1] | $ 0.0001 | [1] | |||
TSIA | ||||||||
Business Acquisition [Line Items] | ||||||||
Assets held-in-trust | $ | $ 300,000 | |||||||
Legacy Latch Stockholders | Latch, Inc | ||||||||
Business Acquisition [Line Items] | ||||||||
Noncontrolling interest, ownership percentage by parent | Rate | 60.00% | |||||||
Common Stock | ||||||||
Business Acquisition [Line Items] | ||||||||
Stock issued during period, conversion of convertible securities (in shares) | 63,800,000 | |||||||
Common Stock | PIPE Investment | ||||||||
Business Acquisition [Line Items] | ||||||||
Sale of stock, price per share (in dollars per share) | $ / shares | $ 10.00 | |||||||
Sale of stock, consideration received on transaction | $ | $ 192,600 | |||||||
Common Class A | IPO | TSIA | ||||||||
Business Acquisition [Line Items] | ||||||||
Sale of stock, number of shares issued in transaction (in shares) | 5,916 | |||||||
Sale of stock, number of business days prior to business combination in which calculation occurred | day | 2 | |||||||
Sale of stock, price per share (in dollars per share) | $ / shares | $ 10.00 | |||||||
Sale of stock, consideration received on transaction | $ | $ 60 | |||||||
Common Class B | TSIA | ||||||||
Business Acquisition [Line Items] | ||||||||
Stock issued during period, conversion of convertible securities (in shares) | 7,400,000 | |||||||
Vesting conditions, volume-weighted average price per share (in dollars per share) | $ / shares | $ 14.00 | |||||||
Vesting conditions, number of trading days within trading day period | 20 days | |||||||
Vesting conditions, trading day period | 30 days | |||||||
Vesting conditions, anniversary period | 5 years | |||||||
Convertible Debt | ||||||||
Business Acquisition [Line Items] | ||||||||
Debt conversion, converted instrument, amount | $ | $ 50,000 | |||||||
Secured Debt | Term Loan | ||||||||
Business Acquisition [Line Items] | ||||||||
Repayments of long-term debt | $ | $ 5,000 | |||||||
|
DESCRIPTION OF BUSINESS - Reverse Recapitalization (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Jun. 04, 2021 |
Dec. 31, 2021 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Cash - TSIA trust and cash, net of redemptions | $ 300,122 | |
Cash - PIPE Investment including cash election funding | $ 192,600 | 192,550 |
Less: transaction costs and advisory fees paid | (36,783) | |
Less: cash election payment, net | (2,313) | |
Less: issuance and other costs paid | (5,621) | |
Net proceeds from Business Combination | $ 450,000 | 447,955 |
Less: Private placement warrants received as part of Business Combination | (13,872) | |
Plus: prepaid expenses received as part of Business Combination | 510 | |
Reverse recapitalization, net of transaction costs | $ 434,593 |
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION - Impact of the Restatement Adjustments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | $ 9,830 | $ 13,556 | $ 6,745 | [1] | $ 23,386 | $ 11,719 | [1] | ||||||
Cost of revenue | 13,080 | [2] | 13,944 | 6,677 | [1],[2] | 27,024 | [2] | 11,635 | [1],[2] | ||||
Hardware | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | 4,710 | 9,288 | 4,948 | [1] | 13,998 | 8,445 | [1] | ||||||
Cost of revenue | 11,003 | [2] | 11,849 | 6,001 | [1],[2] | 22,852 | [2] | 10,825 | [1],[2] | ||||
Software | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | 3,239 | 2,707 | 1,627 | [1] | 5,946 | 3,104 | [1] | ||||||
Cost of revenue | $ 334 | [2] | 327 | 174 | [1],[2] | $ 661 | [2] | 308 | [1],[2] | ||||
Restated | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | (99) | (2,267) | (3,922) | ||||||||||
Cost of revenue | 911 | (1,565) | (2,769) | ||||||||||
Restated | Hardware | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | 233 | (2,084) | (3,601) | ||||||||||
Cost of revenue | 857 | (1,566) | (2,770) | ||||||||||
Restated | Hardware | Revision of Prior Period, Related to Hardware Revenue Recognition | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Cost of revenue | 909 | (1,650) | (2,953) | ||||||||||
Restated | Hardware revenue excluding channel partner discounts | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | 1,012 | (1,002) | (1,592) | ||||||||||
Restated | Hardware revenue excluding channel partner discounts | Revision of Prior Period, Related to Hardware Revenue Recognition | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Cost of revenue | 1,688 | (568) | (944) | ||||||||||
Restated | Hardware revenue - channel partner discounts | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | (779) | (1,082) | (2,009) | ||||||||||
Restated | Hardware revenue - channel partner discounts | Revision of Prior Period, Related to Hardware Revenue Recognition | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Cost of revenue | (779) | (1,082) | (2,009) | ||||||||||
Restated | Software | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | (332) | (183) | (321) | ||||||||||
Cost of revenue | 4 | 1 | 1 | ||||||||||
Restated | Access related | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | (296) | (167) | (293) | ||||||||||
Restated | Other | |||||||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
Revenue | $ (36) | $ (16) | $ (28) | ||||||||||
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
Income (loss) before income taxes | $ (51,599) | $ (46,815) | $ (41,451) | [1] | $ (98,414) | $ (80,007) | [1] | ||
Revision of Prior Period, Adjustment | |||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
Income (loss) before income taxes | (2,601) | (1,390) | (1,845) | ||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Internally Developed Software and Software in Development | |||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
Income (loss) before income taxes | (400) | (100) | (300) | ||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Other Corrections | |||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
Income (loss) before income taxes | (400) | (400) | (400) | ||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Stock-Based Compensation | |||||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
Income (loss) before income taxes | $ (300) | $ (100) | $ (30) | ||||||
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION - Consolidated Statements of Operations and Comprehensive Loss (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||||||||||
Revenue: | ||||||||||||||||
Total revenue | $ 9,830 | $ 13,556 | $ 6,745 | [1] | $ 23,386 | $ 11,719 | [1] | |||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 13,080 | [2] | 13,944 | 6,677 | [1],[2] | 27,024 | [2] | 11,635 | [1],[2] | |||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 16,710 | 18,822 | 7,063 | [1] | 35,532 | 16,905 | [1] | |||||||||
Sales and marketing | 16,824 | 17,423 | 5,097 | [1] | 34,247 | 8,872 | [1] | |||||||||
General and administrative | 12,341 | 15,480 | 10,585 | [1] | 27,821 | 28,100 | [1] | |||||||||
Depreciation and amortization | 1,381 | 1,130 | 678 | [1] | 2,511 | 1,345 | [1],[3] | |||||||||
Total operating expenses | 47,256 | 52,855 | 23,423 | [1] | 100,111 | 55,222 | [1] | |||||||||
Loss from operations | (50,506) | (53,243) | (23,355) | [1] | (103,749) | (55,138) | [1] | |||||||||
Other income (expense), net | ||||||||||||||||
Change in fair value of derivative liabilities | 0 | (8,991) | [1] | 0 | (12,512) | [1],[3] | ||||||||||
Change in fair value of warrant liability | 2,699 | 6,267 | (4,795) | [1] | 8,966 | (4,795) | [1],[3] | |||||||||
Change in fair value of trading securities | (2,500) | 1,000 | 0 | [1] | (1,500) | 0 | [1],[3] | |||||||||
Loss on extinguishment of debt | 0 | (1,469) | [1] | 0 | (1,469) | [1],[3] | ||||||||||
Interest expense, net | (1,263) | (837) | (2,864) | [1] | (2,100) | (6,177) | [1] | |||||||||
Other expense, net | (29) | (2) | 23 | [1] | (31) | 84 | [1] | |||||||||
Total other income (expense), net | (1,093) | 6,428 | (18,096) | [1] | 5,335 | (24,869) | [1] | |||||||||
Loss before income taxes | (51,599) | (46,815) | (41,451) | [1] | (98,414) | (80,007) | [1] | |||||||||
Provision for income taxes | 17 | 17 | 34 | [1] | 34 | 34 | [1] | |||||||||
Net loss | (51,616) | (46,832) | (41,485) | [1] | $ (38,556) | (98,448) | (80,041) | [1],[3] | ||||||||
Other comprehensive loss | ||||||||||||||||
Unrealized loss on available-for-sale securities | (281) | (1,618) | 0 | [1] | (1,899) | 0 | [1] | |||||||||
Foreign currency translation adjustment | (1) | 2 | 2 | [1] | $ (7) | 1 | (5) | [1] | ||||||||
Comprehensive loss | $ (51,898) | $ (48,448) | $ (41,483) | [1] | $ (100,346) | $ (80,046) | [1] | |||||||||
Net loss per common share | ||||||||||||||||
Basic net loss per common share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | [1] | $ (0.69) | $ (2.59) | [1] | |||||||||
Diluted net loss per common share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | [1] | $ (0.69) | $ (2.59) | [1] | |||||||||
Weighted average shares outstanding | ||||||||||||||||
Basic net loss - adjusted weighted-average common shares (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | [1] | 142,615,560 | 30,960,173 | [1] | |||||||||
Diluted weighted average shares outstanding (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | [1] | 142,615,560 | 30,960,173 | [1] | |||||||||
Previously Reported | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | $ 13,655 | $ 9,012 | $ 15,641 | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 13,033 | 8,242 | 14,404 | |||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 18,257 | 6,989 | 16,604 | |||||||||||||
Sales and marketing | 17,296 | 5,055 | 8,805 | |||||||||||||
General and administrative | 14,178 | 9,993 | 27,689 | |||||||||||||
Depreciation and amortization | 1,506 | 689 | 1,342 | |||||||||||||
Total operating expenses | 51,237 | 22,726 | 54,440 | |||||||||||||
Loss from operations | (50,615) | (21,956) | (53,203) | |||||||||||||
Other income (expense), net | ||||||||||||||||
Change in fair value of derivative liabilities | (8,991) | (12,588) | ||||||||||||||
Change in fair value of warrant liability | 6,267 | (4,795) | (4,795) | |||||||||||||
Change in fair value of trading securities | 1,000 | |||||||||||||||
Loss on extinguishment of debt | (1,469) | (1,469) | ||||||||||||||
Interest expense, net | (864) | (2,873) | (6,191) | |||||||||||||
Other expense, net | (2) | 23 | 84 | |||||||||||||
Total other income (expense), net | 6,401 | (18,105) | (24,959) | |||||||||||||
Loss before income taxes | (44,214) | (40,061) | (78,162) | |||||||||||||
Provision for income taxes | 17 | 10 | 10 | |||||||||||||
Net loss | (44,231) | (40,071) | (78,172) | |||||||||||||
Other comprehensive loss | ||||||||||||||||
Unrealized loss on available-for-sale securities | (1,618) | |||||||||||||||
Foreign currency translation adjustment | 2 | 2 | (5) | |||||||||||||
Comprehensive loss | $ (45,847) | $ (40,069) | $ (78,177) | |||||||||||||
Net loss per common share | ||||||||||||||||
Basic net loss per common share (in dollars per share) | $ (0.31) | $ (0.78) | $ (2.52) | |||||||||||||
Diluted net loss per common share (in dollars per share) | $ (0.31) | $ (0.78) | $ (2.52) | |||||||||||||
Weighted average shares outstanding | ||||||||||||||||
Basic net loss - adjusted weighted-average common shares (in shares) | 141,970,190 | 51,256,111 | 30,960,173 | |||||||||||||
Diluted weighted average shares outstanding (in shares) | 141,970,190 | 51,256,111 | 30,960,173 | |||||||||||||
Revision of Prior Period, Adjustment | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | $ (99) | $ (2,267) | $ (3,922) | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 911 | (1,565) | (2,769) | |||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 565 | 74 | 301 | |||||||||||||
Sales and marketing | 127 | 42 | 67 | |||||||||||||
General and administrative | 1,302 | 592 | 411 | |||||||||||||
Depreciation and amortization | (376) | (11) | 3 | |||||||||||||
Total operating expenses | 1,618 | 697 | 782 | |||||||||||||
Loss from operations | (2,628) | (1,399) | (1,935) | |||||||||||||
Other income (expense), net | ||||||||||||||||
Change in fair value of derivative liabilities | 0 | 76 | ||||||||||||||
Change in fair value of warrant liability | 0 | 0 | 0 | |||||||||||||
Change in fair value of trading securities | 0 | |||||||||||||||
Loss on extinguishment of debt | 0 | 0 | ||||||||||||||
Interest expense, net | 27 | 9 | 14 | |||||||||||||
Other expense, net | 0 | 0 | 0 | |||||||||||||
Total other income (expense), net | 27 | 9 | 90 | |||||||||||||
Loss before income taxes | (2,601) | (1,390) | (1,845) | |||||||||||||
Provision for income taxes | 0 | 24 | 24 | |||||||||||||
Net loss | (2,601) | (1,414) | (1,869) | |||||||||||||
Other comprehensive loss | ||||||||||||||||
Unrealized loss on available-for-sale securities | 0 | |||||||||||||||
Foreign currency translation adjustment | 0 | 0 | 0 | |||||||||||||
Comprehensive loss | $ (2,601) | $ (1,414) | $ (1,869) | |||||||||||||
Net loss per common share | ||||||||||||||||
Basic net loss per common share (in dollars per share) | $ (0.02) | $ (0.03) | $ (0.06) | |||||||||||||
Diluted net loss per common share (in dollars per share) | $ (0.02) | $ (0.03) | $ (0.06) | |||||||||||||
Weighted average shares outstanding | ||||||||||||||||
Basic net loss - adjusted weighted-average common shares (in shares) | 0 | |||||||||||||||
Diluted weighted average shares outstanding (in shares) | 0 | |||||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Hardware Revenue Recognition | ||||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
General and administrative | $ 295 | $ 149 | $ 143 | |||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Other Corrections | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | (1) | |||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 42 | (67) | (8) | |||||||||||||
Sales and marketing | (94) | 33 | 57 | |||||||||||||
General and administrative | 482 | 289 | 214 | |||||||||||||
Other income (expense), net | ||||||||||||||||
Loss before income taxes | (400) | (400) | (400) | |||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Stock-Based Compensation | ||||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 78 | 27 | 61 | |||||||||||||
Sales and marketing | 221 | 9 | 10 | |||||||||||||
General and administrative | 35 | 54 | (42) | |||||||||||||
Other income (expense), net | ||||||||||||||||
Loss before income taxes | (300) | (100) | (30) | |||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Software Revenue Recognition | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 2 | |||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
General and administrative | 183 | 100 | 96 | |||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Internally Developed Software and Software in Development | ||||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
Research and development | 445 | 114 | 248 | |||||||||||||
Depreciation and amortization | (70) | |||||||||||||||
Other income (expense), net | ||||||||||||||||
Loss before income taxes | (400) | (100) | (300) | |||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Previously Reported Amounts Reclassified | ||||||||||||||||
Operating Costs and Expenses [Abstract] | ||||||||||||||||
General and administrative | 307 | |||||||||||||||
Depreciation and amortization | (306) | |||||||||||||||
Hardware | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | $ 4,710 | 9,288 | 4,948 | [1] | $ 13,998 | 8,445 | [1] | |||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 11,003 | [2] | 11,849 | 6,001 | [1],[2] | 22,852 | [2] | 10,825 | [1],[2] | |||||||
Hardware | Previously Reported | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 9,055 | 7,032 | 12,046 | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 10,992 | 7,567 | 13,595 | |||||||||||||
Hardware | Revision of Prior Period, Adjustment | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 233 | (2,084) | (3,601) | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 857 | (1,566) | (2,770) | |||||||||||||
Hardware | Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Hardware Revenue Recognition | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 909 | (1,650) | (2,953) | |||||||||||||
Hardware | Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Other Corrections | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | (56) | 81 | 180 | |||||||||||||
Hardware | Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Stock-Based Compensation | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 4 | 3 | 3 | |||||||||||||
Software | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 3,239 | 2,707 | 1,627 | [1] | 5,946 | 3,104 | [1] | |||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 334 | [2] | 327 | 174 | [1],[2] | 661 | [2] | 308 | [1],[2] | |||||||
Software | Previously Reported | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 3,039 | 1,810 | 3,425 | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 323 | 173 | 307 | |||||||||||||
Software | Revision of Prior Period, Adjustment | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | (332) | (183) | (321) | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 4 | 1 | 1 | |||||||||||||
Software | Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Other Corrections | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | (4) | (1) | ||||||||||||||
Software | Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Software Revenue Recognition | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 8 | 2 | ||||||||||||||
Installation services | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 1,881 | 1,561 | 170 | [1] | 3,442 | 170 | [1] | |||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | $ 1,743 | [2] | 1,768 | 502 | [1],[2] | $ 3,511 | [2] | 502 | [1],[2] | |||||||
Installation services | Previously Reported | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 1,561 | 170 | 170 | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | 1,718 | 502 | 502 | |||||||||||||
Installation services | Revision of Prior Period, Adjustment | ||||||||||||||||
Revenue: | ||||||||||||||||
Total revenue | 0 | 0 | 0 | |||||||||||||
Cost of revenue | ||||||||||||||||
Total cost of revenue | $ 50 | $ 0 | $ 0 | |||||||||||||
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION - Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
||||||||
Operating activities | |||||||||||||
Net loss | $ (51,616) | $ (46,832) | $ (41,485) | [1] | $ (38,556) | $ (98,448) | $ (80,041) | [1],[2] | |||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||||||
Depreciation and amortization | 1,381 | 1,130 | 678 | [1] | 2,511 | 1,345 | [1],[2] | ||||||
Non-cash interest expense | 952 | 1,622 | 3,490 | [2] | |||||||||
Change in fair value of derivative liabilities | 0 | 8,991 | [1] | 0 | 12,512 | [1],[2] | |||||||
Change in fair value of warrant liability | (2,699) | (6,267) | 4,795 | [1] | (8,966) | 4,795 | [1],[2] | ||||||
Change in fair value of trading securities | 2,500 | (1,000) | 0 | [1] | 1,500 | 0 | [1],[2] | ||||||
Impairment loss on intangible assets | 307 | 428 | 0 | [2] | |||||||||
Loss on extinguishment of debt | 0 | 1,469 | [1] | 0 | 1,469 | [1],[2] | |||||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | (110) | (50) | 53 | [2] | |||||||||
(Reversal) provision for doubtful accounts | 428 | 795 | 397 | [2] | |||||||||
Stock-based compensation | 12,118 | 19,276 | 14,952 | [2] | |||||||||
Changes in assets and liabilities | |||||||||||||
Accounts receivable | (4,256) | (1,496) | (3,388) | [2] | |||||||||
Inventories, net | (5,460) | (13,992) | (1,489) | [2] | |||||||||
Prepaid expenses and other current assets | 707 | (3,231) | 731 | [2] | |||||||||
Other non-current assets | (681) | (833) | (86) | [2] | |||||||||
Accounts payable | (626) | 1,580 | 406 | [2] | |||||||||
Accrued expenses | 1,263 | 5,465 | 3,867 | [2] | |||||||||
Other current liabilities | (330) | (28) | 299 | [2] | |||||||||
Other non-current liabilities | 178 | 141 | 1,157 | [2] | |||||||||
Deferred revenue | 4,780 | 10,254 | 6,344 | [2] | |||||||||
Net cash used in operating activities | (43,699) | (83,464) | (33,187) | [2] | |||||||||
Investing activities | |||||||||||||
Purchase of available-for-sale securities | (24,367) | (44,487) | 0 | [2] | |||||||||
Proceeds from maturities and call redemptions | 55,800 | 39,587 | 95,399 | 0 | [2] | ||||||||
Purchases of trading securities | (250) | (250) | 0 | [2] | |||||||||
Purchase of property and equipment | (1,219) | (1,956) | (624) | [2] | |||||||||
Capitalized internally-developed software | (1,688) | (3,823) | (3,416) | [2] | |||||||||
Net cash provided by (used in) investing activities | 12,063 | 44,883 | (4,040) | [2] | |||||||||
Financing activities | |||||||||||||
Proceeds from Business Combination and private offering, net of issuance costs | 0 | 449,967 | [2] | ||||||||||
Repayment of term loan | 0 | (5,000) | [2] | ||||||||||
Proceeds from issuance of common stock | 178 | 707 | 2,933 | [2] | |||||||||
Payments for tax withholding on net settlement of equity awards | (1,293) | (3,176) | 0 | [2] | |||||||||
Proceeds from revolving credit facility | 1,345 | 1,345 | 855 | [2] | |||||||||
Repayment of revolving credit facility | (2,409) | (4,472) | (53) | [2] | |||||||||
Net cash (used in) provided by financing activities | (2,179) | (5,596) | 448,702 | [2] | |||||||||
Effect of exchange rate on cash | (8) | (7) | (5) | [2] | |||||||||
Net change in cash and cash equivalents | (33,823) | (44,184) | 411,470 | [2] | |||||||||
Beginning of period | 90,959 | 124,782 | 60,529 | [2] | 124,782 | 60,529 | [2] | ||||||
End of period | 80,598 | 90,959 | 471,999 | [2] | 80,598 | 471,999 | [2] | ||||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||||||
Capitalization of stock-based compensation to internally developed software | 682 | 957 | (16) | 1,639 | 51 | [2] | |||||||
Accrued issuance costs | 0 | 25 | 1,715 | [2] | 0 | 1,715 | [2] | ||||||
Accrued fixed assets | 0 | 0 | 93 | [2] | |||||||||
Private placement warrants received as part of Business Combination | 13,872 | ||||||||||||
Prepaid expense received as part of Business Combination | 510 | ||||||||||||
Previously Reported | |||||||||||||
Operating activities | |||||||||||||
Net loss | (44,231) | (40,071) | (78,172) | ||||||||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||||||
Depreciation and amortization | 1,506 | 689 | 1,342 | ||||||||||
Non-cash interest expense | 994 | 3,490 | |||||||||||
Change in fair value of derivative liabilities | 8,991 | 12,588 | |||||||||||
Change in fair value of warrant liability | (6,267) | 4,795 | 4,795 | ||||||||||
Change in fair value of trading securities | (1,000) | ||||||||||||
Impairment loss on intangible assets | 0 | ||||||||||||
Loss on extinguishment of debt | 1,469 | 1,469 | |||||||||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | 665 | 53 | |||||||||||
(Reversal) provision for doubtful accounts | (50) | 159 | |||||||||||
Stock-based compensation | 11,718 | 14,916 | |||||||||||
Changes in assets and liabilities | |||||||||||||
Accounts receivable | (4,241) | (4,076) | |||||||||||
Inventories, net | (8,046) | (726) | |||||||||||
Prepaid expenses and other current assets | 811 | 742 | |||||||||||
Other non-current assets | (713) | (92) | |||||||||||
Accounts payable | (471) | 274 | |||||||||||
Accrued expenses | 199 | 3,875 | |||||||||||
Other current liabilities | (344) | 299 | |||||||||||
Other non-current liabilities | 178 | 1,185 | |||||||||||
Deferred revenue | 5,489 | 5,044 | |||||||||||
Net cash used in operating activities | (43,803) | (32,835) | |||||||||||
Investing activities | |||||||||||||
Purchase of available-for-sale securities | (24,367) | ||||||||||||
Proceeds from maturities and call redemptions | 39,587 | ||||||||||||
Purchases of trading securities | (250) | ||||||||||||
Purchase of property and equipment | (736) | (584) | |||||||||||
Capitalized internally-developed software | (2,069) | (3,727) | |||||||||||
Net cash provided by (used in) investing activities | 12,165 | (4,311) | |||||||||||
Financing activities | |||||||||||||
Proceeds from Business Combination and private offering, net of issuance costs | 450,003 | ||||||||||||
Repayment of term loan | (5,000) | ||||||||||||
Proceeds from issuance of common stock | 180 | 2,816 | |||||||||||
Payments for tax withholding on net settlement of equity awards | (1,293) | ||||||||||||
Proceeds from revolving credit facility | 1,345 | 855 | |||||||||||
Repayment of revolving credit facility | (2,409) | (53) | |||||||||||
Net cash (used in) provided by financing activities | (2,177) | 448,621 | |||||||||||
Effect of exchange rate on cash | (8) | (5) | |||||||||||
Net change in cash and cash equivalents | (33,823) | 411,470 | |||||||||||
Beginning of period | 90,959 | 124,782 | 60,529 | 124,782 | 60,529 | ||||||||
End of period | 90,959 | 471,999 | 471,999 | ||||||||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||||||
Capitalization of stock-based compensation to internally developed software | 1,019 | 56 | |||||||||||
Accrued issuance costs | 25 | 1,715 | 1,715 | ||||||||||
Accrued fixed assets | 251 | 133 | |||||||||||
Private placement warrants received as part of Business Combination | 13,872 | ||||||||||||
Prepaid expense received as part of Business Combination | 510 | ||||||||||||
Revision of Prior Period, Adjustment | |||||||||||||
Operating activities | |||||||||||||
Net loss | (2,601) | (1,414) | (1,869) | ||||||||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||||||
Depreciation and amortization | (376) | (11) | 3 | ||||||||||
Non-cash interest expense | (42) | 0 | |||||||||||
Change in fair value of derivative liabilities | 0 | (76) | |||||||||||
Change in fair value of warrant liability | 0 | 0 | 0 | ||||||||||
Change in fair value of trading securities | 0 | ||||||||||||
Impairment loss on intangible assets | 307 | ||||||||||||
Loss on extinguishment of debt | 0 | 0 | |||||||||||
Provision for non-cancellable purchase commitments and excess and obsolete inventory | (775) | 0 | |||||||||||
(Reversal) provision for doubtful accounts | 478 | 238 | |||||||||||
Stock-based compensation | 400 | 36 | |||||||||||
Changes in assets and liabilities | |||||||||||||
Accounts receivable | (15) | 688 | |||||||||||
Inventories, net | 2,586 | (763) | |||||||||||
Prepaid expenses and other current assets | (104) | (11) | |||||||||||
Other non-current assets | 32 | 6 | |||||||||||
Accounts payable | (155) | 132 | |||||||||||
Accrued expenses | 1,064 | (8) | |||||||||||
Other current liabilities | 14 | 0 | |||||||||||
Other non-current liabilities | 0 | (28) | |||||||||||
Deferred revenue | (709) | 1,300 | |||||||||||
Net cash used in operating activities | 104 | (352) | |||||||||||
Investing activities | |||||||||||||
Purchase of available-for-sale securities | 0 | ||||||||||||
Proceeds from maturities and call redemptions | 0 | ||||||||||||
Purchases of trading securities | 0 | ||||||||||||
Purchase of property and equipment | (483) | (40) | |||||||||||
Capitalized internally-developed software | 381 | 311 | |||||||||||
Net cash provided by (used in) investing activities | (102) | 271 | |||||||||||
Financing activities | |||||||||||||
Proceeds from Business Combination and private offering, net of issuance costs | (36) | ||||||||||||
Repayment of term loan | 0 | ||||||||||||
Proceeds from issuance of common stock | (2) | 117 | |||||||||||
Payments for tax withholding on net settlement of equity awards | 0 | ||||||||||||
Proceeds from revolving credit facility | 0 | 0 | |||||||||||
Repayment of revolving credit facility | 0 | 0 | |||||||||||
Net cash (used in) provided by financing activities | (2) | 81 | |||||||||||
Effect of exchange rate on cash | 0 | 0 | |||||||||||
Net change in cash and cash equivalents | 0 | 0 | |||||||||||
Beginning of period | $ 0 | 0 | $ 0 | $ 0 | 0 | ||||||||
End of period | 0 | 0 | 0 | ||||||||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||||||
Capitalization of stock-based compensation to internally developed software | (62) | (5) | |||||||||||
Accrued issuance costs | 0 | $ 0 | 0 | ||||||||||
Accrued fixed assets | $ (251) | (40) | |||||||||||
Private placement warrants received as part of Business Combination | 0 | ||||||||||||
Prepaid expense received as part of Business Combination | $ 0 | ||||||||||||
|
RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS AND INFORMATION - Consolidated Balance Sheets (Details) - USD ($) $ / shares in Units, $ in Thousands |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Jun. 30, 2021 |
Jun. 04, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current assets | |||||||||||||
Cash and cash equivalents | $ 80,598 | $ 124,782 | [1] | ||||||||||
Available-for-sale securities, current | 174,945 | 158,973 | [1] | ||||||||||
Accounts receivable, net | 12,589 | 11,888 | [1] | ||||||||||
Inventories, net current | 28,692 | 23,075 | [1] | ||||||||||
Prepaid expenses and other current assets | 14,647 | 12,705 | [1] | ||||||||||
Total current assets | 311,471 | 331,423 | [1] | ||||||||||
Available-for-sale securities, non-current | 32,431 | 102,878 | [1] | ||||||||||
Property and equipment, net | 2,947 | 2,039 | [1] | ||||||||||
Internally developed software, net | 14,348 | 11,005 | [1] | ||||||||||
Other non-current assets | 2,933 | 2,256 | [1] | ||||||||||
Total assets | 372,555 | 449,601 | [1] | ||||||||||
Current liabilities | |||||||||||||
Accounts payable | 8,096 | 6,517 | [1] | ||||||||||
Accrued expenses | 29,373 | 24,309 | [1] | ||||||||||
Deferred revenue, current | 9,919 | 7,259 | [1] | ||||||||||
Other current liabilities | 1,373 | 4,528 | [1] | ||||||||||
Total current liabilities | 48,761 | 42,613 | [1] | ||||||||||
Deferred revenue, non-current | 30,803 | 23,209 | [1] | ||||||||||
Warrant liability | 821 | 9,787 | [1] | ||||||||||
Total liabilities | 80,526 | 75,609 | [1] | ||||||||||
Commitments and contingencies (see Note 9) | |||||||||||||
Stockholders’ Equity | |||||||||||||
Common stock, $0.0001 par value, 1,000,000,000 shares authorized, and 141,592,388 shares issued and outstanding as of December 31, 2021 | [2] | 16 | 15 | [1] | |||||||||
Additional paid-in-capital | 724,285 | 705,865 | [1] | ||||||||||
Accumulated other comprehensive loss | (2,574) | (676) | [1] | ||||||||||
Accumulated deficit | (429,698) | (331,212) | [1] | ||||||||||
Total stockholders’ equity | 292,029 | $ 337,441 | 373,992 | [1] | $ 448,768 | $ (177,226) | $ (155,930) | ||||||
Total liabilities and stockholders’ equity | $ 372,555 | $ 449,601 | [1] | ||||||||||
Common stock, par value (in dollars per share) | $ 0.0001 | [2] | $ 0.0001 | [2] | $ 0.0001 | ||||||||
Common stock, authorized (in shares) | 1,000,000,000 | [2] | 1,000,000,000 | [2] | 1,000,000,000.0 | ||||||||
Common stock, issued (in shares) | 144,086,282 | [2] | 141,585,530 | [2] | 140,500,000 | ||||||||
Common stock, outstanding (in shares) | 144,086,282 | [2] | 141,585,530 | [2] | 140,500,000 | ||||||||
Shares subject to vesting restrictions (in shares) | 738,000 | 738,000 | 738,000 | ||||||||||
Previously Reported | |||||||||||||
Current assets | |||||||||||||
Cash and cash equivalents | $ 124,782 | ||||||||||||
Available-for-sale securities, current | 158,973 | ||||||||||||
Accounts receivable, net | 25,642 | ||||||||||||
Inventories, net current | 11,615 | ||||||||||||
Prepaid expenses and other current assets | 11,606 | ||||||||||||
Total current assets | 332,618 | ||||||||||||
Available-for-sale securities, non-current | 102,878 | ||||||||||||
Property and equipment, net | 2,039 | ||||||||||||
Internally developed software, net | 12,475 | ||||||||||||
Other non-current assets | 2,294 | ||||||||||||
Total assets | 452,304 | ||||||||||||
Current liabilities | |||||||||||||
Accounts payable | 6,229 | ||||||||||||
Accrued expenses | 24,184 | ||||||||||||
Deferred revenue, current | 6,016 | ||||||||||||
Other current liabilities | 4,342 | ||||||||||||
Total current liabilities | 40,771 | ||||||||||||
Deferred revenue, non-current | 24,190 | ||||||||||||
Warrant liability | 9,787 | ||||||||||||
Total liabilities | 74,748 | ||||||||||||
Commitments and contingencies (see Note 9) | |||||||||||||
Stockholders’ Equity | |||||||||||||
Common stock, $0.0001 par value, 1,000,000,000 shares authorized, and 141,592,388 shares issued and outstanding as of December 31, 2021 | 25 | ||||||||||||
Additional paid-in-capital | 706,713 | ||||||||||||
Accumulated other comprehensive loss | (676) | ||||||||||||
Accumulated deficit | (328,506) | ||||||||||||
Total stockholders’ equity | 377,556 | $ (155,930) | |||||||||||
Total liabilities and stockholders’ equity | 452,304 | ||||||||||||
Revision of Prior Period, Adjustment | |||||||||||||
Current assets | |||||||||||||
Cash and cash equivalents | 0 | ||||||||||||
Available-for-sale securities, current | 0 | ||||||||||||
Accounts receivable, net | (13,754) | ||||||||||||
Inventories, net current | 11,460 | ||||||||||||
Prepaid expenses and other current assets | 1,099 | ||||||||||||
Total current assets | (1,195) | ||||||||||||
Available-for-sale securities, non-current | 0 | ||||||||||||
Property and equipment, net | 0 | ||||||||||||
Internally developed software, net | (1,470) | ||||||||||||
Other non-current assets | (38) | ||||||||||||
Total assets | (2,703) | ||||||||||||
Current liabilities | |||||||||||||
Accounts payable | 288 | ||||||||||||
Accrued expenses | 125 | ||||||||||||
Deferred revenue, current | 1,243 | ||||||||||||
Other current liabilities | 186 | ||||||||||||
Total current liabilities | 1,842 | ||||||||||||
Deferred revenue, non-current | (981) | ||||||||||||
Warrant liability | 0 | ||||||||||||
Total liabilities | 861 | ||||||||||||
Commitments and contingencies (see Note 9) | |||||||||||||
Stockholders’ Equity | |||||||||||||
Common stock, $0.0001 par value, 1,000,000,000 shares authorized, and 141,592,388 shares issued and outstanding as of December 31, 2021 | (10) | ||||||||||||
Additional paid-in-capital | (848) | ||||||||||||
Accumulated other comprehensive loss | 0 | ||||||||||||
Accumulated deficit | (2,706) | ||||||||||||
Total stockholders’ equity | (3,564) | ||||||||||||
Total liabilities and stockholders’ equity | (2,703) | ||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Hardware Revenue Recognition | |||||||||||||
Current assets | |||||||||||||
Accounts receivable, net | (11,846) | ||||||||||||
Inventories, net current | 11,949 | ||||||||||||
Prepaid expenses and other current assets | 24 | ||||||||||||
Current liabilities | |||||||||||||
Accounts payable | 181 | ||||||||||||
Accrued expenses | 218 | ||||||||||||
Deferred revenue, current | 467 | ||||||||||||
Deferred revenue, non-current | 1 | ||||||||||||
Stockholders’ Equity | |||||||||||||
Additional paid-in-capital | 10 | ||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Software Revenue Recognition | |||||||||||||
Current assets | |||||||||||||
Accounts receivable, net | (1,275) | ||||||||||||
Prepaid expenses and other current assets | 55 | ||||||||||||
Current liabilities | |||||||||||||
Deferred revenue, current | 776 | ||||||||||||
Deferred revenue, non-current | (982) | ||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Previously Reported Amounts Reclassified | |||||||||||||
Current assets | |||||||||||||
Accounts receivable, net | (633) | ||||||||||||
Prepaid expenses and other current assets | 633 | ||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Other Corrections | |||||||||||||
Current assets | |||||||||||||
Inventories, net current | (489) | ||||||||||||
Prepaid expenses and other current assets | 387 | ||||||||||||
Current liabilities | |||||||||||||
Accounts payable | 107 | ||||||||||||
Accrued expenses | (93) | ||||||||||||
Revision of Prior Period, Adjustment | Revision of Prior Period, Related to Stock-Based Compensation | |||||||||||||
Stockholders’ Equity | |||||||||||||
Additional paid-in-capital | $ (858) | ||||||||||||
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Rollforward of Accounts Receivable (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2022 |
Jun. 30, 2022 |
Jun. 30, 2021 |
[1] | |||
Accounting Policies [Abstract] | ||||||
Beginning balance | $ 1,241 | $ 1,241 | ||||
Provision for doubtful accounts | $ 428 | 795 | $ 397 | |||
Ending balance | $ 2,036 | |||||
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Depreciation and amortization calculated using straight-line method (Details) |
Jun. 30, 2022 |
---|---|
Office furniture | |
Property, Plant and Equipment [Line Items] | |
Useful life in years | 5 years |
Computers and equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life in years | 3 years |
Computers and equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life in years | 5 years |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
segment
|
Jun. 30, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
|
Jan. 01, 2022
USD ($)
|
|||||
Loss Contingencies [Line Items] | |||||||||||
Intangible assets | $ 1,059 | $ 1,059 | $ 1,059 | ||||||||
Amortization | 100 | $ 0 | 200 | $ 0 | |||||||
Goodwill, Impairment Loss | 0 | 0 | 0 | 0 | |||||||
Revenue | $ 9,830 | $ 13,556 | 6,745 | [1] | $ 23,386 | 11,719 | [1] | ||||
Capitalized contract cost, amortization period | 10 years | 10 years | |||||||||
Deferred contract costs recognition period | 1 year | ||||||||||
Deferred revenue, revenue recognized | $ 5,200 | 4,500 | |||||||||
Advertising expense | $ 1,200 | 200 | 2,100 | 300 | |||||||
Impairment charges | 100 | 0 | $ 400 | 0 | |||||||
Number of operating segments | segment | 1 | ||||||||||
Number of reportable segments | segment | 1 | ||||||||||
Cumulative Effect, Period of Adoption, Adjustment | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Operating lease ROU assets | $ 400 | ||||||||||
Operating lease, current | 200 | ||||||||||
Operating lease, non-current | $ 200 | ||||||||||
Assembled workforce | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Intangible assets | 700 | $ 700 | 700 | ||||||||
Accounts Receivable | Customer Concentration Risk | One Customer | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Accounts receivable, gross | 3,000 | $ 3,000 | $ 2,700 | ||||||||
Concentration risk, percentage | 19.00% | 19.00% | |||||||||
Revenue Benchmark | Customer Concentration Risk | One Customer | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue | $ 2,200 | $ 6,600 | $ 1,900 | ||||||||
Concentration risk, percentage | 22.00% | 28.00% | 16.00% | ||||||||
Revenue Benchmark | Customer Concentration Risk | Two Large Customers | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue | $ 2,400 | ||||||||||
Concentration risk, percentage | 35.00% | ||||||||||
Minimum | Assembled workforce | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Finite-lived intangible asset, useful life | 3 years | 3 years | |||||||||
Minimum | Software Development | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Finite-lived intangible asset, useful life | 3 years | 3 years | |||||||||
Maximum | Software Development | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Finite-lived intangible asset, useful life | 5 years | 5 years | |||||||||
Hardware | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Reserve for returns of defective products, percentage | 2.00% | 2.00% | 2.00% | 2.00% | |||||||
Revenue | $ 4,710 | 9,288 | $ 4,948 | [1] | $ 13,998 | $ 8,445 | [1] | ||||
Hardware Device, Electrical Components | Minimum | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Standard product warranty, return period | 1 year | ||||||||||
Hardware Device, Electrical Components | Maximum | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Standard product warranty, return period | 2 years | ||||||||||
Hardware Device, Mechanical Components | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Standard product warranty, return period | 5 years | ||||||||||
Software | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Interest expense | 1,400 | 700 | $ 2,400 | 1,300 | |||||||
Revenue | 3,239 | $ 2,707 | 1,627 | [1] | 5,946 | 3,104 | [1] | ||||
Professional Service Revenue | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue | 1,900 | 200 | 3,400 | 200 | |||||||
Hardware | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Reserve for returns of defective products | $ 0 | $ (400) | $ (400) | $ (200) | |||||||
Software | Contract With Customer, Duration One | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue recognition, customer contract period | 1 year | ||||||||||
Software | Contract With Customer, Duration Two | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue recognition, customer contract period | 2 years | ||||||||||
Software | Contract With Customer, Duration Three | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue recognition, customer contract period | 5 years | ||||||||||
Software | Contract With Customer, Duration Four | |||||||||||
Loss Contingencies [Line Items] | |||||||||||
Revenue recognition, customer contract period | 10 years | ||||||||||
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | $ 1,059 | $ 1,059 |
Less: accumulated amortization | (371) | (213) |
Total intangible assets, net | 688 | 846 |
Domain names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | 318 | 318 |
Assembled workforce | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | 700 | 700 |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | 37 | 37 |
Other intangibles | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | $ 4 | $ 4 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful life of the intangible assets (Details) |
Jun. 30, 2022 |
---|---|
Assembled workforce | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Finite-lived intangible asset, useful life | 3 years |
Domain names | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Finite-lived intangible asset, useful life | 3 years |
Domain names | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Finite-lived intangible asset, useful life | 13 years |
Patents | |
Finite-Lived Intangible Assets [Line Items] | |
Finite-lived intangible asset, useful life | 12 years |
Other intangibles | |
Finite-Lived Intangible Assets [Line Items] | |
Finite-lived intangible asset, useful life | 5 years |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Contract Costs (Details) $ in Thousands |
6 Months Ended |
---|---|
Jun. 30, 2022
USD ($)
| |
Movement In Capitalized Contract Costs, Net [Roll Forward] | |
Beginning balance | $ 1,237 |
Additions to deferred contract costs | 711 |
Amortization of deferred contract costs | (111) |
Ending balance | $ 1,837 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Accounting Policies [Abstract] | ||
Contract assets (unbilled receivables) | $ 1,182 | $ 713 |
Contract liabilities (deferred revenue) | $ 40,722 | $ 30,468 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Performance Obligations (Details) $ in Millions |
Jun. 30, 2022
USD ($)
|
---|---|
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 40.7 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 9.9 |
Deferred revenue, expected timing of satisfaction, period | 12 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | Revenue | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 14.6 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | Interest Expense | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | 4.6 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 30.8 |
Deferred revenue, expected timing of satisfaction, period | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Revenue | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 41.7 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Interest Expense | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 10.9 |
INVESTMENTS - Marketable Securities by Security Type Summarized (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 209,951 | $ 262,527 |
Gross Unrealized Loss | (2,575) | (676) |
Estimated Fair Value | 207,376 | 261,851 |
Asset backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 8,034 | 11,101 |
Gross Unrealized Loss | (210) | (56) |
Estimated Fair Value | 7,824 | 11,045 |
Commercial paper and corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 178,285 | 234,497 |
Gross Unrealized Loss | (1,904) | (551) |
Estimated Fair Value | 176,381 | 233,946 |
U.S. government agency debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 23,632 | 16,929 |
Gross Unrealized Loss | (461) | (69) |
Estimated Fair Value | $ 23,171 | $ 16,860 |
INVESTMENTS - Narrative (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 |
Nov. 30, 2021 |
Jul. 31, 2021 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
[2] | Jun. 30, 2022 |
Jun. 30, 2021 |
[1] | Dec. 31, 2021 |
|||||
Debt Securities, Available-for-sale [Line Items] | |||||||||||||||
Gross unrealized losses | $ 2,575 | $ 2,575 | $ 676 | ||||||||||||
Proceeds from maturities and call redemptions | 55,800 | $ 39,587 | 95,399 | $ 0 | |||||||||||
Proceeds from sale of debt securities, available-for-sale | 20,600 | 95,400 | |||||||||||||
Proceeds from sale and maturity of debt securities, available-for-sale | 28,700 | ||||||||||||||
Payments to acquire convertible promissory note | 250 | 250 | 0 | ||||||||||||
Loss on trading securities | 2,500 | $ (1,000) | $ 0 | 1,500 | $ 0 | [2] | |||||||||
Trading securities | $ 3,100 | $ 3,100 | |||||||||||||
Trading securities | |||||||||||||||
Debt Securities, Available-for-sale [Line Items] | |||||||||||||||
Payments to acquire convertible promissory note | $ 300 | $ 300 | $ 4,000 | ||||||||||||
Interest rate | 6.00% | ||||||||||||||
|
INVESTMENTS - Contractual Maturities of Marketable Securities (Details) $ in Thousands |
Jun. 30, 2022
USD ($)
|
---|---|
Amortized Cost | |
Due in less than one year | $ 181,014 |
Due in one to five years | 33,437 |
Total investments | 214,451 |
Estimated Fair Value | |
Due in less than one year | 177,995 |
Due in one to five years | 32,431 |
Total investments | $ 210,426 |
FAIR VALUE MEASUREMENTS - Financial Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Assets | |||||
Debt securities, available-for-sale, fair value | $ 207,376 | $ 261,851 | |||
Trading securities | 3,100 | ||||
Liabilities | |||||
Warrant liability | 821 | 9,787 | [1] | ||
Fair Value, Recurring | |||||
Assets | |||||
Total cash and cash equivalents | 80,598 | 124,782 | |||
Debt securities, available-for-sale, fair value | 207,376 | 261,851 | |||
Trading securities | 3,050 | 4,300 | |||
Total assets | 291,024 | 390,933 | |||
Liabilities | |||||
Warrant liability | 821 | 9,787 | |||
Total liabilities | 821 | 9,787 | |||
Fair Value, Recurring | Cash | |||||
Assets | |||||
Total cash and cash equivalents | 38,759 | 8,983 | |||
Fair Value, Recurring | Money market funds and other cash equivalents | |||||
Assets | |||||
Total cash and cash equivalents | 41,839 | 115,799 | |||
Level 1 | Fair Value, Recurring | |||||
Assets | |||||
Total cash and cash equivalents | 74,100 | 85,684 | |||
Debt securities, available-for-sale, fair value | 0 | 0 | |||
Trading securities | 0 | 0 | |||
Total assets | 74,100 | 85,684 | |||
Liabilities | |||||
Warrant liability | 0 | 0 | |||
Total liabilities | 0 | 0 | |||
Level 1 | Fair Value, Recurring | Cash | |||||
Assets | |||||
Total cash and cash equivalents | 38,759 | 8,983 | |||
Level 1 | Fair Value, Recurring | Money market funds and other cash equivalents | |||||
Assets | |||||
Total cash and cash equivalents | 35,341 | 76,701 | |||
Level 2 | Fair Value, Recurring | |||||
Assets | |||||
Total cash and cash equivalents | 6,498 | ||||
Debt securities, available-for-sale, fair value | 207,376 | 261,851 | |||
Trading securities | 0 | 0 | |||
Total assets | 213,874 | 300,949 | |||
Liabilities | |||||
Warrant liability | 821 | 9,787 | |||
Total liabilities | 821 | 9,787 | |||
Level 2 | Fair Value, Recurring | Cash | |||||
Assets | |||||
Total cash and cash equivalents | 0 | 0 | |||
Level 2 | Fair Value, Recurring | Money market funds and other cash equivalents | |||||
Assets | |||||
Total cash and cash equivalents | 6,498 | 39,098 | |||
Level 3 | Fair Value, Recurring | |||||
Assets | |||||
Total cash and cash equivalents | 0 | ||||
Debt securities, available-for-sale, fair value | 0 | 0 | |||
Trading securities | 3,050 | 4,300 | |||
Total assets | 3,050 | 4,300 | |||
Liabilities | |||||
Warrant liability | 0 | 0 | |||
Total liabilities | 0 | 0 | |||
Level 3 | Fair Value, Recurring | Cash | |||||
Assets | |||||
Total cash and cash equivalents | 0 | 0 | |||
Level 3 | Fair Value, Recurring | Money market funds and other cash equivalents | |||||
Assets | |||||
Total cash and cash equivalents | $ 0 | $ 0 | |||
|
FAIR VALUE MEASUREMENTS - Narrative (Details) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2022
USD ($)
$ / shares
|
Jun. 30, 2022
USD ($)
$ / shares
|
Dec. 31, 2021
USD ($)
$ / shares
|
||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Warrant liability | $ 821,000 | $ 821,000 | $ 9,787,000 | [1] | ||
Sales issues | 0 | 0 | ||||
Transfers into or out of Level 3 | $ 0 | $ 0 | ||||
Measurement Input, Price Volatility [Member] | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Debt securities, trading, measurement input | 0.80 | 0.80 | ||||
Measurement Input, Expected Term [Member] | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Debt securities, trading, measurement input | 0.24 | 0.24 | ||||
Public Warrants | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Share price (in dollars per share) | $ / shares | $ 0.15 | $ 0.15 | $ 1.84 | |||
Private Placement Warrants | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Warrant liability | $ 800,000 | $ 800,000 | $ 9,800,000 | |||
|
FAIR VALUE MEASUREMENTS - Activity of the Level 3 Instruments (Details) - Convertible Debt $ in Thousands |
6 Months Ended |
---|---|
Jun. 30, 2022
USD ($)
| |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |
Beginning balance | $ 4,300 |
Purchases | 250 |
Change in fair value | 1,500 |
Ending balance | $ 3,050 |
INVENTORIES, NET (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Inventory Disclosure [Abstract] | |||||
Raw materials | $ 3,851 | $ 2,513 | |||
Finished goods | 17,897 | 9,843 | |||
Channel inventory | 7,284 | 11,109 | |||
Excess and obsolete inventory reserve | (340) | (390) | |||
Inventories, net current | 28,692 | 23,075 | [1] | ||
Finished goods - non-current | 8,425 | 0 | |||
Total inventories, net | $ 37,117 | $ 23,075 | |||
|
INTERNALLY DEVELOPED SOFTWARE, NET (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
||||
Research and Development [Abstract] | ||||||||
Internally-developed software | $ 13,321 | $ 13,321 | $ 9,667 | |||||
Software-in-development | 6,233 | 6,233 | 4,853 | |||||
Less: Accumulated amortization | (5,206) | (5,206) | (3,515) | |||||
Total internally-developed software, net | 14,348 | 14,348 | $ 11,005 | [1] | ||||
Capitalized computer software, additions | 2,700 | $ 2,100 | 5,100 | $ 3,500 | ||||
Amortization of software | 900 | 500 | 1,700 | 1,000 | ||||
Related to the decision not to proceed with further development of certain software products | $ 100 | $ 0 | $ 400 | $ 0 | ||||
|
ACCRUED EXPENSES (Details) - USD ($) $ in Thousands |
Jun. 30, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Payables and Accruals [Abstract] | |||||
Accrued compensation | $ 4,580 | $ 5,985 | |||
Accrued warranties | 659 | 774 | |||
Accrued purchases | 4,050 | 1,701 | |||
Accrued non-cancellable purchase commitments | 3,981 | 549 | |||
Accrued operating expense | 6,560 | 8,214 | |||
Accrued litigation costs | 6,750 | 6,750 | |||
Accrued restructuring costs | 2,426 | 0 | |||
Other accrued expenses | 367 | 336 | |||
Total accrued expenses | $ 29,373 | $ 24,309 | [1] | ||
|
COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands |
1 Months Ended | |||||
---|---|---|---|---|---|---|
Dec. 02, 2024
USD ($)
|
Nov. 12, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
|
Jun. 30, 2021
USD ($)
tranche
|
Jun. 30, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
Loss Contingencies [Line Items] | ||||||
Accrued non-cancellable purchase commitments | $ 3,981 | $ 549 | ||||
Amount accrued in connection with the dispute | 6,800 | $ 6,800 | ||||
Subsequent Event | Brennan Action | ||||||
Loss Contingencies [Line Items] | ||||||
Settlement amount, net of amount receivable from insurers | $ 1,950 | $ 1,950 | ||||
Subsequent Event | Fiduciary Lawsuits | ||||||
Loss Contingencies [Line Items] | ||||||
Settlement amount, including amount recoverable from insurers | $ 29,750 | |||||
Settlement amount, receivable from insurers | 10,000 | |||||
Settlement amount, net of amount receivable from insurers | $ 14,875 | |||||
Registration Rights Agreement | ||||||
Loss Contingencies [Line Items] | ||||||
Number of times stockholders may each request to sell all or any portion of their registrable securities in an underwritten offering (up to) | tranche | 2 | |||||
Stockholders may each request to sell all or any portion of their registrable securities in an underwritten offering, period | 12 months | |||||
Sale of stock, expected consideration received on transaction | $ 75,000 | |||||
Maximum | ||||||
Loss Contingencies [Line Items] | ||||||
Unrecorded purchase commitment | $ 26,300 |
EQUITY - Narrative (Details) - $ / shares |
Jun. 04, 2021 |
Jun. 30, 2022 |
Dec. 31, 2021 |
[1] | |||
---|---|---|---|---|---|---|---|
Equity, Class of Treasury Stock [Line Items] | |||||||
Shares, authorized (in shares) | 1,100,000,000 | ||||||
Common stock, authorized (in shares) | 1,000,000,000.0 | 1,000,000,000 | [1] | 1,000,000,000 | |||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | [1] | $ 0.0001 | |||
Preferred stock, shares authorized (in shares) | 100,000,000.0 | ||||||
Preferred stock, par or stated value per share (in dollars per share) | $ 0.0001 | ||||||
Stock voting rights, percentage | 100.00% | ||||||
Public Warrants, TSIA IPO | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Class of warrant or right, conversion of securities (in shares) | 10,000,000 | ||||||
Public Warrants, Post Combination Company | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Number of securities called by warrants or rights (in shares) | 10,000,000 | ||||||
Class of warrant or right, outstanding (in shares) | 10,000,000 | ||||||
Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ 11.50 | ||||||
|
EQUITY - Common Stock Shares Reserved For Future Issuance (Details) - shares |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 58,172,143 | 53,573,645 |
Stock options issued and outstanding | ||
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 13,365,270 | 15,009,656 |
Restricted stock units issued and outstanding | ||
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 12,380,472 | 6,498,869 |
Public warrants outstanding | ||
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 9,999,967 | 9,999,967 |
Private placement warrants outstanding | ||
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 5,333,334 | 5,333,334 |
2021 Incentive Award Plan available shares | ||
Class of Stock [Line Items] | ||
Reserved shares of common stock for future issuance (in shares) | 17,093,100 | 16,731,819 |
EARNINGS PER SHARE - Computation of Basic and Diluted Net Income Per Share for Common Stock and Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||||
Earnings Per Share [Abstract] | |||||||||
Numerator for basic net loss per share - net loss | $ (51,616) | $ (41,485) | $ (98,448) | $ (80,041) | |||||
Numerator for diluted net loss per share - net loss | $ (51,616) | $ (41,485) | $ (98,448) | $ (80,041) | |||||
Basic net loss - adjusted weighted-average common shares (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | [1] | 142,615,560 | 30,960,173 | [1] | ||
Effect of dilutive securities | 0 | 0 | 0 | 0 | |||||
Diluted net loss - adjusted weighted-average common shares (in shares) | 143,253,837 | 141,970,190 | 51,256,111 | [1] | 142,615,560 | 30,960,173 | [1] | ||
Basic net loss per share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | [1] | $ (0.69) | $ (2.59) | [1] | ||
Diluted net loss per share (in dollars per share) | $ (0.36) | $ (0.33) | $ (0.81) | [1] | $ (0.69) | $ (2.59) | [1] | ||
|
EARNINGS PER SHARE - Outstanding Common Stock Options RSUs and Common Stock Warrant (Details) - shares |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2022 |
Dec. 31, 2021 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Outstanding common stock options (in shares) | 41,096,416 | 36,841,826 |
Stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Outstanding common stock options (in shares) | 13,365,270 | 15,009,656 |
Restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Outstanding common stock options (in shares) | 12,397,845 | 6,498,869 |
Warrants | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Outstanding common stock options (in shares) | 15,333,301 | 15,333,301 |
INCOME TAXES (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
[1] | Jun. 30, 2022 |
Jun. 30, 2021 |
[1] | |||
Income Tax Disclosure [Abstract] | |||||||||
Income tax provision | $ 17 | $ 17 | $ 34 | $ 34 | $ 34 | ||||
Unrecognized tax benefits | $ 0 | $ 0 | |||||||
|
STOCK-BASED COMPENSATION - Stock-Based Compensation Activity (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Capitalized costs | $ (682) | $ (957) | $ 16 | $ (1,639) | $ (51) | [1] | ||
Stock based compensation expense | 7,158 | 568 | 19,276 | 14,952 | ||||
Stock options | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Stock based compensation expense, expensed and capitalized | 340 | 552 | 1,825 | 15,003 | ||||
Restricted stock units | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Stock based compensation expense, expensed and capitalized | $ 7,500 | $ 0 | $ 19,090 | $ 0 | ||||
|
STOCK-BASED COMPENSATION - Other Operating Cost and Expense, by Component (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | $ 7,158 | $ 568 | $ 19,276 | $ 14,952 |
Cost of revenue | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | 170 | 19 | 362 | 33 |
Research and development | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | 3,471 | 176 | 8,197 | 4,162 |
Sales and marketing | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | 1,448 | 52 | 3,990 | 214 |
General and administrative | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | $ 2,069 | $ 321 | $ 6,727 | $ 10,543 |
STOCK-BASED COMPENSATION - Narrative (Details) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 13, 2024
shares
|
Aug. 11, 2024 |
Jan. 01, 2024
shares
|
Jan. 01, 2023
shares
|
Jun. 04, 2021
USD ($)
shares
|
Jan. 19, 2021
USD ($)
$ / shares
shares
|
Jan. 01, 2021
shares
|
Jun. 30, 2022
USD ($)
shares
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
employee
shares
|
Jun. 30, 2021
USD ($)
$ / shares
|
Jun. 03, 2021
$ / shares
shares
|
Jan. 31, 2021
shares
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Grants in period, weighted average grant date fair value (in dollars per share) | $ / shares | $ 1.60 | ||||||||||||
Options granted (in shares) | 0 | ||||||||||||
Total stock-based compensation expense | $ | $ 7,158 | $ 568 | $ 19,276 | $ 14,952 | |||||||||
Accelerated vesting, number of employees | employee | 70 | ||||||||||||
Accelerated vesting (in shares) | 505,451 | ||||||||||||
Accelerated vesting, reversal of previous cost | $ | $ 4,000 | ||||||||||||
Accelerated vesting, fair value of new award | $ | 700 | ||||||||||||
Accelerated vesting, net reversal of cost | $ | 3,300 | ||||||||||||
Sale of stock, number of shares issued in transaction (in shares) | 19,300,000 | ||||||||||||
Options, canceled, percent (up to) | 25.00% | ||||||||||||
Options, canceled in period (in dollars per share) | $ / shares | $ 10.00 | ||||||||||||
Options, canceled in period (in shares) | 300,000 | ||||||||||||
Consideration received on transaction, used to fund cash election | $ | $ 2,600 | ||||||||||||
Number of shares issued in transaction, used to fund cash election (in shares) | 300,000 | ||||||||||||
Secondary Purchase | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Total stock-based compensation expense | $ | $ 13,800 | ||||||||||||
Sale of stock, number of shares issued in transaction (in shares) | 2,800,000 | ||||||||||||
Sale of stock, price per share (in dollars per share) | $ / shares | $ 9.92 | ||||||||||||
Cost of revenue | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Total stock-based compensation expense | $ | 170 | $ 19 | 362 | $ 33 | |||||||||
Stock options issued and outstanding | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Compensation cost not yet recognized related to unvested stock options | $ | 1,000 | $ 1,000 | |||||||||||
Compensation cost not yet recognized related to unvested stock options, period for recognition | 1 year 6 months | ||||||||||||
Restricted stock units issued and outstanding | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Grants in period (in shares) | 12,166,276 | ||||||||||||
Compensation cost not yet recognized related to unvested stock options, period for recognition | 2 years 2 months 12 days | ||||||||||||
Compensation cost not yet recognized related to unvested stock options | $ | 66,800 | $ 66,800 | |||||||||||
Share-based payment arrangement, RSU vesting not yet released at the time of vesting | $ | 100 | $ 200 | |||||||||||
Vested in period (in shares) | 2,322,733 | ||||||||||||
Restricted stock units issued and outstanding | Liability | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Grants in period (in shares) | 0 | ||||||||||||
Compensation cost not yet recognized related to unvested stock options, period for recognition | 2 years | ||||||||||||
Compensation cost not yet recognized | $ | $ 20 | $ 20 | |||||||||||
Vested in period (in shares) | 1,992 | 3,983 | |||||||||||
Settlement of liability-based awards for cash | $ | $ 10 | ||||||||||||
Restricted stock units issued and outstanding | Liability | Cost of revenue | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Total stock-based compensation expense | $ | $ 3 | ||||||||||||
Subsequent Event | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Vesting period | 3 years | ||||||||||||
Options granted (in shares) | 8,600,000 | ||||||||||||
2016 Stock Plan | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Number of shares authorized (in shares) | 22,797,955 | ||||||||||||
Expiration period | 10 years | ||||||||||||
Vesting period | 4 years | ||||||||||||
2021 Plan | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Expiration period | 10 years | ||||||||||||
Number of shares available for grant (in shares) | 22,500,611 | ||||||||||||
Period for annual increase for common stock available for issuance | 10 years | ||||||||||||
Percentage of aggregate common stock shares outstanding | 5.00% | ||||||||||||
Reserved shares of common stock for future issuance (in shares) | 7,116,177 | ||||||||||||
Grants in period (in shares) | 24,359,792 | ||||||||||||
2021 Plan | Restricted stock units issued and outstanding | Minimum | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Vesting period | 1 year | 1 year | |||||||||||
2021 Plan | Restricted stock units issued and outstanding | Maximum | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Vesting period | 4 years | 4 years | |||||||||||
2021 Plan | Subsequent Event | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Reserved shares of common stock for future issuance (in shares) | 8,810,007 | 7,267,376 |
STOCK-BASED COMPENSATION - Stock Options Activity (Details) - USD ($) |
6 Months Ended |
---|---|
Jun. 30, 2022 | |
Options Outstanding | |
Options, outstanding, beginning balance (in shares) | 15,009,656 |
Options forfeited (in shares) | (640,214) |
Options expired (in shares) | (2,283) |
Options exercised (in shares) | (1,001,889) |
Options, outstanding, ending balance (in shares) | 13,365,270 |
Options, exercisable (in shares) | 11,470,516 |
Weighted Average Exercise Price | |
Options, outstanding, weighted average exercise price, beginning balance (in dollars per share) | $ 0.75 |
Options, forfeited (in dollars per share) | 1.14 |
Options expired (in dollars per share) | 2.56 |
Options, exercised (in dollars per share) | 0.84 |
Options, outstanding, weighted average exercise price, ending balance (in dollars per share) | 0.72 |
Options, exercisable (in dollars per share) | $ 0.64 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] | |
Options, weighted average remaining contractual term | 6 years |
Exercisable, weighted average remaining contractual term | 6 years |
Options outstanding, aggregate intrinsic value | $ 6,724,000 |
Options, exercisable, aggregate intrinsic value | $ 6,384,000 |
STOCK-BASED COMPENSATION - Restricted Stock Units Activity (Details) - Restricted stock units - $ / shares |
3 Months Ended | 6 Months Ended |
---|---|---|
Jun. 30, 2022 |
Jun. 30, 2022 |
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||
Beginning balance (in shares) | 6,477,513 | |
Grants in period (in shares) | 12,166,276 | |
Vested in period (in shares) | (2,322,733) | |
Forfeited (in shares) | (3,940,584) | |
Ending balance (in shares) | 12,380,472 | 12,380,472 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ||
Beginning balance, weighted average grant date fair value (in dollars per share) | $ 12.14 | |
Grants in period, weighted average grant date fair value (in dollars per share) | 4.14 | |
Vested in period, weighted average grant date fair value (in dollars per share) | 10.84 | |
Forfeited in period, weighted average grant date fair value (in dollars per share) | 7.15 | |
Ending balance, weighted average grant date fair value (in dollars per share) | $ 6.12 | $ 6.12 |
Liability | ||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||
Beginning balance (in shares) | 21,356 | |
Grants in period (in shares) | 0 | |
Vested in period (in shares) | (1,992) | (3,983) |
Forfeited (in shares) | 0 | |
Ending balance (in shares) | 17,373 | 17,373 |
RELATED-PARTY TRANSACTIONS (Details) - Related Party - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
|
Related Party Transaction [Line Items] | |||||
Accounts Receivable, after Allowance for Credit Loss | $ 200 | $ 200 | $ 400 | ||
Hardware | |||||
Related Party Transaction [Line Items] | |||||
Revenues | 10 | $ 200 | 10 | $ 300 | |
Software | |||||
Related Party Transaction [Line Items] | |||||
Revenues | $ 40 | $ 100 | $ 100 | $ 300 |
SUBSEQUENT EVENTS - Other Narrative (Details) - Subsequent Event $ / shares in Units, ft² in Thousands |
1 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 11, 2024 |
Jul. 21, 2024
USD ($)
|
Apr. 26, 2024
USD ($)
|
May 15, 2023
USD ($)
$ / shares
shares
|
Jul. 31, 2023
USD ($)
employee
shares
|
Jan. 31, 2023
USD ($)
|
Jul. 15, 2024
USD ($)
Rate
|
Jul. 01, 2024
USD ($)
|
Jan. 31, 2024
USD ($)
ft²
|
Nov. 01, 2023
ft²
|
May 31, 2023
USD ($)
employee
|
|
Subsequent Event [Line Items] | |||||||||||
Volume weighted average price, period | 60 days | ||||||||||
Registration rights, period during which holders may sell up to twice | 12 months | ||||||||||
Number of positions eliminated | employee | 95 | ||||||||||
Reduction in headcount, percentage | 70.00% | ||||||||||
Payments for merger related costs | $ 250,000 | ||||||||||
Mr. Schoenfelder | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Severance costs | $ 708,000 | ||||||||||
Mr. Schaeffer | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Severance costs | $ 403,200,000 | ||||||||||
Mr. Jones | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Severance costs | $ 406,250,000 | ||||||||||
Post-termination exercise (in shares) | shares | 50,000 | ||||||||||
Term Loan Due 2029 | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Debt instrument, face amount | $ 6,000,000 | ||||||||||
Interest rate | Rate | 6.00% | ||||||||||
Minimum liquidity ratio | 4.00 | ||||||||||
Prior Loan Agreement | Term Loan | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Debt assumed | $ 6,900,000 | ||||||||||
New Headquarters | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Area of real estate property for lease | ft² | 13 | 49 | |||||||||
Operating lease liabilities | $ 2,100,000 | ||||||||||
Weighted average remaining lease term | 5 years | ||||||||||
Honest Day’s Work, Inc. | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Business combination, consideration transferred | $ 22,000,000 | ||||||||||
Shares issued (in shares) | shares | 29,000,000 | ||||||||||
Share price (in dollars per share) | $ / shares | $ 0.76 | ||||||||||
Cash consideration paid | $ 20,000.00 | ||||||||||
Cash acquired | $ 8,000,000 | ||||||||||
Number of team members joined | employee | 35 | ||||||||||
Volume weighted average price, period | 60 days | ||||||||||
Restricted stock, repurchase rights, denominator | 1,825 | ||||||||||
Repurchase rights, percentage | 40.00% | ||||||||||
Registration rights, offering price minimum | $ 25,000,000 | ||||||||||
Honest Day’s Work, Inc. | Promissory Note | |||||||||||
Subsequent Event [Line Items] | |||||||||||
Note payable, interest rate | 10.00% | ||||||||||
Repayments of notes payable | $ 23,900,000 |
SUBSEQUENT EVENTS - Consideration Shares Threshold (Details) - Subsequent Event - Honest Day’s Work, Inc. |
May 15, 2023
$ / shares
|
---|---|
Subsequent Event [Line Items] | |
Share price threshold one (in usd per share) | $ 2.00 |
Share price threshold two (in usd per share) | 3.00 |
Share price threshold three (in usd per share) | 4.00 |
Share price threshold four (in usd per share) | $ 5.00 |
Share consideration released percent threshold one | 25.00% |
Share consideration released percent threshold two | 25.00% |
Share consideration released percent threshold three | 25.00% |
Share consideration released percent threshold four | 25.00% |
SUBSEQUENT EVENTS - Compensation Program and Executive Officer Appointment (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Sep. 13, 2024 |
Aug. 11, 2024 |
Jun. 30, 2022 |
|
Subsequent Event [Line Items] | |||
Options granted (in shares) | 0 | ||
Subsequent Event | |||
Subsequent Event [Line Items] | |||
Volume weighted average price, period | 60 days | ||
Performance period | 7 years | ||
Vesting period | 3 years | ||
Options granted (in shares) | 8,600,000 | ||
Options granted (in dollars per share) | $ 0.48 | ||
Subsequent Event | Mr. Siminoff | |||
Subsequent Event [Line Items] | |||
Annual contributions per employee, amount | $ 1,550 | ||
Number of shares authorized (in shares) | 8,000,000 | ||
Subsequent Event | Mr. Lillis | |||
Subsequent Event [Line Items] | |||
Annual contributions per employee, amount | $ 475 | ||
Number of shares authorized (in shares) | 3,000,000 | ||
Subsequent Event | Mr. Mitura | |||
Subsequent Event [Line Items] | |||
Annual contributions per employee, amount | $ 650 | ||
Number of shares authorized (in shares) | 7,500,000 | ||
Subsequent Event | Share-Based Payment Arrangement, Tranche One | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | $ 4.00 | ||
Vesting percentage | 33.33% | ||
Subsequent Event | Share-Based Payment Arrangement, Tranche Two | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | $ 5.00 | ||
Vesting percentage | 33.33% | ||
Subsequent Event | Share-Based Payment Arrangement, Tranche Three | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | $ 6.00 | ||
Vesting percentage | 33.34% | ||
Subsequent Event | Share-Based Payment Arrangement, Attainment of Stock Price Hurdle | |||
Subsequent Event [Line Items] | |||
Vesting percentage | 25.00% | ||
Subsequent Event | Share-Based Payment Arrangement, Vest Equally In Three Annual Installments | |||
Subsequent Event [Line Items] | |||
Vesting percentage | 75.00% | ||
Subsequent Event | PSUs | |||
Subsequent Event [Line Items] | |||
Percentage of grant | 50.00% | ||
Vesting period | 3 years | ||
Subsequent Event | PSUs | Share-Based Payment Arrangement, Tranche One | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | $ 1 | ||
Subsequent Event | PSUs | Share-Based Payment Arrangement, Tranche Two | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | 2 | ||
Subsequent Event | PSUs | Share-Based Payment Arrangement, Tranche Three | |||
Subsequent Event [Line Items] | |||
Stock price hurdle (in dollars per share) | $ 3 | ||
Subsequent Event | Performance Options | |||
Subsequent Event [Line Items] | |||
Percentage of grant | 50.00% | ||
Vesting period | 3 years | ||
Exercise price (in dollars per share) | $ 0.41 | ||
Expiration period | 10 years | ||
Subsequent Event | Performance Options | Share-Based Payment Arrangement, Tranche One | |||
Subsequent Event [Line Items] | |||
Vesting period | 4 years | ||
Stock price hurdle (in dollars per share) | $ 4 | ||
Subsequent Event | Performance Options | Share-Based Payment Arrangement, Tranche Two | |||
Subsequent Event [Line Items] | |||
Vesting period | 4 years | ||
Stock price hurdle (in dollars per share) | $ 5 | ||
Subsequent Event | Performance Options | Share-Based Payment Arrangement, Tranche Three | |||
Subsequent Event [Line Items] | |||
Vesting period | 4 years | ||
Stock price hurdle (in dollars per share) | $ 6 |
SUBSEQUENT EVENTS - November 2024 Executive Transactions (Details) - Subsequent Event - USD ($) |
Nov. 18, 2024 |
Aug. 11, 2024 |
May 15, 2023 |
---|---|---|---|
Subsequent Event [Line Items] | |||
Volume weighted average price, period | 60 days | ||
Honest Day’s Work, Inc. | |||
Subsequent Event [Line Items] | |||
Shares issued (in shares) | 29,000,000 | ||
Volume weighted average price, period | 60 days | ||
Mr. Siminoff | |||
Subsequent Event [Line Items] | |||
Stock repurchased (in shares) | 15,260,540 | ||
Stock repurchased, price (in dollars per share) | $ 0.00005080 | ||
Stock repurchased | $ 775.24 | ||
Stock repurchased, percentage of business combination shares | 80.00% | ||
Restricted stock outstanding (in shares) | 3,815,135 | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | |||
Subsequent Event [Line Items] | |||
Restricted stock outstanding (in shares) | 2,861,351 | ||
Restricted stock, percentage | 75.00% | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | Restricted Stock, Tranche One | |||
Subsequent Event [Line Items] | |||
Restricted stock, percentage released from restriction | 20.00% | ||
Volume weighted average price, period | 60 days | ||
Threshold price for release from restriction (in dollars per share) | $ 1.00 | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | Restricted Stock, Tranche Two | |||
Subsequent Event [Line Items] | |||
Restricted stock, percentage released from restriction | 20.00% | ||
Threshold price for release from restriction (in dollars per share) | $ 2.00 | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | Restricted Stock, Tranche Three | |||
Subsequent Event [Line Items] | |||
Restricted stock, percentage released from restriction | 20.00% | ||
Threshold price for release from restriction (in dollars per share) | $ 3.00 | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | Restricted Stock, Tranche Four | |||
Subsequent Event [Line Items] | |||
Restricted stock, percentage released from restriction | 20.00% | ||
Threshold price for release from restriction (in dollars per share) | $ 4.00 | ||
Mr. Siminoff | Restricted Stock, Separation Shares Tranche | Restricted Stock, Tranche Five | |||
Subsequent Event [Line Items] | |||
Restricted stock, percentage released from restriction | 20.00% | ||
Threshold price for release from restriction (in dollars per share) | $ 5.00 | ||
Mr. Siminoff | Restricted Stock, Advisory Shares Tranche | |||
Subsequent Event [Line Items] | |||
Restricted stock outstanding (in shares) | 953,784 | ||
Restricted stock, percentage | 25.00% | ||
Restricted stock, termination, numerator | 1 | ||
Restricted stock, termination, denominator | 730 | ||
Mr. Siminoff | Honest Day’s Work, Inc. | |||
Subsequent Event [Line Items] | |||
Shares issued (in shares) | 19,075,675 |
\C[4%%LKV&E[(#'"(DU&29D^%)5D,%XSNZ9O18"@0@1C \'3@DM
M2#G56=T4CT(GB=BI] =DZD.INVE$\>L08,8J*NA?7.;TS6M'AWP3"GAG:@O1
M7[(D>,OD,-L]$M8PRX]CSOA/?2>D'*D?^YS=WUUCS@X=)G1\*_\[.\;9L2D7
M1S@MIMN.AY!ZKKS69!KY_FRN_-($7=,@';)E2:H>^6+BJ6P:KL+0Y-#\))XK
MES,!E;DR;Q.92)-#DY0*TVDSF9A*+C"^
M&\K7(F3TKKM[' 2'4.+A,^M\PR*7>*WHMTGDDAA+L1\Z)Q(UWL;%1/ %)SQY
M@#98G;[0O3XT'0233R(+V7)B0:$>!XG4X&22HD&F.ZBQQ5J2D+P+;J)16A\;
M)G4>_Q3NP"92N<&@?M<2X4\"4J]!QI*RZZWM2(6/Z)R.2 E1%"^<42 1]+1W
M#LM "R-!B?W0Q##T0R)2CW.2T@$S
^CQPPGM<94@)E08J9=?M